10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2025

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For transition period from to

Commission File Number: 001-39773

Hydrofarm Holdings Group, Inc.

(Exact name of registrant as specified in its charter)

Former Name or Former Address, if changed since last report: Not Applicable

Delaware	81-4895761
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification Number)

1510 Main Street

Shoemakersville, Pennsylvania 19555

(707) 765-9990

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, $0.0001 par value per share	HYFM	Nasdaq Stock Market LLC

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☐ No ☒

As of May 5, 2025, the registrant had 4,642,957 shares of common stock, $0.0001 par value per share, outstanding.

EXPLANATORY NOTE REGARDING REVERSE STOCK SPLIT

On February 12, 2025, Hydrofarm Holdings Group, Inc. (“Hydrofarm Holdings”) filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, as amended (the “Charter Amendment”), with the Secretary of State of the State of Delaware to effect a 1-for-10 reverse stock split (the “Reverse Stock Split”) of Hydrofarm Holdings’ common stock, par value $0.0001 per share (the “Common Stock”), effective February 12, 2025 at 5:00 p.m., Eastern Time (the “Effective Time”) and Hydrofarm Holdings’ shares of Common Stock began trading on a split-adjusted basis on The Nasdaq Capital Market at the commencement of trading on February 13, 2025, under Hydrofarm Holdings’ existing trading symbol “HYFM”. The new CUSIP number for the Common Stock following the Reverse Stock Split is 44888K407.

As previously reported, the Reverse Stock Split was approved by Hydrofarm Holdings’ stockholders at Hydrofarm Holdings’ annual meeting of stockholders held on June 6, 2024, at a ratio ranging from any whole number between 1-for-1.1 and 1-for-25, as determined by Hydrofarm Holdings’ board of directors in its discretion. On February 6, 2025, the board of directors approved a ratio of 1-for-10 for the Reverse Stock Split.

The Charter Amendment provides that at the Effective Time, every 10 shares of Hydrofarm Holdings’ issued and outstanding shares of Common Stock immediately prior to the Effective Time, were automatically converted, without any action on the part of the holder thereof, into one share of Common Stock. The number of authorized shares of Common Stock and the par value of each share of Common Stock remained unchanged. No fractional shares were issued as a result of the Reverse Stock Split. Stockholders who otherwise would have been entitled to receive a fractional share in connection with the Reverse Stock Split received a cash payment in lieu thereof.

The Company has adjusted the presentation of all periods covered by the condensed consolidated financial statements contained herein to give retroactive effect to the Reverse Stock Split, including adjustments to net loss per share and other per share of Common Stock amounts.

TABLE OF CONTENTS

		Page
Part I - Financial Information
Item 1.	Financial Statements	1
	Condensed Consolidated Balance Sheets	1
	Condensed Consolidated Statements of Operations	2
	Condensed Consolidated Statements of Comprehensive Loss	3
	Condensed Consolidated Statements of Changes in Stockholders' Equity	4
	Condensed Consolidated Statements of Cash Flows	5
	Notes to the Condensed Consolidated Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	30
Item 4.	Controls and Procedures	31
Part II - Other Information
Item 1.	Legal Proceedings	32
Item 1A.	Risk Factors	32
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	32
Item 3.	Defaults Upon Senior Securities	32
Item 4.	Mine Safety Disclosures	32
Item 5.	Other Information	32
Item 6.	Exhibits	33
	Signatures	35

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this Quarterly Report on Form 10-Q other than statements of historical fact, including statements concerning our business strategy and plans, future operating results and financial position, as well as our objectives and expectations for our future operations, are forward-looking statements.

In some cases, you can identify forward-looking statements by such terminology as “believe,” “may,” “will,” “potentially,” “estimate,” “continue,” “anticipate,” “intend,” “could,” “would,” “project,” “plan,” “expect” and similar expressions that convey uncertainty of future events or outcomes, although not all forward-looking statements contain these words. Forward-looking statements include, but are not limited to, statements about:

•industry conditions, including oversupply and decreasing prices of our customers' products which, in turn, have materially adversely impacted our sales and other results of operations and which may continue to do so in the future;

•potential tariffs or interruptions to global trade;

•the potential for future charges associated with the impairment of our long-lived assets, inventory allowances and purchase commitment losses, and accounts receivable reserves;

•our liquidity;

•our ability to meet the continued listing standards of The Nasdaq Capital Market ("Nasdaq");

•the anticipated impact of our restructuring activities on our expenses and cash expenditures;

•potential dilution that may result from equity financings while our stock prices are depressed;

•the conditions impacting our customers, including related crop prices and other factors impacting growers;

•the adverse effects of public health epidemics, including the COVID-19 pandemic, on our business, results of operations and financial condition;

•interruptions in our supply chain;

•federal and state legislation and regulations pertaining to agricultural products and the use and cultivation of cannabis in the United States and Canada;

•public perceptions and acceptance of cannabis use;

•fluctuations in the price of various crops and other factors affecting growers;

•the results of our acquisitions, dispositions and strategic alliances;

•our long-term non-cancellable leases under which many of our facilities operate, and our ability to renew or terminate our leases;

•our reliance on, and relationships with, a limited base of key suppliers for certain products;

•our ability to keep pace with technological advances;

•our ability to execute our e-commerce business;

•the costs of being a public company;

•our ability to successfully identify appropriate acquisition targets, successfully acquire identified targets or successfully integrate the business of acquired companies;

•the success of our marketing activities;

•the potential for a disruption or breach of our information technology systems or cyber-attack;

•our current level of indebtedness;

•our dependence on third parties, or the performance of third parties on which we depend;

•any change to our reputation or to the reputation of our products;

•the fluctuation in the prices of the products we distribute;

•competitive industry pressures;

•the consolidation of businesses within our industry;

•compliance with environmental, health and safety laws;

•our ability to protect and defend against litigation, including claims related to intellectual property rights;

•product shortages and relationships with key suppliers;

•our ability to attract and retain key employees;

•the volatility of the price of our common stock;

•the marketability of our common stock; and

•other risks and uncertainties, including those listed herein as well as under the heading “Risk Factors” in our Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 5, 2025 (the “2024 Annual Report”).

We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, results of operations, prospects, and financial needs. These forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q and are subject to a number of risks, uncertainties and assumptions described in the section titled “Risk Factors” and elsewhere in this Quarterly Report on Form 10-Q. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. We disclaim any intention or obligation to publicly update or revise any forward-looking statements for any reason or to conform such statements to actual results or revised expectations, except as required by law.

SPECIAL NOTE REGARDING USE OF TRADE NAMES AND TRADEMARKS

“Hydrofarm” and other trade names and trademarks of ours appearing in this Quarterly Report on Form 10-Q are our property. This Quarterly Report on Form 10-Q contains trade names and trademarks of other companies, which are the property of their respective owners. We do not intend our use or display of other companies’ trade names or trademarks to imply an endorsement or sponsorship of us by such companies, or any relationship with any of these companies.

SPECIAL NOTE REGARDING CERTAIN TERMINOLOGY IN THIS ANNUAL REPORT ON FORM 10-Q

Unless the context otherwise indicates, references in this Quarterly Report on Form 10-Q to the terms “Hydrofarm,” “the Company,” “we,” “our” and “us” refer to Hydrofarm Holdings Group, Inc. and its subsidiaries.

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

Hydrofarm Holdings Group, Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(In thousands, except share and per share amounts)

	March 31,		December 31,
	2025		2024
Assets
Current assets:
Cash and cash equivalents	$	13,728	$	26,111
Accounts receivable, net	20,919		14,756
Inventories	49,902		50,633
Prepaid expenses and other current assets	4,137		3,712
Total current assets	88,686		95,212
Property, plant and equipment, net	36,456		37,545
Operating lease right-of-use assets	40,863		42,869
Intangible assets, net	243,079		249,002
Other assets	1,473		1,476
Total assets	$	410,557	$	426,104
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$	16,092	$	12,279
Accrued expenses and other current liabilities	7,414		10,647
Deferred revenue	2,307		2,611
Current portion of operating lease liabilities	7,785		7,731
Current portion of finance lease liabilities	467		459
Current portion of long-term debt	5,876		1,260
Total current liabilities	39,941		34,987
Long-term operating lease liabilities	35,629		37,553
Long-term finance lease liabilities	7,711		7,830
Long-term debt	109,968		114,693
Deferred tax liabilities	3,047		3,047
Other long-term liabilities	4,316		4,272
Total liabilities	200,612		202,382
Commitments and contingencies (Note 14)
Stockholders’ equity
Common stock ($0.0001 par value; 300,000,000 shares authorized; 4,615,725 and 4,614,279 shares issued and outstanding at March 31, 2025, and December 31, 2024, respectively)	—		—
Additional paid-in capital	790,565		790,094
Accumulated other comprehensive loss	(8,774)		(8,911)
Accumulated deficit	(571,846)		(557,461)
Total stockholders’ equity	209,945		223,722
Total liabilities and stockholders’ equity	$	410,557	$	426,104

The accompanying notes are an integral part of the condensed consolidated financial statements.

1

Hydrofarm Holdings Group, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(In thousands, except share and per share amounts)

	Three months ended March 31,
	2025		2024
Net sales	$	40,534	$	54,172
Cost of goods sold	33,657		43,247
Gross profit	6,877		10,925
Operating expenses:
Selling, general and administrative	17,863		19,621
Loss from operations	(10,986)		(8,696)
Interest expense	(3,377)		(3,931)
Other income, net	60		215
Loss before tax	(14,303)		(12,412)
Income tax expense	(82)		(196)
Net loss	$	(14,385)	$	(12,608)
Net loss per share:
Basic	$	(3.12)	$	(2.75)
Diluted	$	(3.12)	$	(2.75)
Weighted-average shares of common stock outstanding:
Basic	4,614,510		4,581,221
Diluted	4,614,510		4,581,221

The accompanying notes are an integral part of the condensed consolidated financial statements.

2

Hydrofarm Holdings Group, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED)

(In thousands)

	Three months ended March 31,
	2025		2024
Net loss	$	(14,385)	$	(12,608)
Other comprehensive loss:
Foreign currency translation gain (loss)	137		(729)
Total comprehensive loss	$	(14,248)	$	(13,337)

The accompanying notes are an integral part of the condensed consolidated financial statements.

3

Hydrofarm Holdings Group, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED)

(In thousands, except for share amounts)

	Common Stock			Additional Paid-In Capital		Accumulated Other Comprehensive Loss		Accumulated Deficit		Total Stockholders’ Equity
	Shares	Amount
Balance, December 31, 2023	4,578,841	$	—	$	787,851	$	(6,497)	$	(490,744)	$	290,610
Issuance of common stock for vesting of stock awards	29,301	—		—		—		—		—
Shares repurchased for withholding tax on stock awards	(104,973)	—		(97)		—		—		(97)
Stock-based compensation expense	—	—		853		—		—		853
Net loss	—	—		—		—		(12,608)		(12,608)
Foreign currency translation loss	—	—		—		(729)		—		(729)
Balance, March 31, 2024	4,503,169	$	—	$	788,607	$	(7,226)	$	(503,352)	$	278,029
Balance, December 31, 2024	4,614,279	$	—	$	790,094	$	(8,911)	$	(557,461)	$	223,722
Issuance of common stock for vesting of stock awards	2,267	—		—		—		—		—
Shares repurchased for withholding tax on stock awards	(821)	—		(3)		—		—		(3)
Stock-based compensation expense	—	—		474		—		—		474
Net loss	—	—		—		—		(14,385)		(14,385)
Foreign currency translation gain	—	—		—		137		—		137
Balance, March 31, 2025	4,615,725	$	—	$	790,565	$	(8,774)	$	(571,846)	$	209,945

The accompanying notes are an integral part of the condensed consolidated financial statements.

4

Hydrofarm Holdings Group, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(In thousands)

	Three months ended March 31,
	2025		2024
Operating activities
Net loss	$	(14,385)	$	(12,608)
Adjustments to reconcile net loss to net cash from operating activities:
Depreciation, depletion and amortization	7,309		7,885
Provision for inventory obsolescence	312		568
Stock-based compensation expense	474		853
Non-cash operating lease expense	1,941		2,244
Other	905		43
Changes in assets and liabilities:
Accounts receivable	(6,768)		(5,715)
Inventories	413		2,156
Prepaid expenses and other current assets	(421)		442
Other assets	(37)		100
Accounts payable	3,831		2,892
Accrued expenses and other current liabilities	(3,221)		1,282
Deferred revenue	(304)		(370)
Lease liabilities	(1,812)		(1,976)
Other long-term liabilities	—		(93)
Net cash used in operating activities	(11,763)		(2,297)
Investing activities
Capital expenditures of property, plant and equipment	(244)		(1,442)
Other	(4)		34
Net cash used in investing activities	(248)		(1,408)
Financing activities
Borrowings under foreign revolving credit facilities	95		158
Repayments of foreign revolving credit facilities	(86)		(190)
Repayments of Term Loan	(307)		(1,974)
Payment of withholding tax related to stock awards	(3)		(97)
Finance lease principal payments	(112)		(255)
Net cash used in financing activities	(413)		(2,358)
Effect of exchange rate changes on cash and cash equivalents	41		(97)
Net decrease in cash and cash equivalents	(12,383)		(6,160)
Cash and cash equivalents at beginning of period	26,111		30,312
Cash and cash equivalents at end of period	$	13,728	$	24,152
Non-cash investing and financing activities
Right-of-use assets relinquished under operating lease obligations, net	$	(81)	$	—
Capital expenditures included in accounts payable and accrued liabilities	28		155
Supplemental information
Cash paid for interest	5,212		4,708
Cash paid for income taxes	110		5

The accompanying notes are an integral part of the condensed consolidated financial statements.

5

Hydrofarm Holdings Group, Inc.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(dollars in thousands, except share and per share amounts)

1. DESCRIPTION OF THE BUSINESS

Description of the business

Hydrofarm Holdings Group, Inc. (collectively with its subsidiaries, the “Company”) was formed in May 2017 under the laws of the state of Delaware to acquire and continue the business originally founded in 1977. The Company is a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture ("CEA"), including grow lights, climate control solutions, grow media and nutrients, as well as a broad portfolio of innovative, proprietary branded products. Products offered include agricultural lighting devices, indoor climate control equipment, nutrients, and plant additives used to grow, farm and cultivate cannabis, flowers, fruits, plants, vegetables, grains and herbs in controlled environment settings that allow end users to control key farming variables including temperature, humidity, CO2, light intensity and color, nutrient concentration and pH.

2. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the requirements of the SEC for interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP can be condensed or omitted. These condensed consolidated financial statements have been prepared on the same basis as the Company's annual consolidated financial statements and, in the opinion of management, reflect all normal and recurring adjustments which are necessary for the fair statement of the Company’s financial information. These interim results are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2025, or for any other interim period or for any other future year. All intercompany balances and transactions have been eliminated in consolidation.

The condensed consolidated balance sheet as of December 31, 2024, has been derived from the audited consolidated financial statements of the Company, which is included in the 2024 Annual Report. These condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto included in the 2024 Annual Report.

On February 12, 2025, the Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware to effect a 1-for-10 reverse stock split of the Company's common stock, effective February 12, 2025 at 5:00 p.m., Eastern Time and the Company's shares of common stock began trading on a split-adjusted basis on The Nasdaq Capital Market at the commencement of trading on February 13, 2025, under the Company's existing trading symbol “HYFM”. There was no adjustment to the number of authorized shares or the par value. The Company has adjusted the presentation of all periods covered by the condensed consolidated financial statements contained herein to give retroactive effect to the Reverse Stock Split, including adjustments to net loss per share and other per share of Common Stock amounts.

Use of estimates

The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Significant estimates include provisions for sales returns, rebates and claims from customers, realization of accounts receivable and inventories, fair value of assets acquired and liabilities assumed for business combinations, valuation of intangible assets, estimated useful lives of long-lived assets, incremental borrowing rate applied in lease accounting, valuation of stock-based compensation, recognition of deferred income taxes, classification of debt pursuant to certain terms in the Company's credit agreements, recognition of liabilities related to commitments and contingencies, asset retirement obligations ("AROs"), and valuation allowances. Actual results may differ from these estimates.

6

Hydrofarm Holdings Group, Inc.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(dollars in thousands, except share and per share amounts)

On an ongoing basis, the Company reviews its estimates to ensure that these estimates appropriately reflect changes in its business or new information available.

Segment and entity-wide information

Segment information

The Company's chief operating decision maker ("CODM") is the Chief Executive Officer who reviews financial information for the purposes of making operating decisions, assessing financial performance and allocating resources. The business is organized as one operating segment managed on a consolidated basis, and one reportable segment, which is the distribution and manufacture of CEA equipment and supplies.

For the purposes of making operating decisions, assessing financial performance and allocating resources, the CODM reviews financial statement metrics on a consolidated basis, including net sales, gross profit, selling. general and administrative expenses ("SG&A"), and net income (loss) as presented in the condensed consolidated statements of operations. Net income (loss) is the primary measure of profit or loss reviewed by the CODM. In addition, the CODM reviews consolidated total assets and significant components such as inventories, cash and other assets for the purposes of evaluating financial performance. Significant expense categories regularly reviewed by the CODM are comprised of cost of goods sold and SG&A. The other components of net income (loss) as disclosed in the statements of operations that are not significant segment expenses are loss on asset disposition, interest expense, other income, net, and income tax expense. Therefore, the Company is cross referencing to the U.S. GAAP financial statement measures as presented in the condensed consolidated statement of operations, in connection with adoption of ASU 2023-07. Since the Company operates as one reportable segment, all required segment financial information is found in the condensed consolidated financial statements and footnotes, and within the entity-wide disclosures presented below.

Entity-wide information

Net sales and property, plant and equipment, net and operating lease right-of-use assets in the United States and Canada, as determined by the location of the subsidiaries, are shown below. Other foreign locations, which are immaterial, individually and in the aggregate, are included in the United States below.

	Three months ended March 31,
	2025		2024
United States	$	32,277	$	40,455
Canada	9,022		14,425
Eliminations	(765)		(708)
Total consolidated net sales	$	40,534	$	54,172

	March 31, 2025		December 31, 2024
United States	$	48,558	$	50,928
Canada	28,761		29,513
Total property, plant and equipment, net and operating lease right-of-use assets	$	77,319	$	80,441

All of the products sold by the Company are similar and classified as CEA equipment and supplies.

Fair value measurements

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company has applied the framework for measuring fair value which requires a fair value hierarchy to be applied to all fair value measurements. All financial instruments recognized at fair value are classified into one of three levels in the fair value hierarchy as follows:

Level 1 — Valuation based on quoted prices (unadjusted) observed in active markets for identical assets or liabilities.

7

Hydrofarm Holdings Group, Inc.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(dollars in thousands, except share and per share amounts)

Level 2 — Valuation techniques based on inputs that are quoted prices of similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not in active markets; inputs other than quoted prices used in a valuation model that are observable for that instrument; and inputs that are derived from or, corroborated by, observable market data by correlation or other means.

Level 3 — Valuation techniques with significant unobservable market inputs.

The Company measures certain non-financial assets and liabilities, including long-lived assets and intangible assets at fair value on a nonrecurring basis.

Inventories

Inventories consist of finished goods, work-in-process, and raw materials used in manufacturing products. Inventories are stated at the lower of cost or net realizable value, principally determined by the first in, first out method of accounting. The Company maintains an allowance for excess and obsolete inventory. The estimate for excess and obsolete inventory is based upon assumptions about current and anticipated demand, customer preferences, business strategies, and market conditions. Management reviews these assumptions periodically to determine if any adjustments are needed to the allowance for excess and obsolete inventory. The establishment of an allowance for excess and obsolete inventory establishes a new cost basis in the inventory. Such allowance is not reduced until the product is sold or otherwise disposed. If inventory is sold, any related reserves would be reversed in the period of sale. During the year ended December 31, 2024, the Company estimated inventory markdowns relating to restructuring charges based upon current and anticipated demand, customer preferences, business strategies, and market conditions including management's actions with respect to inventory raw materials and products and brands being removed from the Company's portfolio.

Revenue recognition

The Company follows ASC 606 - Revenue from Contracts with Customers which requires that revenue recognized from contracts with customers be disaggregated into categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. The Company has determined that revenue is generated from one category, which is the distribution and manufacture of CEA equipment and supplies.

Revenue is recognized as control of promised goods is transferred to customers, which generally occurs upon receipt at customers’ locations determined by the specific terms of the contract. Arrangements generally have a single performance obligation and revenue is reported net of variable consideration which includes applicable volume rebates, cash discounts and sales returns and allowances. Variable consideration is estimated and recorded at the time of sale.

The amount billed to customers for shipping and handling costs included in net sales was $1,403 and $2,939 during the three months ended March 31, 2025 and 2024, respectively. Shipping and handling costs that occur before the customer obtains control of the goods are deemed to be fulfillment activities and are accounted for as fulfillment costs included in cost of goods sold. The Company does not receive noncash consideration for the sale of goods. Contract consideration received from a customer prior to revenue recognition is recorded as a contract liability and is recognized as revenue when the Company satisfies the related performance obligation under the terms of the contract. The Company's contract liabilities, which consist primarily of customer deposits reported within deferred revenue in the condensed consolidated balance sheets, totaled $2,307 and $2,611 as of March 31, 2025, and December 31, 2024, respectively. During the three months ended March 31, 2025, the Company recognized $657 of previously deferred revenue, recorded customer deposits of $589 and noted $236 of additional decreases primarily due to customer refunds. There are no significant financing components and the majority of revenue is recognized within one year. Excluded from revenue are any taxes assessed by governmental authorities, including value-added and other sales-related taxes that are imposed on and concurrent with revenue-generating activities.

Income taxes

The income tax provision is calculated for an interim period by distinguishing between elements recognized in the income tax provision through applying an estimated annual effective tax rate to a measure of year-to-date operating results referred to as “ordinary income (or loss),” and discretely recognizing specific events referred to as “discrete items” as they occur. The income tax provision or benefit for each interim period is the difference between the year-to-date amount for the current period and the year-to-date amount for the prior period.

8

Hydrofarm Holdings Group, Inc.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(dollars in thousands, except share and per share amounts)

Recent accounting pronouncements

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires greater disaggregation of information in the effective tax rate reconciliation, income taxes paid disaggregated by jurisdiction, and certain other amendments related to income tax disclosures. This guidance will be effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of this ASU on its consolidated financial statements.

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires a public entity to disclose additional information about specific expense categories in the notes to financial statements on an annual and interim basis. The amendments are effective for annual periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with early adoption permitted. A public entity should apply the amendments either prospectively to financial statements issued for reporting periods after the effective date of this ASU or retrospectively to any or all prior periods presented in the financial statements. The Company is currently evaluating the impact that adoption of this accounting standard will have on its financial disclosures.

3. RESTRUCTURING AND ASSET SALES

Restructuring

The Company began a restructuring plan (the "Restructuring Plan") in 2022, and undertook significant actions to streamline operations, reduce costs and improve efficiencies. The major initiatives of the first phase of the Restructuring Plan included (i) narrowing the Company's product and brand portfolio and (ii) the relocation and consolidation of certain manufacturing and distribution centers, including headcount reductions and reorganization to drive a solution based approach. The Company completed the first phase of the Restructuring Plan during the year ended December 31, 2023.

As a result of the continued adverse market conditions, the Company implemented a second phase of the Restructuring Plan beginning in the third quarter of 2023, including U.S. manufacturing facility consolidations, in particular with respect to production of certain durable equipment products. Restructuring activities included termination and disposal costs associated with inventory, facilities, and headcount reductions, and non-cash charges consisting of fixed asset and inventory write-downs.

During the three months ended March 31, 2024, the Company recorded pre-tax restructuring charges of $138 for the second phase, relating primarily to cash charges associated with the consolidation of U.S. manufacturing facilities. Of the $138 recorded charges, $91 was recorded within Cost of goods sold on the condensed consolidated statements of operations, while $47 was recorded within SG&A expenses on the condensed consolidated statements of operations.

During the three months ended March 31, 2025, the Company incurred approximately $362 of additional restructuring charges for the second phase, which were primarily cash charges and recorded in Cost of goods sold on the condensed consolidated statements of operations. Additionally, the remaining accrual balance of $103 as of December 31, 2024, was settled during the three months ended March 31, 2025, and there is no remaining accrual balance.

The second phase of the Restructuring Plan is complete as of March 31, 2025. Total costs incurred relating to this second phase of the Restructuring Plan, from its commencement in 2023 through completion, were (i) $9,737 of non-cash charges relating primarily to inventory markdowns, and (ii) $2,034 of cash charges relating primarily to the consolidation of U.S. manufacturing facilities.

The following tables present the activity in accrued expenses and other current liabilities for restructuring costs related to the second phase of the Restructuring Plan for the three months ended March 31, 2024:

9

Hydrofarm Holdings Group, Inc.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(dollars in thousands, except share and per share amounts)

	Three Months Ended March 31, 2024
Restructuring Accruals as of December 31, 2023	$	187
Expense	130
Cash Payments	(180)
Restructuring Accruals as of March 31, 2024	$	137

Refer to Item 2. Management’s Discussion And Analysis Of Financial Condition And Results of Operations – Market Conditions for further explanation of the Restructuring Plan. The amounts the Company will ultimately realize could differ from these estimates.

Asset Sales

On May 10, 2024, in connection with the Company's restructuring of its durable manufacturing operations, the Company entered into an agreement (the “Purchase Agreement”) with CM Fabrication, LLC (the “Buyer”) to sell assets relating to the production of Innovative Growers Equipment ("IGE") durable equipment products for $8,660 (the “Asset Sale”) and retain the proprietary brand and customer relationships. The Asset Sale closed on May 31, 2024, and the Company continues to sell its IGE branded durable products, including horticulture benches, racking and LED lighting systems. In connection with the transaction, the Company entered into an exclusive supply agreement with the Buyer to provide for contract manufacturing, which is expected to yield a more efficient cost model.

Assets and liabilities that were sold, disposed or terminated in connection with the Asset Sale included $11,616 of inventories, $3,721 of property, plant and equipment, $2,573 of technology intangible assets, and $90 of other net liabilities. The Company paid cash to terminate the facility operating lease for $1,275 and certain equipment finance leases for $668. The Company incurred an estimated $417 of transaction costs, including legal fees and other transaction-related expenses. The Company recorded a loss on asset disposition of $11,520 on the condensed consolidated statements of operations for the year ended December 31, 2024, which included the aforementioned assets and liabilities derecognized, and operating and finance lease termination payments. The Company estimated the amount of cash proceeds associated with the sale of inventories as $4,960 and property, plant and equipment as $3,700, and classified the amounts within net cash from operating activities and investing activities, respectively, on the condensed consolidated statements of cash flows for the year ended December 31, 2024.

Pursuant to requirements in the Company's Revolving Credit Facility (as defined below) consent was obtained from JPMorgan Chase Bank, N.A., as administrative agent to permit the Asset Sale. The net cash proceeds of approximately $6,300 from this transaction are subject to a provision whereby such net cash proceeds can be reinvested into certain investments, such as capital expenditures. Refer to Note 10 – Debt for further details.

The foregoing description of the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the Purchase Agreement, which was filed as Exhibit 10.23 to the 2024 Annual Report.

During the year ended December 31, 2024, the Company sold approximately 20 acres of the 140 acres of excess owned land at the Goshen, New York location. The sale price less costs to sell were consistent with the carrying value of the land, and therefore no gain or loss was recorded in the year ended December 31, 2024.

10

Hydrofarm Holdings Group, Inc.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(dollars in thousands, except share and per share amounts)

4. INTANGIBLE ASSETS, NET

Intangible assets, net comprised the following:

	March 31, 2025						December 31, 2024
	Gross Carrying Amount		Accumulated Amortization		Net Book Value		Gross Carrying Amount		Accumulated Amortization		Net Book Value
Finite-lived intangible assets:
Computer software	$	8,995	$	(8,688)	$	307	$	8,982	$	(8,625)	$	357
Customer relationships	99,806		(41,066)		58,740		99,806		(39,230)		60,576
Technology, formulations and recipes	110,381		(35,727)		74,654		110,381		(33,401)		76,980
Trade names and trademarks	131,492		(25,106)		106,386		131,492		(23,432)		108,060
Other	4,717		(4,526)		191		4,716		(4,488)		228
Total finite-lived intangible assets, net	355,391		(115,113)		240,278		355,377		(109,176)		246,201
Indefinite-lived intangible asset:
Trade name	2,801		—		2,801		2,801		—		2,801
Total Intangible assets, net	$	358,192	$	(115,113)	$	243,079	$	358,178	$	(109,176)	$	249,002

Amortization expense related to intangible assets was $5,933 and $6,084 for the three months ended March 31, 2025 and 2024, respectively.

The following are the estimated useful lives and the weighted-average amortization period remaining as of March 31, 2025, for the major classes of finite-lived intangible assets:

	Useful lives	Weighted-average amortization period remaining
Computer software	3 to 5 years	1 year
Customer relationships	7 to 18 years	9 years
Technology, formulations and recipes	8 to 12 years	8 years
Trade names and trademarks	15 to 20 years	16 years

The estimated aggregate future amortization expense for intangible assets subject to amortization as of March 31, 2025, is summarized below:

	Estimated Future Amortization Expense
For the period of April 1, 2025 to December 31, 2025	$	17,801
Year ending December 31,
2026	23,532
2027	23,359
2028	22,713
2029	21,582
2030	21,394
Thereafter	109,897
Total	$	240,278

11

Hydrofarm Holdings Group, Inc.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(dollars in thousands, except share and per share amounts)

5. LOSS PER COMMON SHARE

Basic loss per common share is computed using net loss divided by the weighted-average number of common shares outstanding during each period, excluding unvested restricted stock units (“RSUs”) and performance stock units ("PSUs").

Diluted loss per common share represents net loss divided by the weighted-average number of common shares outstanding during the period, including common stock equivalents. Common stock equivalents consist of shares subject to share-based awards with exercise prices less than the average market price of the Company’s common stock for the period, to the extent their inclusion would be dilutive.

The following table presents basic and diluted loss per common share for the three months ended March 31, 2025 and 2024:

	Three months ended March 31,
	2025		2024
Net loss	$	(14,385)	$	(12,608)
Weighted-average shares of common stock outstanding	4,614,510		4,581,221
Dilutive effect of share based compensation awards using the treasury stock method	—		—
Diluted weighted-average shares of common stock outstanding	4,614,510		4,581,221
Basic loss per common share	$	(3.12)	$	(2.75)
Diluted loss per common share	$	(3.12)	$	(2.75)

The computation of the weighted-average shares of common stock outstanding for diluted loss per common share excludes the following potential shares of common stock as their inclusion would have an anti-dilutive effect on diluted loss per common share:

	Three months ended March 31,
	2025	2024
Shares subject to unvested or deferred performance and restricted stock units	377,812	112,949
Shares subject to stock options outstanding	35,975	44,374

6. ACCOUNTS RECEIVABLE, NET, AND INVENTORIES

Accounts receivable, net comprised the following:

	March 31, 2025		December 31, 2024
Trade accounts receivable	$	20,309	$	14,112
Allowance for doubtful accounts	(621)		(706)
Other receivables	1,231		1,350
Total accounts receivable, net	$	20,919	$	14,756

12

Hydrofarm Holdings Group, Inc.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(dollars in thousands, except share and per share amounts)

The change in the allowance for doubtful accounts consisted of the following:

	Three months ended March 31,
	2025		2024
Beginning balance	$	(706)	$	(920)
Changes in estimates	(585)		(124)
Write-offs	712		229
Collections/Other	(42)		31
Ending balance	$	(621)	$	(784)

Inventories comprised the following:

	March 31, 2025		December 31, 2024
Finished goods	$	43,745	$	44,372
Work-in-process	962		1,137
Raw materials	11,863		12,398
Allowance for inventory obsolescence	(6,668)		(7,274)
Total inventories	$	49,902	$	50,633

Inventories are stated at the lower of cost or net realizable value, and the Company maintains an allowance for excess and obsolete inventory that is based upon assumptions about future demand and market conditions. The allowance for excess and obsolete inventory is subject to change from period to period based on a number of factors including sales of products, changes in estimates, and disposals.

7. LEASES

The Company leases its distribution centers and manufacturing facilities from third parties under various non-cancelable lease agreements expiring at various dates through 2038. Also, the Company leases some property, plant and equipment under finance leases. Certain leases contain escalation provisions and/or renewal options, giving the Company the right to extend the leases by up to 20 years. However, these options are generally not reflected in the calculation of the right-of-use assets and lease liabilities due to uncertainty surrounding the likelihood of renewal. The Company recognizes operating lease costs over the respective lease periods, including short-term and month-to-month leases. The Company incurred operating lease costs of $2,384 and $2,750 during the three months ended March 31, 2025 and 2024, respectively. These costs are included primarily within SG&A in the condensed consolidated statements of operations and do not include lease termination costs associated with the Asset Sale. Refer to Note 3 – Restructuring and Asset Sales for further details.

The Company has operating subleases and logistics agreements which have been accounted for by reference to the underlying asset subject to the lease, primarily as an offset to rent expense, primarily within SG&A. For the three months ended March 31, 2025 and 2024, the Company recorded sublease and logistics income of $1,188 and $738, respectively.

13

Hydrofarm Holdings Group, Inc.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(dollars in thousands, except share and per share amounts)

Total right-of-use ("ROU") assets, finance lease assets, and lease liabilities were as follows:

	Balance Sheet Classification	March 31, 2025		December 31, 2024
Lease assets
Operating lease assets	Operating lease right-of-use assets	$	40,863	$	42,869
Finance lease assets	Property, plant and equipment, net	7,091		7,279
Total lease assets		$	47,954	$	50,148
Lease liabilities
Current:
Operating leases	Current portion of operating lease liabilities	$	7,785	$	7,731
Finance leases	Current portion of finance lease liabilities	467		459
Noncurrent:
Operating leases	Long-term operating lease liabilities	35,629		37,553
Finance leases	Long-term finance lease liabilities	7,711		7,830
Total lease liabilities		$	51,592	$	53,573

The aggregate future minimum lease payments under long-term non-cancelable operating and finance leases with remaining terms greater than one year as of March 31, 2025 are as follows:

	Operating		Finance
For the period of April 1, 2025 to December 31, 2025	$	7,137	$	661
Year ending December 31,
2026	8,693		847
2027	8,781		850
2028	8,243		805
2029	5,374		822
2030	4,240		838
Thereafter	6,643		6,379
Total lease payments	49,111		11,202
Less portion representing interest	(5,697)		(3,024)
Total principal	43,414		8,178
Less current portion	(7,785)		(467)
Long-term portion	$	35,629	$	7,711

Subsequent event - Lease Renewal

In April 2025, Hydrofarm renewed the lease at its Edmonton, Canada peat moss harvesting facility. The lease has been extended by a term of seven years, through April 2033, with annual rent of $347 at the beginning of the renewal period, with annual fixed increases until the final year when annual rent is $419. The Company accounts for the lease as an operating lease.

14

Hydrofarm Holdings Group, Inc.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(dollars in thousands, except share and per share amounts)

8. PROPERTY, PLANT AND EQUIPMENT, NET

Property, plant and equipment, net comprised the following:

	March 31, 2025		December 31, 2024
Machinery and equipment	$	23,606	$	23,531
Peat bogs and related development	11,936		11,895
Building and improvements	10,327		10,313
Land	5,640		5,630
Furniture and fixtures	4,267		4,239
Computer equipment	3,160		3,152
Leasehold improvements	3,247		3,185
Gross property, plant and equipment	62,183		61,945
Less: accumulated depreciation	(25,727)		(24,400)
Total property, plant and equipment, net	$	36,456	$	37,545

Depreciation, depletion and amortization expense related to property, plant and equipment, net was $1,376 and $1,801 for the three months ended March 31, 2025 and 2024, respectively.

As of March 31, 2025, Land, Building and improvements, Computer equipment, and Machinery and equipment contain finance leases assets, recorded at cost of $9,801, less accumulated depreciation of $2,710. As of December 31, 2024, Land, Building and improvements, Computer equipment, and Machinery and equipment contain finance leases assets, recorded at cost of $9,823, less accumulated depreciation of $2,544.

The Company operates peat bogs in Alberta, Canada. Under current provincial laws the Company is subject to certain AROs and the remediation of the peat bog sites are under provincial oversight. The Company periodically evaluates expected remediation costs associated with the peat bog sites that it operates. When the Company concludes that it is probable that a liability has been incurred, a provision is made for management's estimate of the liability. As of March 31, 2025, and December 31, 2024, the Company had AROs of $274 and $284, respectively, recorded in Accrued expenses and other current liabilities on the condensed consolidated balance sheets. As of March 31, 2025, and December 31, 2024, the Company had AROs of $4,275 and $4,232, respectively, recorded in Other long-term liabilities on the condensed consolidated balance sheets.

The following table presents changes in asset retirement obligations for the following periods:

	Three months ended March 31,
	2025		2024
Balance, beginning of the period	$	4,516	$	5,216
Liabilities incurred in the period	—		—
Liabilities settled in the period	(10)		(224)
Accretion expense	37		46
Other	6		(110)
Balance, end of the period	$	4,549	$	4,928

15

Hydrofarm Holdings Group, Inc.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(dollars in thousands, except share and per share amounts)

9. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities comprised the following:

	March 31, 2025		December 31, 2024
Accrued compensation and benefits	$	2,448	$	1,987
Interest accrual	73		2,141
Freight, custom and duty accrual	1,007		1,130
Goods in transit accrual	711		574
Income tax accrual	229		127
Asset retirement obligations	274		284
Other accrued liabilities	2,672		4,404
Total accrued expenses and other current liabilities	$	7,414	$	10,647

10. DEBT

Debt is comprised of the following:

	March 31, 2025		December 31, 2024
Term Loan - Principal	$	118,995	$	119,303
Term Loan - unamortized discount and deferred financing costs	(3,258)		(3,443)
Term Loan - net of unamortized discount and deferred financing costs	115,737		115,860
Other	107		93
Total debt	$	115,844	$	115,953
Current portion of long-term debt	$	5,876	$	1,260
Long-term debt - net of unamortized discount and deferred financing costs of $3,258 and $3,443 as of March 31, 2025, and December 31, 2024, respectively	109,968		114,693
Total debt	$	115,844	$	115,953

Term Loan

On October 25, 2021, the Company and certain of its direct and indirect subsidiaries (the "Obligors") entered into a Credit and Guaranty Agreement with JPMorgan Chase Bank, N.A., as administrative agent for the lenders, pursuant to which the Company borrowed a $125,000 senior secured term loan (“Term Loan”). The Term Loan was amended by Amendment No. 1 to the Credit and Guaranty Agreement (“Amendment No. 1”) effective on June 27, 2023, to replace the London Interbank Offered Rate ("LIBOR") referenced rates with Secured Overnight Financing Rate ("SOFR") referenced rates. Pursuant to Amendment No. 1, any Term Loan that constitutes a Eurodollar Rate Loan that is outstanding as of the Amendment No. 1 closing date shall continue until the end of the applicable interest period for such Eurodollar Rate Loan and the provisions of the Term Loan applicable thereto shall continue and remain in effect (notwithstanding the occurrence of the Amendment No. 1 closing date) until the end of the applicable interest period for such Eurodollar Rate Loan, after which such provisions shall have no further force or effect. Such Eurodollar Rate Loan shall subsequently either be an ABR Loan or a Term Benchmark Loan. The ABR Loans shall bear interest at the Alternate Base Rate (with a 2.0% floor) plus 4.50%, and Term Benchmark Loans shall bear interest at the Adjusted Term SOFR Rate (with a 1.0% floor), plus 5.50%. The ABR Loan and Term Benchmark Loan credit spreads of 4.50% and 5.50%, respectively, within the Amendment No. 1 have not changed from the credit spreads in the original Term Loan. The foregoing description of Amendment No. 1 does not purport to be complete and is qualified in its entirety by reference to the provisions of Amendment No. 1, included as Exhibit 10.9 to the 2024 Annual Report. Capitalized terms referenced above are defined in the Term Loan.

16

Hydrofarm Holdings Group, Inc.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(dollars in thousands, except share and per share amounts)

The Term Loan was subject to a call premium of 1% if called prior to October 25, 2023, and 0% thereafter, and matures on October 25, 2028 ("Maturity Date"). Deferred financing costs are being amortized to interest expense over the term of the loan. For the three months ended March 31, 2025, the effective interest rate was 10.93% and interest expense was $3,214, which includes amortization of deferred financing costs and discount of $185.

The principal amounts of the Term Loan are required to be repaid in consecutive quarterly installments in amounts equal to 0.25% of the original principal amount of the Term Loan, reduced pro-rata by any additional payments made, on the last day of each fiscal quarter commencing March 31, 2022, with the balance of the Term Loan payable on the Maturity Date. The Company is also required to make mandatory prepayments in the event of (i) achieving certain excess cash flow criteria, including the achievement and maintenance of a specific leverage ratio, (ii) certain asset sales that are collateral, or (iii) upon the issuance, offering, or placement of new debt obligations.

As described in Note 3 – Restructuring and Asset Sales, the Company completed the Asset Sale for gross proceeds of $8,660 in May 2024. The net cash proceeds of approximately $6,300 from this transaction are subject to a provision whereby such net cash proceeds can be reinvested into certain investments, such as capital expenditures. This provision of the Term Loan includes (i) cash investments made within a one-year period from the Asset Sale, and (ii) investments which are contractually committed within one-year of the Asset Sale and paid within 180 days after entering into such contractual commitment. The amount of any net cash proceeds which are not reinvested would require the Company to make an offer to prepay the corresponding amount on the Term Loan in 2025. As of March 31, 2025, in accordance with this provision, the Company has estimated the total reinvestments and believe it is probable that an offer to prepay may be made in an estimated amount of $4,600. The amount the Company may offer to prepay is uncertain and based on future activity. The estimated amount has been classified as current debt on the condensed consolidated balance sheet. The foregoing description of the reinvestment provision does not purport to be complete and is qualified in its entirety by reference to the provisions of the Term Loan.

The Term Loan requires the Company to maintain certain reporting requirements, affirmative covenants, and negative covenants, and the Company was in compliance with all requirements as of March 31, 2025. The Term Loan is secured by a first lien on the non-working capital assets of the Company and a second lien on the working capital assets of the Company.

Revolving Credit Facility

On March 29, 2021, the Obligors entered into a Senior Secured Revolving Credit Facility (the "Revolving Credit Facility") with JPMorgan Chase Bank, N.A., as administrative agent, issuing bank and swingline lender, and the lenders from time to time party thereto. The Revolving Credit Facility is due on June 30, 2026, or any earlier date on which the revolving commitments are reduced to zero.

The Revolving Credit Facility originally had a borrowing limit of $50,000. On August 31, 2021, the Obligors entered into an amendment to the Revolving Credit Facility (the "First Amendment") to increase their original borrowing limit to $100,000. In connection with the First Amendment, the Company's previously acquired subsidiaries became party to the Revolving Credit Facility as either borrowers or as guarantors. On October 25, 2021, the Company and its subsidiaries entered into a second amendment to the Revolving Credit Facility (the “Second Amendment”), pursuant to which the parties consented to the Term Loan described above, and made certain conforming changes to comport with the Term Loan provisions. The Revolving Credit Facility was further amended by a third amendment and joinder to the Revolving Credit Facility dated August 23, 2022 (the “Third Amendment”), pursuant to which several previously acquired subsidiaries became parties to the Revolving Credit Facility and granted liens on their assets. On December 22, 2022, the Company entered into a fourth amendment to the Revolving Credit Facility (the “Fourth Amendment”), pursuant to which a sale-leaseback transaction was permitted, and certain other changes were made, including a reduction of the maximum commitment amount under the Revolving Credit Facility from $100,000 to $75,000 and transitioning the LIBOR based rates to SOFR based rates. On March 31, 2023, the Company and certain of its subsidiaries entered into a fifth amendment to the Revolving Credit Facility (the “Fifth Amendment”), pursuant to which the maturity date was extended to June 30, 2026, the maximum commitment amount under the Revolving Credit Facility was reduced to $55,000, and the interest rate on borrowings was revised to various spreads, based on the Company's fixed charge coverage ratio. On November 1, 2024, the Company and certain of its subsidiaries entered into a sixth amendment to the Revolving Credit Facility (the “Sixth Amendment”) which reduced the maximum commitment amount under the Revolving Credit Facility to $35,000.

17

Hydrofarm Holdings Group, Inc.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(dollars in thousands, except share and per share amounts)

The unamortized debt discount and deferred financing costs were $203 and $237 as of March 31, 2025, and December 31, 2024, respectively, and are included in other assets in the condensed consolidated balance sheets. Debt discount and deferred financing costs are being amortized to interest expense over the term of the Revolving Credit Facility.

The Revolving Credit Facility is an asset-based facility that is secured by a first priority lien on the working capital assets of the Company and a second priority lien on the non-working capital assets of the Company (including most of the Company’s subsidiaries). The borrowing base is based on a detailed monthly calculation of the sum of (a) a percentage of the Eligible Accounts at such time, plus (b) the lesser of (i) a percentage of the Eligible Inventory, at such time, valued at the lower of cost or market value, determined on a first-in-first-out basis, and (ii) the product of a percentage multiplied by the Net Orderly Liquidation Value percentage identified in the most recent inventory appraisal ordered by the Administrative Agent multiplied by the Eligible Inventory, valued at the lower of cost or market value, determined on a first-in-first-out basis, minus (c) Reserves (each of the defined terms above, as defined in the Revolving Credit Facility documents).

The Company is required to maintain certain reporting requirements, affirmative covenants and negative covenants, pursuant to terms outlined in the agreement. Additionally, if the Company’s Excess Availability is less than an amount equal to 10% of the Aggregate Revolving Commitment ($35,000 as of March 31, 2025), the Company will be required to maintain a minimum fixed charge coverage ratio of 1.1x on a rolling twelve-month basis until the Excess Availability is more than 10% of the Aggregate Revolving Commitment for thirty consecutive days (each of the defined terms above, as defined in the Revolving Credit Facility documents). In order to consummate permitted acquisitions or to make restricted payments, the Company would be required to comply with a higher fixed charge coverage ratio of 1.15x, but no such acquisitions or payments are currently contemplated. The Company received a consent from JPMorgan Chase Bank, N.A., as administrative agent, to permit the cash settlement of fractional shares in connection with the Reverse Stock Split, which is described further in Note 2 – Basis of Presentation and Significant Accounting Policies. As of March 31, 2025, the Company is in compliance with the covenants contained in the Revolving Credit Facility.

The Revolving Credit Facility provides for various interest rate options including the Adjusted Term SOFR Rate, the Adjusted REVSOFR30 Rate, the CB Floating Rate, the Adjusted Daily Simple SOFR, or the CBFR. The rates that use SOFR as the reference rate (Adjusted Term SOFR Rate, the Adjusted REVSOFR30 Rate, the Adjusted Daily Simple SOFR and the CBFR rate) use the Term SOFR Rate plus 1.95%. Each rate has a 0.0% floor. A fee of 0.40% per annum is charged for available but unused borrowings.

As of March 31, 2025, and December 31, 2024, the Company had zero borrowed under the facility. As of March 31, 2025, the Company would be able to borrow approximately $17 million under the Revolving Credit Facility, before the Company would be required to comply with the minimum fixed charge coverage ratio of 1.1x.

Other Debt

Other debt of $107 and $93 as of March 31, 2025, and December 31, 2024, respectively, was primarily comprised of a foreign subsidiary's other debt which constitutes an immaterial revolving line of credit and mortgage.

Aggregate future principal payments

As of March 31, 2025, the aggregate future principal payments under long-term debt are as follows:

	Debt
For the period of April 1, 2025 to December 31, 2025	$	5,563
Year ending December 31,
2026	1,249
2027	1,250
2028 and thereafter	111,040
Total	$	119,102

18

Hydrofarm Holdings Group, Inc.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(dollars in thousands, except share and per share amounts)

Subsequent event - Revolving Credit Facility 7th Amendment

On May 9, 2025, the Company and certain of its subsidiaries entered into a seventh amendment to the Revolving Credit Facility (the “Seventh Amendment”), pursuant to which the maturity date of the Revolving Credit Facility was extended from June 30, 2026 to June 30, 2027, the maximum commitment amount under the Revolving Credit Facility was reduced from $35,000 to $22,000, and certain other changes were made, including the addition of a $2,000 availability block, an increase of the cash dominion trigger from less than 10% of availability to less than 50% of availability and an increase of the fixed charge ratio trigger from less than 10% excess availability to less than 20% of excess availability. The foregoing description of the Seventh Amendment does not purport to be complete and is qualified in its entirety by reference to the Seventh Amendment, filed as Exhibit 10.3 to this Quarterly Report on Form 10-Q.

11. STOCKHOLDERS’ EQUITY

Common stock

Each holder of common stock is entitled to one vote for each share of common stock. Common stockholders have no pre-emptive rights to acquire additional shares of common stock or other securities. The common stock is not subject to redemption rights and carries no subscription or conversion rights. In the event of liquidation, the stockholders are entitled to share in corporate assets on a pro rata basis after the Company satisfies all liabilities and after provision is made for any class of capital stock having preference over the common stock. Subject to corporate regulations and preferences to preferred stock, if any, dividends are at the discretion of the board of directors. As of March 31, 2025, there were 4,615,725 shares outstanding and 300,000,000 shares authorized.

12. STOCK-BASED COMPENSATION

Stock-based compensation plan overview

The Company maintains three equity incentive plans: the 2018 Equity Incentive Plan (“2018 Plan”), the 2019 Employee, Director and Consultant Equity Incentive Plan (“2019 Plan”) and the 2020 Employee, Director, and Consultant Equity Incentive Plan (“2020 Plan” and collectively, “Incentive Plans”). The 2020 Plan serves as the successor to the 2019 Plan and 2018 Plan and provides for the issuance of incentive stock options ("ISOs"), nonqualified stock options, stock grants and stock-based awards to employees, directors, and consultants of the Company. No further awards will be issued under the 2018 Plan and 2019 Plan. As of March 31, 2025, a total of 309,377 shares were available for grant under the 2020 Plan.

The Incentive Plans are administered by the Company's board of directors. Notwithstanding the foregoing, the board of directors may delegate concurrent responsibility for administering each plan, including with respect to designated classes of persons eligible to receive an award under each plan, to a committee or committees (which term shall include subcommittees) consisting of one or more members of the board of directors (collectively, the “Plan Administrator”), subject to such limitations as the board of directors deem appropriate.

In November 2020, the board of directors and stockholders approved the 2020 Plan and reserved an aggregate of 2,284,053 shares of common stock for issuance under the 2020 Plan. Pursuant to the 2020 Plan, the number of shares available for issuance under the 2020 Plan may be increased on January 1 of each year, beginning on January 1, 2021, and ending on January 2, 2030, in an amount equal to the lesser of (i) 4% of the outstanding shares of the Company’s common stock on such date or (ii) such number of shares determined by the Plan Administrator.

The 2020 Plan provides for the grant of ISOs, nonqualified stock options, stock grants, and stock-based awards that are based in whole or in part by reference to the Company’s common stock.

•The Plan Administrator may grant options designated as ISOs or nonqualified stock options. Options shall be granted with an exercise price per share not less than 100% of the fair market value of the common stock on the grant date, subject to certain limitations and exceptions as described in the plan agreements. Generally, the maximum term of an

19

Hydrofarm Holdings Group, Inc.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(dollars in thousands, except share and per share amounts)

option shall be 10 years from the grant date. The Plan Administrator shall establish and set forth in each instrument that evidences an option the time at which, or the installments in which, the option shall vest and become exercisable.

•The Plan Administrator may grant stock grants and stock-based awards, including securities convertible into shares, stock appreciation rights, phantom stock awards or stock units on such terms and conditions which may be based on continuous service with the Company or a related company or the achievement of any performance goals, as the Plan Administrator shall determine in its sole discretion, which terms, conditions and restrictions shall be set forth in the instrument evidencing the award.

The tax benefits recognized in the condensed consolidated statements of operations for stock-based compensation arrangements for the three months ended March 31, 2025, and 2024, were not material to the financial statements.

Restricted Stock Unit Activity

RSUs granted to certain executives, employees and members of the board of directors expire 10 years after the grant date. The awards generally have a time-based vesting requirement (based on continuous employment). Upon vesting, the RSUs convert into shares of the Company's common stock. The stock-based compensation expense related to service-based awards is recorded over the requisite service period. During the three months ended March 31, 2025, the Company granted 91,618 RSU awards to certain executives and employees that are expected to vest with either one, two or three equal vesting tranches, annually on the anniversary of the grant date.

The following table summarizes the activity related to the Company's RSUs for the three months ended March 31, 2025. For purposes of this table, vested RSUs represent the shares for which the service condition had been fulfilled during the three months ended March 31, 2025:

	Number of RSUs	Weighted average grant date fair value
Balance, December 31, 2024	102,030	$	13.82
Granted	91,618	$	5.84
Vested	(2,267)	$	167.01
Forfeited	(34)	$	157.40
Balance, March 31, 2025	191,347	$	8.16

As of March 31, 2025, total unamortized stock-based compensation cost related to unvested RSUs was $800 and the weighted-average period over which the compensation is expected to be recognized is approximately one-year. For the three months ended March 31, 2025, the Company recognized $358 of total stock-based compensation expense for RSUs. As of March 31, 2025, there were 62,521 RSUs which had vested, but were not yet issued due to the recipients' elections.

Performance Stock Unit Activity

The Company granted 137,254 PSUs during the second quarter of 2024 that are subject to a one-year vesting requirement (based on continuous employment) and contain performance conditions based on certain performance metrics. The following table summarizes the activity related to the Company's PSUs for the three months ended March 31, 2025:

	Number of PSUs	Weighted average grant date fair value
Balance, December 31, 2024	125,783	$	9.89
Forfeited	(1,839)	$	9.89
Balance, March 31, 2025	123,944	$	9.89

During the three months ended March 31, 2025, the PSU forfeitures were due to employee terminations. The majority of the PSUs outstanding as of March 31, 2025, will be forfeited during the second quarter of 2025, as a result of not meeting

20

Hydrofarm Holdings Group, Inc.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(dollars in thousands, except share and per share amounts)

certain performance conditions. As of March 31, 2025, total unamortized stock-based compensation cost related to unvested PSUs was $6 and the weighted-average period over which the compensation is expected to be recognized is less than one-year. For the three months ended March 31, 2025, the Company recognized $116 of total stock-based compensation expense for PSUs.

Stock Options

The vesting of stock options is subject to certain change in control provisions as provided in the incentive plan agreements and stock options may be exercised up to 10 years from the date of issuance.

There were no stock options granted or exercised during the three months ended March 31, 2025. The following table summarizes the stock option activity for the three months ended March 31, 2025:

	Number	Weighted average exercise price		Weighted average grant date fair value		Weighted average remaining contractual term (years)
Outstanding and exercisable as of December 31, 2024	40,654	$	96.36	$	22.76	3.67
Cancelled	(4,679)	$	100.56	$	16.30
Outstanding and exercisable as of March 31, 2025	35,975	$	95.81	$	23.60	3.89

As of March 31, 2025, and December 31, 2024, there were no unvested stock awards, and no compensation cost related to options not yet recognized.

13. INCOME TAXES

The Company recorded income tax expense of $82 for the three months ended March 31, 2025, representing an effective tax rate of (0.6)%. The Company’s effective tax rate for the three months ended March 31, 2025, differs from the federal statutory rate of 21% primarily due to U.S. and foreign jurisdictions in full valuation allowance. The income tax expense for the three months ended March 31, 2025, was primarily due to foreign taxes in certain jurisdictions and U.S. state taxes.

The Company recorded income tax expense of $196 for the three months ended March 31, 2024, representing an effective tax rate of (1.6)%. The Company’s effective tax rate for the three months ended March 31, 2024, differs from the federal statutory rate of 21% primarily due to the Company maintaining a full valuation allowance against its net deferred tax assets in the U.S. and most foreign jurisdictions. The income tax expense for the three months ended March 31, 2024, was primarily due to U.S. state taxes and foreign taxes in certain jurisdictions.

14. COMMITMENTS AND CONTINGENCIES

Purchase commitments

From time to time in the normal course of business, the Company will enter into agreements with suppliers which provide favorable pricing in return for a commitment to purchase minimum amounts of inventory over a defined time period.

Contingencies

In the normal course of business, certain claims have been brought against the Company and, where applicable, its suppliers. While there is inherent difficulty in predicting the outcome of such matters, management has vigorously contested the validity of these claims. Based on available information, management does not expect that the outcome of any matters, individually or in the aggregate, would have a material adverse effect on the condensed consolidated financial position, results of operations, cash flows or future earnings of the Company.

21

Hydrofarm Holdings Group, Inc.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(dollars in thousands, except share and per share amounts)

15. FAIR VALUE MEASUREMENTS

Recurring and Nonrecurring

As described in Note 3 – Restructuring and Asset Sales, during 2024, the Company sold approximately 20 acres of the 140 acres of excess owned land at its Goshen, New York location. The Company measured the held-for-sale land asset at estimated fair value based on the agreement, which was considered a Level 2 fair value measurement. The land had a carrying value of $470, which was consistent with the estimated sale price less costs to sell, and therefore no estimated gain or loss was recorded during 2024. The transaction closed in the fourth quarter of 2024.

The Company did not have any other assets or liabilities that were remeasured to fair value on a recurring or nonrecurring basis during the periods presented.

Other Fair Value Measurements

The following table summarizes the fair value of the Company’s assets and liabilities which are provided for disclosure purposes:

		March 31, 2025		December 31, 2024
	Fair Value Hierarchy Level	Carrying Amount	Estimated Fair Value	Carrying Amount	Estimated Fair Value
Assets
Cash and cash equivalents	Level 1	13,728	13,728	26,111	26,111
Liabilities
Finance leases	Level 3	8,178	8,418	8,289	8,437
Term Loan	Level 2	118,995	95,196	119,303	95,442

Cash and cash equivalents included funds deposited in banks, and the fair values approximated carrying values due to their short-term maturities. The fair values of other current assets and liabilities including accounts receivable, accounts payable, accrued expenses and other current liabilities approximated their carrying value due to their short-term maturities.

The estimated fair value of finance leases, which were considered Level 3 fair value measurements, were calculated as the present value of the required future cash outflows discounted at an estimated borrowing rate. The fair value of the Term Loan was estimated based on Level 2 fair value measurements and was based on bank quotes. The carrying amount of the Term Loan reported above excludes unamortized debt discount and deferred financing costs. Refer to Note 7 – Leases and Note 10 – Debt, for further details of the Company's finance leases and Term Loan, respectively.

The Company did not have any transfers between Levels within the fair value hierarchy during the periods presented.

22

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis provides information that we believe is relevant to an assessment and understanding of our results of operations and financial condition. You should read this analysis in conjunction with our audited and unaudited consolidated financial statements and the notes contained elsewhere in this Quarterly Report on Form 10-Q and our 2024 Annual Report. This discussion and analysis contains statements of a forward-looking nature relating to future events or our future financial performance. Actual events or results may differ materially from forward-looking statements. In evaluating such statements, you should carefully consider the various factors identified in this Quarterly Report on Form 10-Q, which could cause actual results to differ materially from those expressed in, or implied by, any forward-looking statements, including those set forth in “Risk Factors” in our 2024 Annual Report. See “Special Note Regarding Forward-Looking Statements.”

Company Overview

We are a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture ("CEA"), including grow lights, climate control solutions, grow media and nutrients, as well as a broad portfolio of innovative, proprietary branded products. We primarily serve the U.S. and Canadian markets, and believe we are one of the leading companies in these markets in an otherwise fragmented industry. For over 40 years, we have helped growers make growing easier and more productive. Our mission is to empower growers, farmers and cultivators with products that enable greater quality, efficiency, consistency, and speed in their grow projects.

Hydroponics is the farming of plants using soilless grow media and often artificial lighting in a controlled indoor or greenhouse environment. Hydroponics is the primary category of CEA and we use the terms CEA and hydroponics interchangeably. Our products are used to grow, farm, and cultivate cannabis, flowers, fruits, plants, vegetables, grains and herbs in controlled environment settings that allow end users to control key farming variables including temperature, humidity, CO2, light intensity spectrum, nutrient concentration and pH. Through CEA, growers are able to be more efficient with physical space, water and resources, while enjoying year-round and more rapid grow cycles as well as more predictable and abundant grow yields, when compared to other traditional growing methods.

We reach commercial farmers and consumers through a broad and diversified network of over 2,000 wholesale customer accounts, who we connect with primarily through our proprietary online ordering platform. Our products are distributed across the United States and Canada through a diversified range of retailers of commercial and home gardening equipment and supplies. Our customers include specialty hydroponic retailers, commercial resellers and greenhouse builders, garden centers, hardware stores, and e-commerce retailers. Specialty hydroponic retailers can provide growers with specialized merchandise assortments and knowledgeable staff.

Market Conditions

We have experienced adverse financial results which we believe are primarily a result of an agricultural oversupply impacting our market and resulting in a decrease in indoor and outdoor cultivation. The extent these market conditions will continue to negatively impact our business and results of operations is uncertain and difficult to predict at this time. We believe COVID-19 may have provided a positive demand impact for the Company in 2020 and 2021 from shelter-in-place orders in the United States, a possible negative supply chain impact from workforce disruption at international and domestic suppliers, and a possible negative growth rate impact in the periods since due to agricultural oversupply initiated during the height of COVID-19 related shelter-in-place orders in 2020 and 2021. In addition, we believe demand for our products has been negatively impacted by the extended period to enact reform of U.S. federal regulations, including cannabis rescheduling, which have been slow to develop and possibly leading cannabis operators to reduce investments in our products, particularly durable goods. In addition, we believe our financial results have been negatively impacted by hydroponic retail store closings and, in some cases, associated accounts receivable allowances.

We are closely monitoring the recent tariff and trade policy actions changes taken by the United States and foreign governments. The situation remains fluid due to the rapidly changing global trade environment, and we are evaluating the potential implications of these actions on our business including net sales and profitability. High tariffs on imported products from China, or new tariffs from other countries, could impact the cost of certain products and may negatively impact the Company's 2025 financial performance. For additional information, see the risk factors in our 2024 Annual Report, including the risk entitled “Potential tariffs or a global trade war could increase the cost of our products, which could adversely impact the competitiveness of our products and our financial results.”

23

We began a Restructuring Plan in 2022, and undertook significant actions to streamline operations, reduce costs and improve efficiencies. The major initiatives of the first phase of the Restructuring Plan included (i) narrowing our product and brand portfolio and (ii) the relocation and consolidation of certain manufacturing and distribution centers, including headcount reductions and reorganization to drive a solution based approach. We completed the first phase of the Restructuring Plan during the year ended December 31, 2023.

As a result of the continued adverse market conditions, we implemented a second phase of the Restructuring Plan in 2023. The second phase is complete as of March 31, 2025 and it included U.S. manufacturing facility consolidations, in particular with respect to production of certain durable equipment products. Restructuring activities included termination and disposal costs associated with inventory, facilities, and headcount reductions, and non-cash charges consisting of fixed asset and inventory write-downs. Total costs incurred relating to this second phase of the Restructuring Plan, from its commencement in 2023 through March 31, 2025, were (i) $9.7 million of non-cash charges relating primarily to inventory markdowns, and (ii) $2.0 million of cash charges relating primarily to the consolidation of U.S. manufacturing facilities.

In 2024, we entered into the Purchase Agreement with the Buyer to sell the inventories, and property, plant and equipment associated with our IGE branded products for approximately $8.7 million, while retaining our proprietary brand and customer relationships. In connection with the Asset Sale, we entered into an exclusive supply agreement with the Buyer, pursuant to which the Buyer provides contract manufacturing and we continue to sell our proprietary branded durable products, which include horticulture benches, racking and LED lighting systems. After completion of the Asset Sale and the aforementioned restructuring actions, we have now consolidated our manufacturing operations into two U.S. locations and our peat moss harvesting and processing operation in Canada.

We continue to evaluate our product portfolio and supply chain, in order to improve efficiency, lower our costs and reduce footprint. We are also evaluating other opportunities to sell excess owned land to supplement our cash position and potential contract manufacturing or other outsourcing arrangements. Depending on the length and severity of the industry and market conditions, including the fluid and complex international tariff situation, impacting our business, it is possible we may execute additional restructuring plan actions.

Additionally, the amount we will ultimately realize as benefits associated with our Restructuring Plan could differ materially from our estimates, and we may incur additional non-cash charges in future periods depending on our ability to execute asset sales or pursue other alternatives. We may not be able to realize the full extent of anticipated cost savings if industry conditions persist and net sales volumes worsen.

Results of Operations—Comparison of three months ended March 31, 2025 and 2024

The following table sets forth our unaudited interim condensed consolidated statements of operations for the three months ended March 31, 2025, and 2024, including amounts and percentages of net sales for each period and the period-to-period change in dollars and percent (amounts in thousands):

	Three months ended March 31,
	2025				2024				Period change
Net sales	$	40,534	100.0	%	$	54,172	100.0	%	$	(13,638)	-25.2	%
Cost of goods sold	33,657		83.0	%	43,247		79.8	%	(9,590)		-22.2	%
Gross profit	6,877		17.0	%	10,925		20.2	%	(4,048)		-37.1	%
Operating expenses:
Selling, general and administrative	17,863		44.1	%	19,621		36.2	%	(1,758)		-9.0	%
Loss from operations	(10,986)		-27.1	%	(8,696)		-16.1	%	(2,290)		-26.3	%
Interest expense	(3,377)		-8.3	%	(3,931)		-7.3	%	(554)		-14.1	%
Other income, net	60		0.1	%	215		0.4	%	(155)		-72.1	%
Loss before tax	(14,303)		-35.3	%	(12,412)		-22.9	%	(1,891)		-15.2	%
Income tax expense	(82)		-0.2	%	(196)		-0.4	%	(114)		-58.2	%
Net loss	$	(14,385)	-35.5	%	$	(12,608)	-23.3	%	$	(1,777)	-14.1	%

24

Net sales

Net sales for the three months ended March 31, 2025, were $40.5 million, a decrease of $13.6 million, or 25.2% compared to the same period in 2024. The 25.2% decrease in net sales for the three months ended March 31, 2025, as compared to the same period in 2024, was primarily due to a 22.6% reduction in volume and mix of products sold and a 1.8% decrease in price. This decline was largely driven by the previously mentioned oversupply in the cannabis industry.

Gross profit

Gross profit for the three months ended March 31, 2025, was $6.9 million, a decrease of $4.0 million, or 37.1%, compared to the same period in 2024. Our gross profit margin percentage decreased to 17.0% for the three months ended March 31, 2025, from 20.2% in the same period in 2024. Gross profit and gross profit margin for the three months ended March 31, 2025, decreased as a result of lower net sales and due to selling a lower proportion of proprietary brand products.

Selling, general and administrative expenses

SG&A expenses for the three months ended March 31, 2025, were $17.9 million, a decrease of $1.8 million, or 9.0% compared to the same period in 2024. The decrease was due to lower expenses, primarily a result of our cost saving and restructuring initiatives, as follows: (i) a $1.3 million decrease in employee compensation costs, including stock-based compensation and salaries and benefits, and (ii) a $0.5 million decrease in facility costs.

Interest expense

Interest expense for the three months ended March 31, 2025, was $3.4 million, a decrease from $3.9 million of interest expense recorded in the same period in the prior year. The decrease for the three months ended March 31, 2025 was primarily due to lower debt outstanding due to principal repayments and lower variable interest rates on our Term Loan.

Other income, net

Other income, net for the three months ended March 31, 2025, was $0.1 million, a decrease compared to $0.2 million during the same period in the prior year. Other income, net for the three months ended March 31, 2025, was primarily driven by interest income.

Income taxes

We recorded income tax expense of $0.1 million for the three months ended March 31, 2025, representing an effective tax rate of (0.6)%. Our effective tax rate for the three months ended March 31, 2025, differs from the federal statutory rate of 21% primarily due to U.S. and foreign jurisdictions in full valuation allowance. The income tax expense for the three months ended March 31, 2025, was primarily due to foreign taxes in certain jurisdictions and U.S. state taxes.

We recorded income tax expense of $0.2 million for the three months ended March 31, 2024, representing an effective tax rate of (1.6)%. Our effective tax rate for the three months ended March 31, 2024, differs from the federal statutory rate of 21% primarily due to maintaining a full valuation allowance against our net deferred tax assets in the United States and most foreign jurisdictions. The income tax expense for the three months ended March 31, 2024, was primarily due to U.S. state taxes and foreign taxes in certain jurisdictions.

25

Liquidity and Capital Resources

Cash Flow from Operating, Investing, and Financing Activities

Comparison of the three months ended March 31, 2025, and March 31, 2024

The following table summarizes our cash flows for the three months ended March 31, 2025, and 2024 (amounts in thousands):

	Three months ended March 31,
	2025		2024
Net cash used in operating activities	$	(11,763)	$	(2,297)
Net cash used in investing activities	(248)		(1,408)
Net cash used in financing activities	(413)		(2,358)
Effect of exchange rate changes on cash and cash equivalents	41		(97)
Net decrease in cash and cash equivalents	(12,383)		(6,160)
Cash and cash equivalents at beginning of period	26,111		30,312
Cash and cash equivalents at end of period	$	13,728	$	24,152

Operating Activities

Net cash used in operating activities was $11.8 million for the three months ended March 31, 2025. The net cash usage was primarily due to a $14.4 million net loss and an $8.3 million net cash outflow from an increase in working capital, partially offset by net non-cash items of $10.9 million. The $8.3 million net increase in working capital was primarily comprised of a $6.8 million increase in accounts receivable, a $3.2 million decrease in accrued expenses and other current liabilities, and a $1.8 million decrease of lease liabilities, partially offset by a $3.8 million decrease in accounts payable. During the three months ended March 31, 2025, we paid $5.2 million in cash interest.

Net cash used in operating activities was $2.3 million for the three months ended March 31, 2024. Consistent with historical seasonal trends, we utilized cash from operating activities in the first quarter to fund our working capital. The $1.3 million net reduction in working capital was primarily driven by a $5.7 million increase of accounts receivable and a $2.0 million decrease of lease liabilities, partially offset by a $4.2 million increase of accounts payable and accrued expenses and other current liabilities and a $2.2 million decrease of inventory. During the three months ended March 31, 2024, we paid $4.7 million in cash interest.

Investing Activities

Net cash used in investing activities was $0.2 million for the three months ended March 31, 2025, compared to $1.4 million for the three months ended March 31, 2024. The net cash used in investing activities for both periods was primarily due to capital expenditures of property, plant and equipment.

Financing Activities

Net cash used in financing activities was $0.4 million for the three months ended March 31, 2025, primarily driven by (i) $0.3 million of Term Loan repayments relating to required quarterly payments of principal, and (ii) finance lease principal payments of $0.1 million.

Net cash used in financing activities was $2.4 million for the three months ended March 31, 2024, primarily driven by $2.0 million of Term Loan repayments relating to required quarterly payments of principal and prepayments made under the Term Loan's reinvestment provision from a sale-leaseback transaction that closed in January 2023.

Availability and Use of Cash

Our ability to make investments in our business, service our debt and maintain liquidity will primarily depend upon our ability to generate excess operating cash flows through our operating subsidiaries. We believe that our cash flows from operating activities, combined with current cash levels and borrowing availability under the Revolving Credit Facility, will be adequate to support our ongoing operations, to fund debt service requirements, capital expenditures, lease obligations and working capital needs through the next twelve months of operations. However, we cannot guarantee that our business will generate sufficient cash flow from operating activities or that future borrowings will be available under our borrowing agreements in amounts sufficient to pay indebtedness or fund other working capital needs. Actual results of operations will

26

depend on numerous factors, many of which are beyond our control as further discussed in Item 1A. Risk Factors included in this Quarterly Report on Form 10-Q and in our 2024 Annual Report.

As further described in Note 3 – Restructuring and Asset Sales and Note 10 – Debt, we closed on the Asset Sale, whereby, in accordance with our Term Loan, the net proceeds, approximately $6.3 million, are required to be reinvested into certain permitted investments, such as capital expenditures or permitted acquisitions/ investments, or offered to prepay Term Loan principal. As of March 31, 2025, in accordance with this provision, we have estimated the total reinvestments and believe it is probable that an offer to prepay may be made in an estimated amount of $4.6 million. The amount we may offer to prepay is uncertain and based on future activity. The estimated amount has been classified as current debt on our condensed consolidated balance sheet. Refer to further discussion below, relating to Term Loan reinvestment provisions regarding the net cash proceeds of the Asset Sale.

If necessary, we believe that we could supplement our cash position through additional asset sales or divestiture of one or more of our brands or lines of business. During 2024, we sold a portion of the excess owned land at our Goshen, New York location, and are evaluating other opportunities to sell excess owned land to supplement our cash position. We believe it is prudent to be prepared if required and, accordingly, continue to be engaged in the process of evaluating and preparing to implement one or more of the aforementioned activities. Any potential such event may be subject to provisions referenced in our Term Loan and Revolving Credit Facility, such as subjecting us to make mandatory prepayments.

Term Loan

On October 25, 2021, we and certain of our direct and indirect subsidiaries entered into the Term Loan with JPMorgan Chase Bank, N.A., as administrative agent for the lenders, pursuant to which we borrowed a $125 million senior secured term loan (the "Term Loan"). The Term Loan was amended by Amendment No. 1 effective as of June 27, 2023, to replace the LIBOR referenced rates with SOFR referenced rates. Pursuant to Amendment No. 1, any Term Loan that constitutes a Eurodollar Rate Loan that is outstanding as of the Amendment No. 1 closing date shall continue until the end of the applicable interest period for such Eurodollar Rate Loan and the provisions of the Term Loan applicable thereto shall continue and remain in effect (notwithstanding the occurrence of the Amendment No. 1 closing date) until the end of the applicable interest period for such Eurodollar Rate Loan, after which such provisions shall have had no further force or effect. Such Eurodollar Rate Loan shall subsequently either be an ABR Loan or a Term Benchmark Loan. The ABR Loans shall bear interest at the Alternate Base Rate (with a 2.0% floor) plus 4.50%, and Term Benchmark Loans shall bear interest at the Adjusted Term SOFR Rate (with a 1.0% floor) plus 5.50%. As of the date of filing this Quarterly Report on Form 10-Q, the ABR Loan and Term Benchmark Loan credit spreads of 4.50% and 5.50%, respectively, within the Amendment No. 1 have not changed from the credit spreads in the original Term Loan. The Term Loan matures on October 25, 2028.

The principal amounts of the Term Loan are scheduled to be repaid in consecutive quarterly installments in amounts equal to 0.25% of the original principal amount of the Term Loan on the last day of each fiscal quarter commencing March 31, 2022, with the balance of the Term Loan payable on the Maturity Date.

We are also required to make mandatory prepayments in the event of (i) achieving certain excess cash flow criteria, including the achievement and maintenance of a specific leverage ratio, (ii) certain asset sales that are collateral, or (iii) upon the issuance, offering, or placement of new debt obligations. As described in Note 3 – Restructuring and Asset Sales and Note 10 – Debt, we received net cash proceeds of approximately $6.3 million in May 2024 from the Asset Sale and are subject to a provision whereby such net cash proceeds can be reinvested into certain investments, such as capital expenditures. This provision of the Term Loan includes (i) cash investments made within a one-year period from the Asset Sale, and (ii) investments which are contractually committed within one-year of the Asset Sale, and paid within 180 days after entering into such contractual commitment. The amount of any net cash proceeds which are not reinvested would require us to make an offer to prepay the corresponding amount on the Term Loan in 2025. As of March 31, 2025, in accordance with this provision, we have estimated the total reinvestments and believe it is probable that an offer to prepay may be made in an estimated amount of $4.6 million. The amount we may offer to prepay is uncertain and based on future activity. The estimated amount has been classified as current debt on our condensed consolidated balance sheet. The foregoing description of the reinvestment provision does not purport to be complete and is qualified in its entirety by reference to the provisions of the Term Loan.

As of March 31, 2025, and December 31, 2024, the outstanding principal balance on the Term Loan was $119.0 million and $119.3 million, respectively.

The Term Loan requires us to maintain certain reporting requirements, affirmative covenants, and negative covenants. We were in compliance with all debt covenants as of March 31, 2025. The Term Loan is secured by a first lien on our non-working capital assets and a second lien on our working capital assets.

27

Revolving Credit Facility

On March 29, 2021, we and certain of our subsidiaries entered into the Revolving Credit Facility (the "Revolving Credit Facility") with JPMorgan Chase Bank, N.A., as administrative agent, issuing bank and swingline lender for a revolving line of credit up to $50 million. The Revolving Credit Facility was amended by the First Amendment dated August 31, 2021, which increased the revolving line of credit by an additional $50 million for an aggregate borrowing limit of $100 million. The Revolving Credit Facility was further amended by the Second Amendment dated October 25, 2021 which, among other things, permitted the incurrence of the Term Loan and made certain other changes including subordinating its liens on non-working capital assets to the obligations under the Term Loan. The Revolving Credit Facility was further amended by the Third Amendment and Joinder dated August 23, 2022, pursuant to which several previously acquired subsidiaries became parties to the Revolving Credit Facility and granted liens on their assets. On December 22, 2022, we entered into the Fourth Amendment to the Revolving Credit Facility pursuant to which a sale-leaseback transaction was permitted, and certain other changes were made, including a reduction of the maximum commitment amount under the Revolving Credit Facility from $100 million to $75 million and transitioning the LIBOR based rates to SOFR based rates. On March 31, 2023, we and certain of our subsidiaries entered into the Fifth Amendment to the Revolving Credit Facility, pursuant to which the maturity date was extended to June 30, 2026, the maximum commitment amount under the Revolving Credit Facility was reduced to $55 million, and the interest rate on borrowings was revised to various spreads, based on our fixed charge coverage ratio. On November 1, 2024, we and certain of our subsidiaries entered into the Sixth Amendment to the Revolving Credit Facility pursuant to which the maximum commitment amount was reduced to $35 million.

The Revolving Credit Facility provides for various interest rate options including the Adjusted Term SOFR Rate, the Adjusted REVSOFR30 Rate, the CB Floating Rate, the Adjusted Daily Simple SOFR, or the CBFR. The rates that use SOFR as the reference rate (Adjusted Term SOFR Rate, the Adjusted REVSOFR30 Rate, the Adjusted Daily Simple SOFR and the CBFR rate) use the Term SOFR Rate plus 1.95%. Each rate has a 0.0% floor. A fee of 0.40% per annum is charged for available but unused borrowings. Our obligations under the Revolving Credit Facility are secured by a first priority lien (subject to certain permitted liens) in substantially all of our and our subsidiaries' respective personal property assets pursuant to the terms of a U.S. and Canadian Pledge and Security Agreement dated March 29, 2021 and other security documents, as amended to include additional subsidiaries.

The Revolving Credit Facility maintains certain reporting requirements, affirmative covenants, negative covenants and financial covenants. A certain financial covenant becomes applicable in the event that our excess availability under the Revolving Credit Facility is less than an amount equal to 10% of the Aggregate Revolving Commitment ($35 million as of March 31, 2025) and would require us to maintain a minimum fixed charge coverage ratio of 1.1x on a rolling twelve-month basis.

In order to consummate permitted acquisitions or to make restricted payments, we would be required to comply with a higher fixed charge coverage ratio of 1.15x, but no such acquisitions or payments are currently contemplated. We received a consent from JPMorgan Chase Bank, N.A., as administrative agent, to permit the cash settlement of fractional shares in connection with the reverse stock split, which is described further in Note 2 – Basis of Presentation and Significant Accounting Policies.

We were in compliance with all debt covenants as of March 31, 2025. As of March 31, 2025, approximately $17 million was available to borrow under the Revolving Credit Facility, before we would be required to comply with the minimum fixed charge coverage ratio of 1.1x.

As of March 31, 2025, and December 31, 2024, we had zero borrowed under the Revolving Credit Facility.

The aforementioned financing arrangements and other transactions are more fully described in the notes to the condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

Subsequent event - Revolving Credit Facility Seventh Amendment

On May 9, 2025, we entered into the Seventh Amendment to the Revolving Credit Facility, pursuant to which the maturity date of the Revolving Credit Facility was extended from June 30, 2026 to June 30, 2027, the maximum commitment amount under the Revolving Credit Facility was reduced from $35,000 to $22,000, and certain other changes were made, including the addition of a $2,000 availability block, an increase of the cash dominion trigger from less than 10% of availability to less than 50% of availability and an increase of the fixed charge ratio trigger from less than 10% excess availability to less than 20% of excess availability.

28

Cash and Cash Equivalents

The cash and cash equivalents balances of $13.7 million and $26.1 million at March 31, 2025, and December 31, 2024, respectively, included $8.3 million and $11.9 million, respectively, held by foreign subsidiaries.

Material Cash Requirements

Our estimated material cash requirements include (i) principal repayments and anticipated interest payments on our long-term debt, (ii) finance lease payments, (iii) operating lease payments, and (iv) balances subject to the Term Loan reinvestment provision, as well as other purchase obligations to support our operations. Variable rates on our Term Loan are subject to change as further described in Item 3. Quantitative and Qualitative Disclosures About Market Risk. Refer to Item 1. Financial Statements, Note 10 – Debt, Note 7 – Leases, and Note 14 – Commitments and Contingencies for details relating to our material cash requirements for debt, our leasing arrangements, including future maturities of our operating lease liabilities, and purchase obligations, respectively. From time to time in the normal course of business, we will enter into agreements with suppliers which provide favorable pricing in return for a commitment to purchase minimum amounts of inventory over a defined time period.

Critical Accounting Policies and Estimates

The preceding discussion and analysis of our consolidated results of operations and financial condition should be read in conjunction with our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q. Our critical accounting policies and estimates are identified in Management's Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7 of the 2024 Annual Report and include the discussion of estimates used in indefinite lived intangible assets, long-lived tangible and finite-lived intangible assets, and inventory valuation. Such accounting policies and estimates require significant judgments and assumptions to be used in the preparation of the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q, and actual results could differ materially from the amounts reported.

Recent Accounting Pronouncements

For information regarding recent accounting pronouncements, refer to Note 2 – Basis of Presentation and Significant Accounting Policies — Recent accounting pronouncements, to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

29

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Market risk is the risk of economic losses due to adverse changes in financial market prices and rates. Our primary market risk has been interest rate, foreign currency and inflation risk. We do not have material exposure to commodity risk.

Interest Rate Risk

We are exposed to interest rate risk through our variable rate debt. As of March 31, 2025, we had $119.0 million of Term Loan debt that is subject to variable interest rates that are based on SOFR or an alternate base rate. Refer to Item 1. Financial Statements, Note 10 – Debt for details relating to the debt. If the rates were to increase by 100 basis points from the rates in effect as of March 31, 2025, our interest expense on the variable-rate debt would increase by an average of $1.1 million annually. There are inherent limitations in the sensitivity analysis presented, primarily due to the assumptions that interest rate changes would be instantaneous, while SOFR changes regularly. We do not currently hedge our interest rate risks, but may determine to do so in the future.

Foreign Currency Risk

The functional currencies of our foreign subsidiary operations are predominantly in the Canadian dollar (“CAD”) and the Euro. For the purposes of presenting these condensed consolidated financial statements, the assets, and liabilities of subsidiaries with CAD or Euro functional currencies are translated into U.S. dollar ("USD") using exchange rates prevailing at the end of each reporting period. Income and expense items are translated at the average rate prevailing during the period with exchange differences impacting other comprehensive income (loss) in equity. Therefore, our results of operations and cash flows are subject to fluctuations due to changes in foreign currency exchange rates, principally the CAD. We are impacted by changes in foreign currency exchange rates when we sell product in currencies different from the currency in which costs were incurred. The functional currencies and our purchasing and sales activities primarily include USD, CAD and Euro. As these currencies fluctuate against each other, and other currencies, we are exposed to foreign currency exchange rate risk on sales, purchasing transactions, and labor. To date, we have not entered into any foreign currency exchange contracts and currently do not expect to enter into foreign currency exchange contracts for trading or speculative purposes.

Inflation Risk

Our results of operations and financial condition are presented based on historical costs. We cannot provide assurances that our results of operations and financial condition will not be materially impacted by inflation in the future.

30

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation and supervision of our Chief Executive Officer and our Chief Financial Officer, have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based upon that evaluation, the Company's management, including the Chief Executive Officer and the Chief Financial Officer, concluded that the Company’s disclosure controls and procedures were effective as of the end of the period covered by this Quarterly Report on Form 10-Q.

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost benefit relationship of possible controls and procedures.

Changes in Internal Controls over Financial Reporting

There were no changes in our internal controls over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during the periods covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

31

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

From time to time, we may become involved in various lawsuits and legal proceedings, which arise, in the ordinary course of business. We are currently not aware of any legal proceedings or claims that we believe will have a material adverse effect on our business, financial condition or operating results.

ITEM 1A. RISK FACTORS

For a discussion of risk factors, please read Item 1A, Risk Factors in our 2024 Annual Report. Such risk factors continue to be relevant to an understanding of our business, financial condition and operating results. As of the date of this Quarterly Report on Form 10-Q, there have been no material changes from the risk factors reported in our 2024 Annual Report.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

(a)    On May 9, 2025, the Company and certain of its subsidiaries entered into a seventh amendment to the Revolving Credit Facility (the “Seventh Amendment”), pursuant to which the maturity date of the Revolving Credit Facility was extended from June 30, 2026 to June 30, 2027, the maximum commitment amount under the Revolving Credit Facility was reduced from $35,000 to $22,000, and certain other changes were made, including the addition of a $2,000 availability block, an increase of the cash dominion trigger from less than 10% of availability to less than 50% of availability and an increase of the fixed charge ratio trigger from less than 10% excess availability to less than 20% of excess availability. The foregoing description of the Seventh Amendment does not purport to be complete and is qualified in its entirety by reference to the Seventh Amendment, filed as Exhibit 10.3 to this Quarterly Report on Form 10-Q.

(b)    Not applicable.

(c)    During the quarter ended March 31, 2025, no director or officer of the Company adopted, modified or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” as such term is defined in Item 408(a) of Regulation S-K.

32

ITEM 6. EXHIBITS

(a)Exhibits.

Exhibit	Description
3.1	Amended and Restated Certificate of Incorporation of Hydrofarm Holdings Group, Inc. (incorporated by reference to the Company’s Registration Statement on Form S-1 (File No. 333-250037), filed with the SEC on November 12, 2020).
3.2	Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Hydrofarm Holdings Group, Inc. (incorporated by reference to the Company’s Registration Statement on Form S-1/A (File No. 333-250037), filed with the SEC on December 1, 2020).
3.3	Certificate of Designations, Preferences and Rights of the Series A Convertible Preferred Stock of Hydrofarm Holdings Group, Inc. (incorporated by reference to the Company’s Registration Statement on Form S-1 (File No. 333-250037), filed with the SEC on November 12, 2020).
3.4	Certificate of Amendment to Amended and Restated Certificate of Incorporation of Hydrofarm Holdings Group, Inc. dated February 12, 2025 (incorporated by reference to Exhibit 3.1 of the Company’s Form 8-K filed with the SEC on February 18, 2025).
3.5	Amended and Restated Bylaws (incorporated by reference to the Company’s Registration Statement on Form S-1/A (File No. 333-250037), filed with the SEC on December 1, 2020).
10.1	Amendment to Offer Letter dated April 14, 2025 by and between Hydrofarm Holdings Group, Inc. and B. John Lindeman (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed with the SEC on April 17, 2025).
10.2*x†	Offer Letter dated March 1, 2022 by and between Hydrofarm Holdings Group Inc. and Mark Parker.
10.3*	Seventh Amendment to Credit Agreement and Limited Consent and Waiver, dated May 9, 2025 by and among Hydrofarm Holdings Group, Inc., Hydrofarm, LLC, Field 16, LLC, Aurora Innovations, LLC, Innovative Growers Equipment, Inc., Manufacturing & Supply Chain Services, Inc., Hydrofarm Investment Corp., Hydrofarm Holdings LLC, EHH Holdings, LLC, Sunblaster LLC, Hydrofarm Canada, LLC, Sunblaster Holdings ULC, Eddi’s Wholesale Garden Supplies Ltd., House & Garden Holdings, LLC, Aurora International, LLC, Aurora Peat Products ULC, Greenstar Plant Products Inc., Innovative Ag Installation, Inc., Innovative Racking Systems, Inc., Innovative Shipping Solutions, Inc., Innovative Growers Equipment Canada, Inc., JPMorgan Chase Bank, N.A. and JPMorgan Chase Bank, N.A.
31.1*	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1#	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2#	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101. INS	Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH	Inline XBRL Taxonomy Schema Linkbase Document.
101.CAL	Inline XBRL Taxonomy Calculation Linkbase Document.
101.DEF	Inline XBRL Taxonomy Definition Linkbase Document.
101.LAB	Inline XBRL Taxonomy Labels Linkbase Document.
101.PRE	Inline XBRL Taxonomy Presentation Linkbase Document.
104	Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

*    Filed herewith.

x    Denotes management contract or compensatory plan or arrangement.

+    In accordance with Item 601(b)(10)(iv) of Regulation S-K, certain information (indicated by “***”) has been excluded from this exhibit because it is both not material and private or confidential. A copy of the omitted portion will be furnished to the Securities and Exchange Commission upon request. Additionally, certain schedules and exhibits have been omitted from this filing pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule or exhibit will be furnished to the Securities and Exchange Commission upon request.

†    Certain confidential portions (indicated by brackets and asterisks) have been omitted from this exhibit.

33

#    The certifications attached as Exhibits 32.1 and 32.2 accompany this Quarterly Report on Form 10-Q pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed “filed” by the Company for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall they be deemed incorporated by reference into any filing of the registrant under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

34

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Quarterly Report on Form 10-Q to be signed on its behalf by the undersigned, thereunto duly authorized.

	Hydrofarm Holdings Group, Inc.
Date: May 13, 2025	/s/ B. John Lindeman
	B. John Lindeman
	Chief Executive Officer
	(Principal Executive Officer)

Date: May 13, 2025	/s/ Kevin O'Brien
	Kevin O'Brien
	Chief Financial Officer
	(Principal Financial Officer)

    

35

EX-10.2

March 1, 2022

Mark Smith Parker,

Dear Mark

We are pleased to inform your promotion to Executive Vice President of Sales and Business Development. This is an exempt position with an estimated annualized salary of $330,000.00 which will be paid in bi-weekly increments as earned and in accordance with the Company’s normal payroll procedures.

This promotion is effective with the Board of Directors approval, that was granted on February 25th. 2022. You will continue to be eligible to participate in the Company’s standard employee benefits (pursuant to the terms and conditions of the benefit plans and applicable policies) that are available to the Company’s employees from time to time.

Also, due to your extraordinary performance in the year of 2021, we are also granting an additional 5000 RSUs, at the grant price of $ 20.04/Unit, with 3 years vesting period under the 2020 HYFM Equity Plan.

For each calendar year, you will be eligible to earn an annual short-term performance bonus of up to fifty percent (50%) of your base salary rate. The Annual Bonus will be based upon the Board’s assessment of your performance and the Company’s attainment of goals, including annual EBITDA versus target EBITDA and other factors that might be included per Board’s consideration. Bonus payments, if any, will be subject to applicable payroll deductions and withholdings. Following the close of each calendar year, the Board will determine whether you have earned an Annual Bonus, and the amount of any such bonus, based on the achievement of such goals. You must remain an active employee through the end of any given calendar year to earn an Annual Bonus for that year and any such bonus will be paid no later than March 15th of the year following the year in which your right to such amount became vested.

If, at any time, the Company terminates your employment without Cause (other than as a result of your death or disability), you resign for Good Reason, provided such termination or resignation constitutes a Separation from Service (as defined under Treasury Regulation Section 1.409A-1(h), without regard to any alternative definition thereunder, a “Separation from Service”), then you will receive , as cash severance, an amount equal to six (6) months of your base salary in effect as of your Separation from Service date . The Severance will be paid, less standard payroll deductions and tax withholdings, in a

(800) 634.9990 · Fax (707) 773.5955 · shanna@hydrofarm.com · www.hydrofarm.com

lump sum payment on or before the day that is sixty (60) days following your Separation from Service date.

As an additional Severance Benefit, if you timely (and properly) elect to continue your coverage under the Company’s group health plan pursuant to Code Section 4980B(f) (“COBRA”), the Company will reimburse you for (or will pay directly, in the discretion of the Company) the premium charged for such coverage until the earliest to occur of (i) the six (6) month anniversary of your Separation from Service date, (ii) the date on which you obtain health care coverage from another source (e.g., a new employer or spouse’s benefit plan), and (iii) the date on which you cease to be entitled to COBRA continuation coverage under the Company’s group health plan; provided, however, that the Company may unilaterally amend or eliminate the benefit provided to the extent it deems necessary to avoid imposition of excise taxes, penalties or similar charges on the Company or any of its Affiliates (or any of their respective successors), including, without limitation, under Code Section 4680D or 4980H. You must notify the Company within two (2) weeks if you obtain coverage from a new source.

Conditions to Receipt of Severance Benefits. Prior to and as a condition to your receipt of the Severance Benefits described above, you shall execute and deliver to the Company an effective release of claims in favor of the Company, within the timeframe set forth therein, but not later than forty-five (45) days following your Separation from Service date, and allow the Release to become effective according to its terms (by not invoking any legal right to revoke it) within any applicable time period set forth. Notwithstanding anything in this Agreement to the contrary, in no event will any Severance Benefits be paid prior to the first business day of the calendar year in which the Release Deadline occurs. The release agreement shall be provided to you at the time of your separation.

Clawback. You hereby acknowledge and agree that any payment hereunder will be subject to recovery by the Company pursuant to applicable law and any applicable Company compensation recovery policy as may be from time to time in effect.

Congratulation again for your promotion Mark.

Sincerely yours,

William Toler

CEO

(800) 634.9990 · Fax (707) 773.5955 · shanna@hydrofarm.com · www.hydrofarm.com

Please indicate your acceptance of our offer by returning a signed and dated copy of this letter by Wednesday, March 2, 2022. Don’t hesitate to contact me directly at [***] or [***], if you have any further questions.

I accept the promotion tendered above from Hydrofarm, LLC. I understand that this is not a contract of employment.

/s/ Mark S. Parker	March 1, 2022
Mark S. Parker	Date

(800) 634.9990 · Fax (707) 773.5955 · shanna@hydrofarm.com · www.hydrofarm.com

EX-10.3

Exhibit 10.3

Execution Version

SEVENTH AMENDMENT TO CREDIT AGREEMENT

This SEVENTH AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of May 9, 2025, is entered into by and among HYDROFARM HOLDINGS GROUP, INC., a Delaware corporation (“Company”), HYDROFARM, LLC, a California limited liability company (“HYD”), FIELD 16, LLC, a Delaware limited liability company (“F16”), INNOVATIVE GROWERS EQUIPMENT, INC., an Illinois corporation, (“IGE”), MANUFACTURING & SUPPLY CHAIN SERVICES, INC., a Delaware corporation (“MSCSI”, and together with the Company, HYD, F16, IGE, and any other Person incorporated under the laws of a jurisdiction located in the U.S. who is joined as a Borrower in accordance with the terms of the Credit Agreement referred to below is referred to hereinafter, each individually, as a “Borrower”, and individually and collectively, jointly and severally, as the “Borrowers”), HYDROFARM INVESTMENT CORP., a Delaware corporation (“HIC”), HYDROFARM HOLDINGS LLC, a Delaware limited liability company (“HHL”), EHH HOLDINGS, LLC, a Delaware limited liability company (“EHH”), SUNBLASTER LLC, a Delaware limited liability company (“Sunblaster”), HYDROFARM CANADA, LLC, a Delaware limited liability company (“HCL”), SUNBLASTER HOLDINGS ULC, an unlimited liability corporation existing under the laws of the Province of British Columbia (“SUN”), EDDI’S WHOLESALE GARDEN SUPPLIES LTD., a corporation organized under the laws of the Province of British Columbia (“EDDI”), HOUSE & GARDEN HOLDINGS, LLC, a Delaware limited liability company (“H&G Holdings”), AURORA INTERNATIONAL, LLC, an Oregon limited liability company (“Aurora International”), AURORA PEAT PRODUCTS ULC, an unlimited liability corporation existing under the laws of the Province of Alberta (“APP”), GREENSTAR PLANT PRODUCTS INC., a federal corporation organized under the laws of Canada (“GPP”), INNOVATIVE AG INSTALLATION, INC., an Illinois corporation (“Innovative AG”), INNOVATIVE RACKING SYSTEMS, INC., an Illinois corporation (“Innovative Racking”), INNOVATIVE SHIPPING SOLUTIONS, INC., an Illinois corporation (“Innovative Shipping”), INNOVATIVE GROWERS EQUIPMENT CANADA, INC., a corporation incorporated under the laws of the Province of Ontario (“Innovative Canada” and together with HIC, HHL, EHH, Sunblaster, HCL, SUN, EDDI, H&G Holdings, Aurora International, APP, Innovative AG, Innovative Racking and Innovating Shipping, and any other Person who is joined as a Loan Guarantor in accordance with the terms of the Credit Agreement referred to below is referred to hereinafter, each individually, as a “Loan Guarantor”, and individually and collectively, jointly and severally, as the “Loan Guarantors”, and the Borrowers and the Loan Guarantors are collectively referred to herein as the “Loan Parties” and each individually, a “Loan Party”), the Lenders (as defined below) party hereto, and JPMORGAN CHASE BANK, N.A., in its capacity as administrative agent for the Lenders (in such capacity, the “Administrative Agent”).

RECITALS

A.Reference is hereby made to that certain Credit Agreement, dated as of March 29, 2021 (as amended by (i) that First Amendment and Joinder to Credit Agreement, dated as of August 31, 2021, (ii) that Second Amendment to Credit Agreement, dated as of October 25, 2021, (iii) that Third Amendment and Joinder to Credit Agreement dated as of August 23, 2022,

DB1/ 157677093.7

(iv) that Fourth Amendment to Credit Agreement and Limited Consent and Waiver, dated as of December 22, 2022, (v) that Fifth Amendment to Credit Agreement, dated as of March 31, 2023, (vi) that Sixth Amendment to Credit Agreement, dated as of November 1, 2024, and (vii) as may be further amended, amended and restated, restated, supplemented, modified or otherwise in effect from time to time prior to the date hereof, the “Existing Credit Agreement”; the Existing Credit Agreement as amended by this Amendment is hereinafter referred to as the “Credit Agreement”), by and among the Borrowers, the other Loan Parties from time to time party thereto, the Administrative Agent, and the financial institutions from time to time party thereto (collectively, the “Lenders”), pursuant to which the Lenders have made certain loans and financial accommodations available to Borrowers.

B.The Loan Parties have requested that the Administrative Agent and the Lenders make certain amendments to the Credit Agreement, and the Administrative Agent and the Lenders are willing to make such amendments, subject to and pursuant to the terms and conditions set forth herein.

C.The Loan Parties are entering into this Amendment with the understanding and agreement that, except as specifically provided herein, neither the Administrative Agent’s nor any Lender’s rights or remedies as set forth in the Credit Agreement and the other Loan Documents are being waived or modified by the terms of this Amendment.

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

AGREEMENT

1.Defined Terms. Unless otherwise specifically defined herein, each capitalized term used herein has the meaning assigned to such term in the Credit Agreement.

2.Amendments to Existing Credit Agreement. Subject to the satisfaction in full of the conditions precedent set forth in Section 3 hereof, effective as of the Effective Date (as defined below), the Existing Credit Agreement is hereby amended as follows:

a.The definition of “Aggregate Revolving Commitment” set forth in Section 1.01 of the Existing Credit Agreement is hereby amended and restated in its entirety to read as follows:

““Aggregate Revolving Commitment” means, at any time, the aggregate of the Revolving Commitments of all of the Lenders, as increased or reduced from time to time pursuant to the terms and conditions hereof. As of the Seventh Amendment Effective Date, the Aggregate Revolving Commitment is $22,000,000.”

b.The definition of “Availability” set forth in Section 1.01 of the Existing Credit Agreement is hereby amended and restated in its entirety to read as follows:

2

DB1/ 157677093.7

““Availability” means, at any time, an amount equal to (a) the lesser of (i) the Aggregate Revolving Commitment and (ii) the Borrowing Base, minus (b) the Aggregate Revolving Exposure (calculated, with respect to any Defaulting Lender, as if such Defaulting Lender had funded its Applicable Percentage of all outstanding Borrowings).”

c.The definition of “Borrowing Base” set forth in Section 1.01 of the Existing Credit Agreement is hereby amended and restated in its entirety to read as follows:

““Borrowing Base” means, at any time, the sum of (a) 85% of the Eligible Accounts at such time, plus (b) the lesser of (i) 65% of the Eligible Inventory, at such time, valued at the lower of cost or market value, determined on a first-in-first-out basis, and (ii) the product of 85% multiplied by the Net Orderly Liquidation Value percentage identified in the most recent inventory appraisal ordered by the Administrative Agent multiplied by the Eligible Inventory, valued at the lower of cost or market value, determined on a first-in-first-out basis, minus (c) Reserves, minus (d) the Availability Block. The Administrative Agent may, in its Permitted Discretion, reduce the advance rates set forth above, adjust Reserves or reduce one or more of the other elements used in computing the Borrowing Base; provided, that the Administrative Agent shall notify the Borrower Representative at least 2 Business Days prior to the date on which any such change is to be made; providedfurther, that (i) the Borrowers may not obtain any new Loans or Letters of Credit to the extent that such Loan or Letter of Credit would cause an Overadvance after giving effect to such change as set forth in such notice; (ii) no such prior notice shall be required for changes to any Reserves resulting solely by virtue of mathematical calculations of the amount of the Reserve in accordance with the methodology of calculation set forth in this Agreement or previously utilized; and (iii) no such prior notice shall be required during the continuance of any Event of Default (provided that, during the continuance of an Event of Default, the Administrative Agent shall endeavor to notify the Borrower Representative at or before any such change, but a non-willful failure of the Administrative Agent to so notify the Borrower Representative shall not be a breach of this Agreement and shall not cause such establishment or increase of any such change to be ineffective). The calculations in clause (b) above may be determined on a combined basis for Eligible Inventory or on a category by category basis for Eligible Inventory, as determined by the Administrative Agent from time to time in its Permitted Discretion based on its review of any appraisal and/or field examination of such Inventory.”

3

DB1/ 157677093.7

d.The definition of “Covenant Testing Trigger Period” set forth in Section 1.01 of the Existing Credit Agreement is hereby amended and restated in its entirety to read as follows:

““Covenant Testing Trigger Period” means the period (a) commencing on any day that Excess Availability is less than an amount equal to 20% of the Aggregate Revolving Commitment, and (b) continuing until Excess Availability has been greater than or equal to an amount equal to 20% of the Aggregate Revolving Commitment at all times for thirty (30) consecutive calendar days.”

e.The definition of “Dominion Period” set forth in Section 1.01 of the Existing Credit Agreement is hereby amended and restated in its entirety to read as follows:

““Dominion Period” means the period (a) commencing on any date at Administrative Agent’s or the Required Lenders’ election if (A) an Event of Default has occurred and is continuing as of the date of such election or (B) Availability is less than 50% of the Aggregate Revolving Commitment as of the date of such election and (b) continuing until the Borrower Representative provides Administrative Agent with a written election to terminate such Dominion Period, so long as, at the proposed date of such termination, during the preceding thirty (30) consecutive calendar days, no Event of Default has existed and Availability has been greater than or equal to an amount equal to 50% of the Aggregate Revolving Commitment at all times.”

f.The definition of “Maturity Date” set forth in Section 1.01 of the Existing Credit Agreement is hereby amended and restated in its entirety to read as follows:

““Maturity Date” means June 30, 2027, or any earlier date on which the Revolving Commitments are reduced to zero or otherwise terminated pursuant to the terms hereof.”

g.Section 1.01 of the Existing Credit Agreement is hereby further amended by adding the following defined terms in the appropriate alphabetical order:

““Availability Block” means an amount equal to $2,000,000.”

““Fifth Amendment” means that certain Fifth Amendment to Credit Agreement, dated as of the Fifth Amendment Effective Date, by and among the Loan Parties party thereto, the Administrative Agent, and the Lenders party thereto.”

““Fifth Amendment Effective Date” means March 31, 2023.”

4

DB1/ 157677093.7

““Seventh Amendment” means that certain Seventh Amendment to Credit Agreement, dated as of the Seventh Amendment Effective Date, by and among the Loan Parties party thereto, the Administrative Agent, and the Lenders party thereto.”

““Seventh Amendment Effective Date” means May 9, 2025.”

h.The Commitment Schedule to the Credit Agreement is hereby amended and restated in its entirety by Annex A attached hereto.

3.Conditions Precedent to Effectiveness of this Amendment. This Amendment shall become effective as of the date on which each of the following conditions precedent has been satisfied in full (the “Effective Date”):

a.Amendment. Each of the Borrowers, the other Loan Parties, the Administrative Agent and the Lenders shall have duly executed and delivered this Amendment, and the Administrative Agent shall have received a fully executed counterpart hereof.

b.No Default Certificate. The Administrative Agent shall have received a certificate, signed by a Financial Officer of each Borrower and each other Loan Party, dated as of the Effective Date (i) stating that no Default has occurred and is continuing, (ii) stating that the representations and warranties contained in this Amendment and the other Loan Documents are true and correct as of such date and (iii) certifying as to any other factual matters as may be reasonably requested by the Administrative Agent.

c.Representations and Warranties. The representations and warranties of the Loan Parties set forth herein and in the Loan Documents must be true and correct in all material respects with the same effect as though made on the date hereof (it being understood and agreed that any representation or warranty which by its terms is made as of a specified date shall be required to be true and correct in all material respects only as of such specified date, and that any representation or warranty which is subject to any materiality qualifier shall be required to be true and correct in all respects).

d.Secretary’s Certificate. The Administrative Agent shall have received (i) a certificate of each U.S. Loan Party, dated the date hereof and executed by its Secretary, Assistant Secretary or other Responsible Officer, which shall (A) certify the resolutions of its Board of Directors, members or other body authorizing the execution, delivery and performance of this Amendment and the other Loan Documents, as amended by this Amendment, to which it is a party, (B) identify by name and title and bear the signatures of the officers of such U.S. Loan Party authorized to sign this Amendment and the other Loan Documents to which it is a party and, in the case of each Borrower, its Financial Officers or certify that the officers whose signatures appear on the officer’s certificate most recently delivered to the Administrative Agent remain duly authorized and empowered to execute this Amendment and each other Loan Document, (C) contain either (x) appropriate attachments, including the certificate, constitution or articles of

5

DB1/ 157677093.7

incorporation or organization (“Charter”) of each U.S. Loan Party certified by the relevant authority of the jurisdiction of organization or incorporation of such U.S. Loan Party and a true and correct copy of its memorandum and articles of association, bylaws, constitution or operating, management or partnership agreement, or other organizational or governing documents (“Bylaws”) or (y) certify that (x) no action for any amendment, modification or other change to the Charter of each U.S. Loan Party and all amendments thereto has been taken since the prior delivery of such Charter to the Administrative Agent, or is pending, and each Charter previously delivered by each U.S. Loan Party to the Lenders and Administrative Agent remains in full force and effect as of the date hereof and (y) no action for any amendment, modification or other change to the Bylaws of each U. S. Loan Party and all amendments thereto has been taken since the prior delivery of such Bylaws to the Administrative Agent, or is pending, and the Bylaws previously delivered by each U.S. Loan Party to the Lenders and Administrative Agent remain in full force and effect as of the date hereof; and (ii) a good standing certificate for each U.S. Loan Party from its jurisdiction of organization or the substantive equivalent available in the jurisdiction of organization for each U.S. Loan Party from the appropriate governmental officer in such jurisdiction.

e.Legal Opinions. Each U.S. Loan Party shall have delivered a written opinion of each Loan Party’s counsel, addressed to the Administrative Agent, Issuing Bank, the Lenders and the other Secured Parties, each in form and substance satisfactory to the Administrative Agent and its counsel.

f.Amendment Fee. Borrowers shall have paid to the Administrative Agent, for the pro rata benefit of the Lenders (including Administrative Agent in its capacity as a Lender), an amendment fee in an amount equal to $30,000.00, which amendment fee shall be fully earned as of and payable on the date hereof.

g.Fees and Expenses. The Lenders and the Administrative Agent shall have received all fees required to be paid, and all expenses for which invoices have been presented (including the reasonable fees and expenses of legal counsel), on or before the Effective Date.

h.Other Required Documentation. The Administrative Agent shall have received such other documents as the Administrative Agent, the Issuing Bank, any Lender or their respective counsel may have reasonably requested.

4.Representations and Warranties. Each Borrower and each other Loan Party represents and warrants as follows:

a.Authority; Enforceability. The transactions contemplated by this Amendment are within each Loan Party’s corporate or other organizational powers and have been duly authorized by all necessary corporate or other organizational actions and approvals and, if required, actions and approvals by equity holders. This Amendment and each other Loan Document (as amended or modified hereby) to which each Loan Party is a party has been duly executed and delivered by such Loan Party and constitutes

6

DB1/ 157677093.7

a legal, valid and binding obligation of such Loan Party, enforceable in accordance with its terms, subject to applicable Insolvency Laws, examinership, reorganization, moratorium or other laws affecting creditors’ rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law.

b.Representations and Warranties. After giving effect to this Amendment, the representations and warranties of the Loan Parties set forth in the Loan Documents shall be true and correct in all material respects with the same effect as though made on and as of the date hereof (it being understood and agreed that any representation or warranty which by its terms is made as of a specified date shall be required to be true and correct in all material respects only as of such specified date, and that any representation or warranty which is subject to any materiality qualifier shall be required to be true and correct in all respects).

c.No Default. At the time of and immediately after giving to this Amendment, no Default has occurred and is continuing.

5.Post-Closing.

a.Lien Searches. Within five (5) Business Days of the Effective Date (or such other date as determined by the Administrative Agent in its sole discretion), the Administrative Agent shall have received the results of a recent lien search in each jurisdiction where the Loan Parties are organized and where the assets of the Loan Parties are located, and such search shall reveal no Liens on any of the assets of such Loan Parties except for Liens permitted by Section 6.02 of the Credit Agreement or discharged on or prior to the date hereof pursuant to a pay-off letter or other documentation satisfactory to the Administrative Agent.

b.Secretary’s Certificate. Within five (5) Business Days of the Effective Date (or such other date as determined by the Administrative Agent in its sole discretion), the Administrative Agent shall have received (i) a certificate of each Canadian Loan Party, dated the date hereof and executed by its Secretary, Assistant Secretary or other Responsible Officer, which shall (A) certify the resolutions of its Board of Directors, members or other body authorizing the execution, delivery and performance of this Amendment and the other Loan Documents, as amended by this Amendment, to which it is a party, (B) identify by name and title and bear the signatures of the officers of such Canadian Loan Party authorized to sign this Amendment and the other Loan Documents to which it is a party and, in the case of each Borrower, its Financial Officers or certify that the officers whose signatures appear on the officer’s certificate most recently delivered to the Administrative Agent remain duly authorized and empowered to execute this Amendment and each other Loan Document, (C) contain either (x) appropriate attachments, including the certificate, constitution or articles of incorporation or organization (“Charter”) of each Canadian Loan Party certified by the relevant authority of the jurisdiction of organization or incorporation of such Canadian Loan Party and a true and correct copy of its memorandum and articles of association, bylaws, constitution or operating, management or partnership agreement, or other organizational or governing

7

DB1/ 157677093.7

documents (“Bylaws”) or (y) certify that (x) no action for any amendment, modification or other change to the Charter of each Canadian Loan Party and all amendments thereto has been taken since the prior delivery of such Charter to the Administrative Agent, or is pending, and each Charter previously delivered by each Canadian Loan Party to the Lenders and Administrative Agent remains in full force and effect as of the date hereof and (y) no action for any amendment, modification or other change to the Bylaws of each Canadian Loan Party and all amendments thereto has been taken since the prior delivery of such Bylaws to the Administrative Agent, or is pending, and the Bylaws previously delivered by each Canadian Loan Party to the Lenders and Administrative Agent remain in full force and effect as of the date hereof; and (ii) a good standing certificate for each Canadian Loan Party from its jurisdiction of organization or the substantive equivalent available in the jurisdiction of organization for each Canadian Loan Party from the appropriate governmental officer in such jurisdiction.

6.Governing Law; Waiver of Jury Trial. This Amendment shall be governed by and construed in accordance with the internal laws (and not the law of conflicts) of the State of New York, but giving effect to federal laws applicable to national banks. The other terms of Section 9.09 and 9.10 of the Credit Agreement shall apply hereto as if fully set forth herein, mutatis mutandis.

7.Counterparts; Electronic Execution. This Amendment may be executed in any number of counterparts and by different parties and separate counterparts, each of which when so executed and delivered, shall be deemed an original, and all of which, when taken together, shall constitute one and the same instrument. Delivery of an executed counterpart of a signature page to this Amendment by telecopy, emailed pdf. or any other electronic means that complies with the federal Electronic Signatures in Global and National Commerce Act, state enactments of the Uniform Electronic Transactions Act, or any other relevant and applicable electronic signatures law shall be effective as delivery of a manually executed counterpart of this Amendment. Each party agrees that this Amendment may be electronically signed, and that any electronic signatures appearing on this Amendment are the same as handwritten signatures for the purposes of validity, enforceability, and admissibility. As used herein, “electronic signatures” mean any electronic sound, symbol, or process attached to or logically associated with a record and executed and adopted by a party with the intent to sign such record. Notwithstanding the foregoing, the Loan Parties shall promptly deliver original signatures of this Amendment to the Administrative Agent.

8.Reference to and Effect on the Loan Documents.

a.Upon and after the effectiveness of this Amendment, each reference in the Credit Agreement to “this Agreement”, “hereunder”, “hereof” or words of like import referring to the Credit Agreement, and each reference in the other Loan Documents to “the Credit Agreement”, “hereunder”, “thereof” or words of like import referring to the Credit Agreement, shall mean and be a reference to the Credit Agreement as modified and amended hereby.

8

DB1/ 157677093.7

b.Except as specifically set forth in this Amendment, the Credit Agreement and all other Loan Documents are and shall continue to be in full force and effect and are hereby in all respects ratified, and confirmed and shall constitute the legal, valid, binding, and enforceable obligations of the Borrowers and the other Loan Parties to Administrative Agent and the Lenders without defense, offset, claim, or contribution.

c.The execution, delivery and effectiveness of this Amendment shall not, except as expressly provided herein, operate as a waiver of any right, power, or remedy of Administrative Agent or any Lender under any of the Loan Documents, nor constitute a waiver of any provision of any of the Loan Documents.

9.Ratification. Each Borrower and each other Loan Party hereby restates, ratifies and reaffirms each and every term and condition set forth in the Credit Agreement, as amended hereby, and the Loan Documents effective as of the date hereof.

10.Release; Covenant Not to Sue.

a.Each Loan Party hereby absolutely and unconditionally releases and forever discharges Administrative Agent and each Lender, and any and all participants, parent corporations, subsidiary corporations, affiliated corporations, insurers, indemnitors, successors and assigns thereof, together with all of the present and former directors, officers, agents and employees of any of the foregoing (each a “Released Party”), from any and all claims, demands or causes of action of any kind, nature or description, whether arising in law or equity or upon contract or tort or under any state or federal law or otherwise, which any Loan Party has had, now has or has made claim to have against any such person for or by reason of any act, omission, matter, cause or thing whatsoever arising under or related to the Loan Documents from the beginning of time to and including the date of this Amendment, whether such claims, demands and causes of action are matured or unmatured or known or unknown. It is the intention of each Loan Party in providing this release that the same shall be effective as a bar to each and every claim, demand and cause of action specified.

b.Each Loan Party acknowledges that it may hereafter discover facts different from or in addition to those now known or believed to be true with respect to such claims, demands, or causes of action and agree that this instrument shall be and remain effective in all respects notwithstanding any such differences or additional facts. Each Loan Party understands, acknowledges and agrees that the release set forth above may be pleaded as a full and complete defense and may be used as a basis for an injunction against any action, suit or other proceeding which may be instituted, prosecuted or attempted in breach of the provisions of such release.

c.Each Loan Party, on behalf of itself and its successors, assigns, and other legal representatives, hereby absolutely, unconditionally and irrevocably, covenants and agrees with and in favor of each Released Party above that it will not sue (at law, in equity, in any regulatory proceeding or otherwise) any Released Party on the basis of any claim released, remised and discharged by Borrower pursuant to the above release. If any

9

DB1/ 157677093.7

Loan Party or any of its successors, assigns or other legal representatives violates the foregoing covenant, each Loan Party for itself and its successors, assigns and legal representatives, agree to pay, in addition to such other damages as any Released Party may sustain as a result of such violation, all attorneys’ fees and costs incurred by such Released Party as a result of such violation.

11.Estoppel. To induce Administrative Agent and Lenders to enter into this Amendment and to induce Administrative Agent and the Lenders to continue to make advances to Borrowers under the Credit Agreement, each Borrower and each other Loan Party hereby acknowledges and agrees that, as of the date hereof, there exists no Default or Event of Default and no right of offset, defense, counterclaim, or objection in favor of any Borrower or any other Loan Party as against Administrative Agent or any Lender with respect to the Obligations.

12.Integration. This Amendment, together with the other Loan Documents, incorporates all negotiations of the parties hereto with respect to the subject matter hereof and is the final expression and agreement of the parties hereto with respect to the subject matter hereof.

13.Entire Agreement. The Credit Agreement, as amended hereby, and the other Loan Documents constitute the entire agreement and understanding among the parties hereto and supersedes any and all prior agreements and understandings, oral or written, relating to the subject matter hereof.

14.Severability. In case any provision in this Amendment shall be invalid, illegal, or unenforceable, such provision shall be severable from the remainder of this Amendment and the validity, legality, and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.

15.Submission of Amendment. The submission of this Amendment to the parties or their agents or attorneys for review or signature does not constitute a commitment by Administrative Agent or any Lender to waive any of their respective rights and remedies under the Loan Documents, and this Amendment shall have no binding force or effect until all of the conditions to the effectiveness of this Amendment have been satisfied as set forth herein.

[REMAINDER OF PAGE LEFT INTENTIONALLY BLANK; SIGNATURE PAGES FOLLOW.]

10

DB1/ 157677093.7

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed by their respective authorized officers as of the day and year first above written.

BORROWERS:

HYDROFARM HOLDINGS GROUP, INC.,
a Delaware corporation

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Executive Officer

HYDROFARM, LLC,
a California limited liability company

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Financial Officer

FIELD 16, LLC,

a Delaware limited liability company

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Financial Officer

[Hydrofarm – Signature Page to Seventh Amendment to Credit Agreement]

BORROWERS (CONT’D):

INNOVATIVE GROWERS EQUIPMENT, INC.,

an Illinois corporation

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Financial Officer

MANUFACTURING & SUPPLY CHAIN SERVICES, INC.,

a Delaware corporation

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Financial Officer

[Hydrofarm – Signature Page to Seventh Amendment to Credit Agreement]

LOAN GUARANTORS:

HYDROFARM INVESTMENT CORP.,a Delaware corporation

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Financial Officer

HYDROFARM HOLDINGS LLC,
a Delaware limited liability company

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Financial Officer

EHH HOLDINGS, LLC,
a Delaware limited liability company

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Financial Officer

SUNBLASTER LLC,
a Delaware limited liability company

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Financial Officer

HYDROFARM CANADA, LLC,
a Delaware limited liability company

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Financial Officer

[Hydrofarm – Signature Page to Seventh Amendment to Credit Agreement]

LOAN GUARANTORS (CONT’D):

SUNBLASTER HOLDINGS ULC,
an unlimited liability corporation existing under the laws of the Province of British Columbia

By:	/s/ William Toler
	Name: William Toler
	Title: Director

EDDI’S WHOLESALE GARDEN SUPPLIES LTD.,
a corporation organized under the laws of the province of British Columbia

By:	/s/ William Toler
	Name: William Toler
	Title: President

HOUSE & GARDEN HOLDINGS, LLC,

a Delaware limited liability company

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Financial Officer

[Hydrofarm – Signature Page to Seventh Amendment to Credit Agreement]

LOAN GUARANTORS (CONT’D):

AURORA INTERNATIONAL, LLC,

an Oregon limited liability company

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Financial Officer

AURORA PEAT PRODUCTS ULC,

an unlimited liability corporation existing under the laws of the Province of Alberta

By:	/s/ William Toler
	Name: William Toler
	Title: President

GREENSTAR PLANT PRODUCTS INC.,

a federal corporation organized under the laws of Canada

By:	/s/ William Toler
	Name: William Toler
	Title: Director

INNOVATIVE AG INSTALLATION, INC.,

an Illinois corporation

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Financial Officer

[Hydrofarm – Signature Page to Seventh Amendment to Credit Agreement]

LOAN GUARANTORS (CONT’D):

INNOVATIVE RACKING SYSTEMS, INC.,

an Illinois corporation

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Financial Officer

INNOVATIVE SHIPPING SOLUTIONS, INC.,

an Illinois corporation

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Financial Officer

INNOVATIVE GROWERS EQUIPMENT CANADA, INC.,

a corporation incorporated under the laws of Ontario, Canada

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Director

[Hydrofarm – Signature Page to Seventh Amendment to Credit Agreement]

Acknowledged and accepted as of the date hereof by:

BORROWERS:

HYDROFARM HOLDINGS GROUP, INC.,

a Delaware corporation

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Executive Officer

HYDROFARM, LLC,

a California limited liability company

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Financial Officer

FIELD 16, LLC,

a Delaware limited liability company

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Financial Officer

[Hydrofarm – Signature Page to Seventh Amendment to Credit Agreement]

BORROWERS (CONT’D):

INNOVATIVE GROWERS EQUIPMENT, INC.,

an Illinois corporation

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Financial Officer

MANUFACTURING & SUPPLY CHAIN SERVICES, INC.,

a Delaware corporation

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Financial Officer

[Hydrofarm – Signature Page to Seventh Amendment to Credit Agreement]

LOAN GUARANTORS:

HYDROFARM INVESTMENT CORP.,

a Delaware corporation

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Financial Officer

HYDROFARM HOLDING LLC,

a Delaware limited liability company

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Financial Officer

EHH HOLDINGS, LLC,

a Delaware limited liability company

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Financial Officer

SUNBLASTER LLC,

a Delaware limited liability company

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Financial Officer

HYDROFARM CANADA, LLC,

a Delaware limited liability company

By:	/s/ B. John Lindeman
	Name: B. John Lindeman
	Title: Chief Financial Officer

[Hydrofarm – Signature Page to Seventh Amendment to Credit Agreement]

JPMORGAN CHASE BANK, N.A., as a Lender, Administrative Agent, Issuing Bank and Swingline Lender

By:	/s/ George Burnett
	Name: George Burnett
	Title: Authorized Signatory

[Hydrofarm – Signature Page to Seventh Amendment to Credit Agreement]

JPMORGAN CHASE BANK, N.A., Toronto Branch

By:	/s/ Bruce Watson
	Name: Bruce Watson
	Title: Authorized Signatory

[Hydrofarm – Signature Page to Seventh Amendment to Credit Agreement]

ANNEX A

Commitment Schedule

to

Credit Agreement

Lenders	Amount of Revolving Commitment
JPMORGAN CHASE BANK, N.A.	$22,000,000
TOTAL	$22,000,000

DB1/ 157677093.7

EX-31.1

Exhibit 31.1

CERTIFICATIONS UNDER SECTION 302

I, B. John Lindeman, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Hydrofarm Holdings Group, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 13, 2025

By:	/s/ B. John Lindeman
B. John Lindeman
Chief Executive Officer
(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATIONS UNDER SECTION 302

I, Kevin O’Brien, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Hydrofarm Holdings Group, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 13, 2025

By:	/s/ Kevin O’Brien
Kevin O’Brien
Chief Financial Officer
(Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATIONS UNDER SECTION 906

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Hydrofarm Holdings Group, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Quarterly Report for the quarter ended March 31, 2025 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: May 13, 2025	/s/ B. John Lindeman
	B. John Lindeman
	Chief Executive Officer
	(Principal Executive Officer)

EX-32.2

Exhibit 32.2

CERTIFICATIONS UNDER SECTION 906

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Hydrofarm Holdings Group, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Quarterly Report for the quarter ended March 31, 2025 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: May 13, 2025	/s/ Kevin O’Brien
	Kevin O’Brien
	Chief Financial Officer
	(Principal Financial Officer)

XML

Cover - shares	3 Months Ended
	Mar. 31, 2025	May 05, 2025
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2025
Document Transition Report	false
Entity File Number	001-39773
Entity Registrant Name	Hydrofarm Holdings Group, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	81-4895761
Entity Address, Address Line One	1510 Main Street
Entity Address, City or Town	Shoemakersville
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	19555
City Area Code	707
Local Phone Number	765-9990
Title of 12(b) Security	Common Stock, $0.0001 par value per share
Trading Symbol	HYFM
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		4,642,957
Amendment Flag	false
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q1
Entity Central Index Key	0001695295
Current Fiscal Year End Date	--12-31

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 13,728	$ 26,111
Accounts receivable, net	20,919	14,756
Inventories	49,902	50,633
Prepaid expenses and other current assets	4,137	3,712
Total current assets	88,686	95,212
Property, plant and equipment, net	36,456	37,545
Operating lease right-of-use assets	40,863	42,869
Intangible assets, net	243,079	249,002
Other assets	1,473	1,476
Total assets	410,557	426,104
Current liabilities:
Accounts payable	16,092	12,279
Accrued expenses and other current liabilities	7,414	10,647
Deferred revenue	2,307	2,611
Current portion of operating lease liabilities	7,785	7,731
Current portion of finance lease liabilities	467	459
Current portion of long-term debt	5,876	1,260
Total current liabilities	39,941	34,987
Long-term operating lease liabilities	35,629	37,553
Long-term finance lease liabilities	7,711	7,830
Long-term debt	109,968	114,693
Deferred tax liabilities	3,047	3,047
Other long-term liabilities	4,316	4,272
Total liabilities	200,612	202,382
Commitments and contingencies (Note 14)
Stockholders’ equity
Common stock ($0.0001 par value; 300,000,000 shares authorized; 4,615,725 and 4,614,279 shares issued and outstanding at March 31, 2025, and December 31, 2024, respectively)	0	0
Additional paid-in capital	790,565	790,094
Accumulated other comprehensive loss	(8,774)	(8,911)
Accumulated deficit	(571,846)	(557,461)
Total stockholders’ equity	209,945	223,722
Total liabilities and stockholders’ equity	$ 410,557	$ 426,104

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares	Mar. 31, 2025	Dec. 31, 2024
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	300,000,000	300,000,000
Common stock, shares issued (in shares)	4,615,725	4,614,279
Common stock, shares outstanding (in shares)	4,615,725	4,614,279

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Income Statement [Abstract]
Net sales	$ 40,534	$ 54,172
Cost of goods sold	33,657	43,247
Gross profit	6,877	10,925
Operating expenses:
Selling, general and administrative	17,863	19,621
Loss from operations	(10,986)	(8,696)
Interest expense	(3,377)	(3,931)
Other income, net	60	215
Loss before tax	(14,303)	(12,412)
Income tax expense	(82)	(196)
Net loss	$ (14,385)	$ (12,608)
Net loss per share:
Basic (in dollars per share)	$ (3.12)	$ (2.75)
Diluted (in dollars per share)	$ (3.12)	$ (2.75)
Weighted-average shares of common stock outstanding:
Basic (in shares)	4,614,510	4,581,221
Diluted (in shares)	4,614,510	4,581,221

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Statement of Comprehensive Income [Abstract]
Net loss	$ (14,385)	$ (12,608)
Other comprehensive loss:
Foreign currency translation gain (loss)	137	(729)
Total comprehensive loss	$ (14,248)	$ (13,337)

XML

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023		4,578,841
Beginning balance at Dec. 31, 2023	$ 290,610	$ 0	$ 787,851	$ (6,497)	$ (490,744)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for vesting of stock awards (in shares)		29,301
Shares repurchased for withholding tax on stock awards (in shares)		(104,973)
Shares repurchased for withholding tax on stock awards	(97)		(97)
Stock-based compensation expense	853		853
Net loss	(12,608)				(12,608)
Foreign currency translation gain (loss)	(729)			(729)
Ending balance (in shares) at Mar. 31, 2024		4,503,169
Ending balance at Mar. 31, 2024	$ 278,029	$ 0	788,607	(7,226)	(503,352)
Beginning balance (in shares) at Dec. 31, 2024	4,614,279	4,614,279
Beginning balance at Dec. 31, 2024	$ 223,722	$ 0	790,094	(8,911)	(557,461)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for vesting of stock awards (in shares)		2,267
Shares repurchased for withholding tax on stock awards (in shares)		(821)
Shares repurchased for withholding tax on stock awards	(3)		(3)
Stock-based compensation expense	474		474
Net loss	(14,385)				(14,385)
Foreign currency translation gain (loss)	$ 137			137
Ending balance (in shares) at Mar. 31, 2025	4,615,725	4,615,725
Ending balance at Mar. 31, 2025	$ 209,945	$ 0	$ 790,565	$ (8,774)	$ (571,846)

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2025	Mar. 31, 2024	Dec. 31, 2024
Operating activities
Net loss	$ (14,385)	$ (12,608)
Adjustments to reconcile net loss to net cash from operating activities:
Depreciation, depletion and amortization	7,309	7,885
Provision for inventory obsolescence	312	568
Stock-based compensation expense	474	853
Non-cash operating lease expense	1,941	2,244
Other	905	43
Changes in assets and liabilities:
Accounts receivable	(6,768)	(5,715)
Inventories	413	2,156
Prepaid expenses and other current assets	(421)	442
Other assets	(37)	100
Accounts payable	3,831	2,892
Accrued expenses and other current liabilities	(3,221)	1,282
Deferred revenue	(304)	(370)
Lease liabilities	(1,812)	(1,976)
Other long-term liabilities	0	(93)
Net cash used in operating activities	(11,763)	(2,297)
Investing activities
Capital expenditures of property, plant and equipment	(244)	(1,442)
Other	(4)	34
Net cash used in investing activities	(248)	(1,408)
Financing activities
Borrowings under foreign revolving credit facilities	95	158
Repayments of foreign revolving credit facilities	(86)	(190)
Repayments of Term Loan	(307)	(1,974)
Payment of withholding tax related to stock awards	(3)	(97)
Finance lease principal payments	(112)	(255)
Net cash used in financing activities	(413)	(2,358)
Effect of exchange rate changes on cash and cash equivalents	41	(97)
Net decrease in cash and cash equivalents	(12,383)	(6,160)
Cash and cash equivalents at beginning of period	26,111	30,312	$ 30,312
Cash and cash equivalents at end of period	13,728	24,152	$ 26,111
Non-cash investing and financing activities
Right-of-use assets relinquished under operating lease obligations, net	(81)	0
Capital expenditures included in accounts payable and accrued liabilities	28	155
Supplemental information
Cash paid for interest	5,212	4,708
Cash paid for income taxes	$ 110	$ 5

XML

DESCRIPTION OF THE BUSINESS

3 Months Ended

Mar. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

DESCRIPTION OF THE BUSINESS

DESCRIPTION OF THE BUSINESS

Description of the business

Hydrofarm Holdings Group, Inc. (collectively with its subsidiaries, the “Company”) was formed in May 2017 under the laws of the state of Delaware to acquire and continue the business originally founded in 1977. The Company is a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture ("CEA"), including grow lights, climate control solutions, grow media and nutrients, as well as a broad portfolio of innovative, proprietary branded products. Products offered include agricultural lighting devices, indoor climate control equipment, nutrients, and plant additives used to grow, farm and cultivate cannabis, flowers, fruits, plants, vegetables, grains and herbs in controlled environment settings that allow end users to control key farming variables including temperature, humidity, CO2, light intensity and color, nutrient concentration and pH.

XML

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

3 Months Ended

Mar. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the requirements of the SEC for interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP can be condensed or omitted. These condensed consolidated financial statements have been prepared on the same basis as the Company's annual consolidated financial statements and, in the opinion of management, reflect all normal and recurring adjustments which are necessary for the fair statement of the Company’s financial information. These interim results are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2025, or for any other interim period or for any other future year. All intercompany balances and transactions have been eliminated in consolidation.

The condensed consolidated balance sheet as of December 31, 2024, has been derived from the audited consolidated financial statements of the Company, which is included in the 2024 Annual Report. These condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto included in the 2024 Annual Report.

On February 12, 2025, the Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware to effect a 1-for-10 reverse stock split of the Company's common stock, effective February 12, 2025 at 5:00 p.m., Eastern Time and the Company's shares of common stock began trading on a split-adjusted basis on The Nasdaq Capital Market at the commencement of trading on February 13, 2025, under the Company's existing trading symbol “HYFM”. There was no adjustment to the number of authorized shares or the par value. The Company has adjusted the presentation of all periods covered by the condensed consolidated financial statements contained herein to give retroactive effect to the Reverse Stock Split, including adjustments to net loss per share and other per share of Common Stock amounts.

Use of estimates

The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Significant estimates include provisions for sales returns, rebates and claims from customers, realization of accounts receivable and inventories, fair value of assets acquired and liabilities assumed for business combinations, valuation of intangible assets, estimated useful lives of long-lived assets, incremental borrowing rate applied in lease accounting, valuation of stock-based compensation, recognition of deferred income taxes, classification of debt pursuant to certain terms in the Company's credit agreements, recognition of liabilities related to commitments and contingencies, asset retirement obligations ("AROs"), and valuation allowances. Actual results may differ from these estimates.

On an ongoing basis, the Company reviews its estimates to ensure that these estimates appropriately reflect changes in its business or new information available.

Segment and entity-wide information

Segment information

The Company's chief operating decision maker ("CODM") is the Chief Executive Officer who reviews financial information for the purposes of making operating decisions, assessing financial performance and allocating resources. The business is organized as one operating segment managed on a consolidated basis, and one reportable segment, which is the distribution and manufacture of CEA equipment and supplies.

For the purposes of making operating decisions, assessing financial performance and allocating resources, the CODM reviews financial statement metrics on a consolidated basis, including net sales, gross profit, selling. general and administrative expenses ("SG&A"), and net income (loss) as presented in the condensed consolidated statements of operations. Net income (loss) is the primary measure of profit or loss reviewed by the CODM. In addition, the CODM reviews consolidated total assets and significant components such as inventories, cash and other assets for the purposes of evaluating financial performance. Significant expense categories regularly reviewed by the CODM are comprised of cost of goods sold and SG&A. The other components of net income (loss) as disclosed in the statements of operations that are not significant segment expenses are loss on asset disposition, interest expense, other income, net, and income tax expense. Therefore, the Company is cross referencing to the U.S. GAAP financial statement measures as presented in the condensed consolidated statement of operations, in connection with adoption of ASU 2023-07. Since the Company operates as one reportable segment, all required segment financial information is found in the condensed consolidated financial statements and footnotes, and within the entity-wide disclosures presented below.

Entity-wide information

Net sales and property, plant and equipment, net and operating lease right-of-use assets in the United States and Canada, as determined by the location of the subsidiaries, are shown below. Other foreign locations, which are immaterial, individually and in the aggregate, are included in the United States below.

	Three months ended March 31,
	2025		2024
United States	$	32,277	$	40,455
Canada	9,022		14,425
Eliminations	(765)		(708)
Total consolidated net sales	$	40,534	$	54,172

	March 31, 2025		December 31, 2024
United States	$	48,558	$	50,928
Canada	28,761		29,513
Total property, plant and equipment, net and operating lease right-of-use assets	$	77,319	$	80,441

All of the products sold by the Company are similar and classified as CEA equipment and supplies.

Fair value measurements

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company has applied the framework for measuring fair value which requires a fair value hierarchy to be applied to all fair value measurements. All financial instruments recognized at fair value are classified into one of three levels in the fair value hierarchy as follows:

Level 1 — Valuation based on quoted prices (unadjusted) observed in active markets for identical assets or liabilities.

Level 2 — Valuation techniques based on inputs that are quoted prices of similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not in active markets; inputs other than quoted prices used in a valuation model that are observable for that instrument; and inputs that are derived from or, corroborated by, observable market data by correlation or other means.

Level 3 — Valuation techniques with significant unobservable market inputs.

The Company measures certain non-financial assets and liabilities, including long-lived assets and intangible assets at fair value on a nonrecurring basis.

Inventories

Inventories consist of finished goods, work-in-process, and raw materials used in manufacturing products. Inventories are stated at the lower of cost or net realizable value, principally determined by the first in, first out method of accounting. The Company maintains an allowance for excess and obsolete inventory. The estimate for excess and obsolete inventory is based upon assumptions about current and anticipated demand, customer preferences, business strategies, and market conditions. Management reviews these assumptions periodically to determine if any adjustments are needed to the allowance for excess and obsolete inventory. The establishment of an allowance for excess and obsolete inventory establishes a new cost basis in the inventory. Such allowance is not reduced until the product is sold or otherwise disposed. If inventory is sold, any related reserves would be reversed in the period of sale. During the year ended December 31, 2024, the Company estimated inventory markdowns relating to restructuring charges based upon current and anticipated demand, customer preferences, business strategies, and market conditions including management's actions with respect to inventory raw materials and products and brands being removed from the Company's portfolio.

Revenue recognition

The Company follows ASC 606 - Revenue from Contracts with Customers which requires that revenue recognized from contracts with customers be disaggregated into categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. The Company has determined that revenue is generated from one category, which is the distribution and manufacture of CEA equipment and supplies.

Revenue is recognized as control of promised goods is transferred to customers, which generally occurs upon receipt at customers’ locations determined by the specific terms of the contract. Arrangements generally have a single performance obligation and revenue is reported net of variable consideration which includes applicable volume rebates, cash discounts and sales returns and allowances. Variable consideration is estimated and recorded at the time of sale.

The amount billed to customers for shipping and handling costs included in net sales was $1,403 and $2,939 during the three months ended March 31, 2025 and 2024, respectively. Shipping and handling costs that occur before the customer obtains control of the goods are deemed to be fulfillment activities and are accounted for as fulfillment costs included in cost of goods sold. The Company does not receive noncash consideration for the sale of goods. Contract consideration received from a customer prior to revenue recognition is recorded as a contract liability and is recognized as revenue when the Company satisfies the related performance obligation under the terms of the contract. The Company's contract liabilities, which consist primarily of customer deposits reported within deferred revenue in the condensed consolidated balance sheets, totaled $2,307 and $2,611 as of March 31, 2025, and December 31, 2024, respectively. During the three months ended March 31, 2025, the Company recognized $657 of previously deferred revenue, recorded customer deposits of $589 and noted $236 of additional decreases primarily due to customer refunds. There are no significant financing components and the majority of revenue is recognized within one year. Excluded from revenue are any taxes assessed by governmental authorities, including value-added and other sales-related taxes that are imposed on and concurrent with revenue-generating activities.

Income taxes

The income tax provision is calculated for an interim period by distinguishing between elements recognized in the income tax provision through applying an estimated annual effective tax rate to a measure of year-to-date operating results referred to as “ordinary income (or loss),” and discretely recognizing specific events referred to as “discrete items” as they occur. The income tax provision or benefit for each interim period is the difference between the year-to-date amount for the current period and the year-to-date amount for the prior period.

Recent accounting pronouncements

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires greater disaggregation of information in the effective tax rate reconciliation, income taxes paid disaggregated by jurisdiction, and certain other amendments related to income tax disclosures. This guidance will be effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of this ASU on its consolidated financial statements.

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires a public entity to disclose additional information about specific expense categories in the notes to financial statements on an annual and interim basis. The amendments are effective for annual periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with early adoption permitted. A public entity should apply the amendments either prospectively to financial statements issued for reporting periods after the effective date of this ASU or retrospectively to any or all prior periods presented in the financial statements. The Company is currently evaluating the impact that adoption of this accounting standard will have on its financial disclosures.

XML

RESTRUCTURING AND ASSET SALES

3 Months Ended

Mar. 31, 2025

Restructuring and Related Activities [Abstract]

RESTRUCTURING AND ASSET SALES

RESTRUCTURING AND ASSET SALES

Restructuring

The Company began a restructuring plan (the "Restructuring Plan") in 2022, and undertook significant actions to streamline operations, reduce costs and improve efficiencies. The major initiatives of the first phase of the Restructuring Plan included (i) narrowing the Company's product and brand portfolio and (ii) the relocation and consolidation of certain manufacturing and distribution centers, including headcount reductions and reorganization to drive a solution based approach. The Company completed the first phase of the Restructuring Plan during the year ended December 31, 2023.

As a result of the continued adverse market conditions, the Company implemented a second phase of the Restructuring Plan beginning in the third quarter of 2023, including U.S. manufacturing facility consolidations, in particular with respect to production of certain durable equipment products. Restructuring activities included termination and disposal costs associated with inventory, facilities, and headcount reductions, and non-cash charges consisting of fixed asset and inventory write-downs.

During the three months ended March 31, 2024, the Company recorded pre-tax restructuring charges of $138 for the second phase, relating primarily to cash charges associated with the consolidation of U.S. manufacturing facilities. Of the $138 recorded charges, $91 was recorded within Cost of goods sold on the condensed consolidated statements of operations, while $47 was recorded within SG&A expenses on the condensed consolidated statements of operations.

During the three months ended March 31, 2025, the Company incurred approximately $362 of additional restructuring charges for the second phase, which were primarily cash charges and recorded in Cost of goods sold on the condensed consolidated statements of operations. Additionally, the remaining accrual balance of $103 as of December 31, 2024, was settled during the three months ended March 31, 2025, and there is no remaining accrual balance.

The second phase of the Restructuring Plan is complete as of March 31, 2025. Total costs incurred relating to this second phase of the Restructuring Plan, from its commencement in 2023 through completion, were (i) $9,737 of non-cash charges relating primarily to inventory markdowns, and (ii) $2,034 of cash charges relating primarily to the consolidation of U.S. manufacturing facilities.

The following tables present the activity in accrued expenses and other current liabilities for restructuring costs related to the second phase of the Restructuring Plan for the three months ended March 31, 2024:

	Three Months Ended March 31, 2024
Restructuring Accruals as of December 31, 2023	$	187
Expense	130
Cash Payments	(180)
Restructuring Accruals as of March 31, 2024	$	137

Refer to Item 2. Management’s Discussion And Analysis Of Financial Condition And Results of Operations – Market Conditions for further explanation of the Restructuring Plan. The amounts the Company will ultimately realize could differ from these estimates.

Asset Sales

On May 10, 2024, in connection with the Company's restructuring of its durable manufacturing operations, the Company entered into an agreement (the “Purchase Agreement”) with CM Fabrication, LLC (the “Buyer”) to sell assets relating to the production of Innovative Growers Equipment ("IGE") durable equipment products for $8,660 (the “Asset Sale”) and retain the proprietary brand and customer relationships. The Asset Sale closed on May 31, 2024, and the Company continues to sell its IGE branded durable products, including horticulture benches, racking and LED lighting systems. In connection with the transaction, the Company entered into an exclusive supply agreement with the Buyer to provide for contract manufacturing, which is expected to yield a more efficient cost model.

Assets and liabilities that were sold, disposed or terminated in connection with the Asset Sale included $11,616 of inventories, $3,721 of property, plant and equipment, $2,573 of technology intangible assets, and $90 of other net liabilities. The Company paid cash to terminate the facility operating lease for $1,275 and certain equipment finance leases for $668. The Company incurred an estimated $417 of transaction costs, including legal fees and other transaction-related expenses. The Company recorded a loss on asset disposition of $11,520 on the condensed consolidated statements of operations for the year ended December 31, 2024, which included the aforementioned assets and liabilities derecognized, and operating and finance lease termination payments. The Company estimated the amount of cash proceeds associated with the sale of inventories as $4,960 and property, plant and equipment as $3,700, and classified the amounts within net cash from operating activities and investing activities, respectively, on the condensed consolidated statements of cash flows for the year ended December 31, 2024.

Pursuant to requirements in the Company's Revolving Credit Facility (as defined below) consent was obtained from JPMorgan Chase Bank, N.A., as administrative agent to permit the Asset Sale. The net cash proceeds of approximately $6,300 from this transaction are subject to a provision whereby such net cash proceeds can be reinvested into certain investments, such as capital expenditures. Refer to Note 10 – Debt for further details.

The foregoing description of the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the Purchase Agreement, which was filed as Exhibit 10.23 to the 2024 Annual Report.

During the year ended December 31, 2024, the Company sold approximately 20 acres of the 140 acres of excess owned land at the Goshen, New York location. The sale price less costs to sell were consistent with the carrying value of the land, and therefore no gain or loss was recorded in the year ended December 31, 2024.

XML

INTANGIBLE ASSETS, NET

3 Months Ended

Mar. 31, 2025

Goodwill and Intangible Assets Disclosure [Abstract]

INTANGIBLE ASSETS, NET

INTANGIBLE ASSETS, NET

Intangible assets, net comprised the following:

	March 31, 2025						December 31, 2024
	Gross Carrying Amount		Accumulated Amortization		Net Book Value		Gross Carrying Amount		Accumulated Amortization		Net Book Value
Finite-lived intangible assets:
Computer software	$	8,995	$	(8,688)	$	307	$	8,982	$	(8,625)	$	357
Customer relationships	99,806		(41,066)		58,740		99,806		(39,230)		60,576
Technology, formulations and recipes	110,381		(35,727)		74,654		110,381		(33,401)		76,980
Trade names and trademarks	131,492		(25,106)		106,386		131,492		(23,432)		108,060
Other	4,717		(4,526)		191		4,716		(4,488)		228
Total finite-lived intangible assets, net	355,391		(115,113)		240,278		355,377		(109,176)		246,201
Indefinite-lived intangible asset:
Trade name	2,801		—		2,801		2,801		—		2,801
Total Intangible assets, net	$	358,192	$	(115,113)	$	243,079	$	358,178	$	(109,176)	$	249,002

Amortization expense related to intangible assets was $5,933 and $6,084 for the three months ended March 31, 2025 and 2024, respectively.

The following are the estimated useful lives and the weighted-average amortization period remaining as of March 31, 2025, for the major classes of finite-lived intangible assets:

	Useful lives	Weighted-average amortization period remaining
Computer software	3 to 5 years	1 year
Customer relationships	7 to 18 years	9 years
Technology, formulations and recipes	8 to 12 years	8 years
Trade names and trademarks	15 to 20 years	16 years

The estimated aggregate future amortization expense for intangible assets subject to amortization as of March 31, 2025, is summarized below:

	Estimated Future Amortization Expense
For the period of April 1, 2025 to December 31, 2025	$	17,801
Year ending December 31,
2026	23,532
2027	23,359
2028	22,713
2029	21,582
2030	21,394
Thereafter	109,897
Total	$	240,278

XML

LOSS PER COMMON SHARE

3 Months Ended

Mar. 31, 2025

Earnings Per Share [Abstract]

LOSS PER COMMON SHARE

LOSS PER COMMON SHARE

Basic loss per common share is computed using net loss divided by the weighted-average number of common shares outstanding during each period, excluding unvested restricted stock units (“RSUs”) and performance stock units ("PSUs").

Diluted loss per common share represents net loss divided by the weighted-average number of common shares outstanding during the period, including common stock equivalents. Common stock equivalents consist of shares subject to share-based awards with exercise prices less than the average market price of the Company’s common stock for the period, to the extent their inclusion would be dilutive.

The following table presents basic and diluted loss per common share for the three months ended March 31, 2025 and 2024:

	Three months ended March 31,
	2025		2024
Net loss	$	(14,385)	$	(12,608)
Weighted-average shares of common stock outstanding	4,614,510		4,581,221
Dilutive effect of share based compensation awards using the treasury stock method	—		—
Diluted weighted-average shares of common stock outstanding	4,614,510		4,581,221
Basic loss per common share	$	(3.12)	$	(2.75)
Diluted loss per common share	$	(3.12)	$	(2.75)

The computation of the weighted-average shares of common stock outstanding for diluted loss per common share excludes the following potential shares of common stock as their inclusion would have an anti-dilutive effect on diluted loss per common share:

	Three months ended March 31,
	2025	2024
Shares subject to unvested or deferred performance and restricted stock units	377,812	112,949
Shares subject to stock options outstanding	35,975	44,374

XML

ACCOUNTS RECEIVABLE, NET, AND INVENTORIES

3 Months Ended

Mar. 31, 2025

Receivables [Abstract]

ACCOUNTS RECEIVABLE, NET, AND INVENTORIES

ACCOUNTS RECEIVABLE, NET, AND INVENTORIES

Accounts receivable, net comprised the following:

	March 31, 2025		December 31, 2024
Trade accounts receivable	$	20,309	$	14,112
Allowance for doubtful accounts	(621)		(706)
Other receivables	1,231		1,350
Total accounts receivable, net	$	20,919	$	14,756

The change in the allowance for doubtful accounts consisted of the following:

	Three months ended March 31,
	2025		2024
Beginning balance	$	(706)	$	(920)
Changes in estimates	(585)		(124)
Write-offs	712		229
Collections/Other	(42)		31
Ending balance	$	(621)	$	(784)

Inventories comprised the following:

	March 31, 2025		December 31, 2024
Finished goods	$	43,745	$	44,372
Work-in-process	962		1,137
Raw materials	11,863		12,398
Allowance for inventory obsolescence	(6,668)		(7,274)
Total inventories	$	49,902	$	50,633

Inventories are stated at the lower of cost or net realizable value, and the Company maintains an allowance for excess and obsolete inventory that is based upon assumptions about future demand and market conditions. The allowance for excess and obsolete inventory is subject to change from period to period based on a number of factors including sales of products, changes in estimates, and disposals.

XML

LEASES

3 Months Ended

Mar. 31, 2025

Leases [Abstract]

LEASES

LEASES

The Company leases its distribution centers and manufacturing facilities from third parties under various non-cancelable lease agreements expiring at various dates through 2038. Also, the Company leases some property, plant and equipment under finance leases. Certain leases contain escalation provisions and/or renewal options, giving the Company the right to extend the leases by up to 20 years. However, these options are generally not reflected in the calculation of the right-of-use assets and lease liabilities due to uncertainty surrounding the likelihood of renewal. The Company recognizes operating lease costs over the respective lease periods, including short-term and month-to-month leases. The Company incurred operating lease costs of $2,384 and $2,750 during the three months ended March 31, 2025 and 2024, respectively. These costs are included primarily within SG&A in the condensed consolidated statements of operations and do not include lease termination costs associated with the Asset Sale. Refer to Note 3 – Restructuring and Asset Sales for further details.

The Company has operating subleases and logistics agreements which have been accounted for by reference to the underlying asset subject to the lease, primarily as an offset to rent expense, primarily within SG&A. For the three months ended March 31, 2025 and 2024, the Company recorded sublease and logistics income of $1,188 and $738, respectively.

Total right-of-use ("ROU") assets, finance lease assets, and lease liabilities were as follows:

	Balance Sheet Classification	March 31, 2025		December 31, 2024
Lease assets
Operating lease assets	Operating lease right-of-use assets	$	40,863	$	42,869
Finance lease assets	Property, plant and equipment, net	7,091		7,279
Total lease assets		$	47,954	$	50,148
Lease liabilities
Current:
Operating leases	Current portion of operating lease liabilities	$	7,785	$	7,731
Finance leases	Current portion of finance lease liabilities	467		459
Noncurrent:
Operating leases	Long-term operating lease liabilities	35,629		37,553
Finance leases	Long-term finance lease liabilities	7,711		7,830
Total lease liabilities		$	51,592	$	53,573

The aggregate future minimum lease payments under long-term non-cancelable operating and finance leases with remaining terms greater than one year as of March 31, 2025 are as follows:

	Operating		Finance
For the period of April 1, 2025 to December 31, 2025	$	7,137	$	661
Year ending December 31,
2026	8,693		847
2027	8,781		850
2028	8,243		805
2029	5,374		822
2030	4,240		838
Thereafter	6,643		6,379
Total lease payments	49,111		11,202
Less portion representing interest	(5,697)		(3,024)
Total principal	43,414		8,178
Less current portion	(7,785)		(467)
Long-term portion	$	35,629	$	7,711

Subsequent event - Lease Renewal

In April 2025, Hydrofarm renewed the lease at its Edmonton, Canada peat moss harvesting facility. The lease has been extended by a term of seven years, through April 2033, with annual rent of $347 at the beginning of the renewal period, with annual fixed increases until the final year when annual rent is $419. The Company accounts for the lease as an operating lease.

LEASES

LEASES

The Company leases its distribution centers and manufacturing facilities from third parties under various non-cancelable lease agreements expiring at various dates through 2038. Also, the Company leases some property, plant and equipment under finance leases. Certain leases contain escalation provisions and/or renewal options, giving the Company the right to extend the leases by up to 20 years. However, these options are generally not reflected in the calculation of the right-of-use assets and lease liabilities due to uncertainty surrounding the likelihood of renewal. The Company recognizes operating lease costs over the respective lease periods, including short-term and month-to-month leases. The Company incurred operating lease costs of $2,384 and $2,750 during the three months ended March 31, 2025 and 2024, respectively. These costs are included primarily within SG&A in the condensed consolidated statements of operations and do not include lease termination costs associated with the Asset Sale. Refer to Note 3 – Restructuring and Asset Sales for further details.

The Company has operating subleases and logistics agreements which have been accounted for by reference to the underlying asset subject to the lease, primarily as an offset to rent expense, primarily within SG&A. For the three months ended March 31, 2025 and 2024, the Company recorded sublease and logistics income of $1,188 and $738, respectively.

Total right-of-use ("ROU") assets, finance lease assets, and lease liabilities were as follows:

	Balance Sheet Classification	March 31, 2025		December 31, 2024
Lease assets
Operating lease assets	Operating lease right-of-use assets	$	40,863	$	42,869
Finance lease assets	Property, plant and equipment, net	7,091		7,279
Total lease assets		$	47,954	$	50,148
Lease liabilities
Current:
Operating leases	Current portion of operating lease liabilities	$	7,785	$	7,731
Finance leases	Current portion of finance lease liabilities	467		459
Noncurrent:
Operating leases	Long-term operating lease liabilities	35,629		37,553
Finance leases	Long-term finance lease liabilities	7,711		7,830
Total lease liabilities		$	51,592	$	53,573

The aggregate future minimum lease payments under long-term non-cancelable operating and finance leases with remaining terms greater than one year as of March 31, 2025 are as follows:

	Operating		Finance
For the period of April 1, 2025 to December 31, 2025	$	7,137	$	661
Year ending December 31,
2026	8,693		847
2027	8,781		850
2028	8,243		805
2029	5,374		822
2030	4,240		838
Thereafter	6,643		6,379
Total lease payments	49,111		11,202
Less portion representing interest	(5,697)		(3,024)
Total principal	43,414		8,178
Less current portion	(7,785)		(467)
Long-term portion	$	35,629	$	7,711

Subsequent event - Lease Renewal

In April 2025, Hydrofarm renewed the lease at its Edmonton, Canada peat moss harvesting facility. The lease has been extended by a term of seven years, through April 2033, with annual rent of $347 at the beginning of the renewal period, with annual fixed increases until the final year when annual rent is $419. The Company accounts for the lease as an operating lease.

XML

PROPERTY, PLANT AND EQUIPMENT, NET

3 Months Ended

Mar. 31, 2025

Property, Plant and Equipment [Abstract]

PROPERTY, PLANT AND EQUIPMENT, NET

PROPERTY, PLANT AND EQUIPMENT, NET

Property, plant and equipment, net comprised the following:

	March 31, 2025		December 31, 2024
Machinery and equipment	$	23,606	$	23,531
Peat bogs and related development	11,936		11,895
Building and improvements	10,327		10,313
Land	5,640		5,630
Furniture and fixtures	4,267		4,239
Computer equipment	3,160		3,152
Leasehold improvements	3,247		3,185
Gross property, plant and equipment	62,183		61,945
Less: accumulated depreciation	(25,727)		(24,400)
Total property, plant and equipment, net	$	36,456	$	37,545

Depreciation, depletion and amortization expense related to property, plant and equipment, net was $1,376 and $1,801 for the three months ended March 31, 2025 and 2024, respectively.

As of March 31, 2025, Land, Building and improvements, Computer equipment, and Machinery and equipment contain finance leases assets, recorded at cost of $9,801, less accumulated depreciation of $2,710. As of December 31, 2024, Land, Building and improvements, Computer equipment, and Machinery and equipment contain finance leases assets, recorded at cost of $9,823, less accumulated depreciation of $2,544.

The Company operates peat bogs in Alberta, Canada. Under current provincial laws the Company is subject to certain AROs and the remediation of the peat bog sites are under provincial oversight. The Company periodically evaluates expected remediation costs associated with the peat bog sites that it operates. When the Company concludes that it is probable that a liability has been incurred, a provision is made for management's estimate of the liability. As of March 31, 2025, and December 31, 2024, the Company had AROs of $274 and $284, respectively, recorded in Accrued expenses and other current liabilities on the condensed consolidated balance sheets. As of March 31, 2025, and December 31, 2024, the Company had AROs of $4,275 and $4,232, respectively, recorded in Other long-term liabilities on the condensed consolidated balance sheets.

The following table presents changes in asset retirement obligations for the following periods:

	Three months ended March 31,
	2025		2024
Balance, beginning of the period	$	4,516	$	5,216
Liabilities incurred in the period	—		—
Liabilities settled in the period	(10)		(224)
Accretion expense	37		46
Other	6		(110)
Balance, end of the period	$	4,549	$	4,928

XML

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

3 Months Ended

Mar. 31, 2025

Payables and Accruals [Abstract]

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities comprised the following:

	March 31, 2025		December 31, 2024
Accrued compensation and benefits	$	2,448	$	1,987
Interest accrual	73		2,141
Freight, custom and duty accrual	1,007		1,130
Goods in transit accrual	711		574
Income tax accrual	229		127
Asset retirement obligations	274		284
Other accrued liabilities	2,672		4,404
Total accrued expenses and other current liabilities	$	7,414	$	10,647

XML

DEBT

3 Months Ended

Mar. 31, 2025

Debt Disclosure [Abstract]

DEBT

DEBT

Debt is comprised of the following:

	March 31, 2025		December 31, 2024
Term Loan - Principal	$	118,995	$	119,303
Term Loan - unamortized discount and deferred financing costs	(3,258)		(3,443)
Term Loan - net of unamortized discount and deferred financing costs	115,737		115,860
Other	107		93
Total debt	$	115,844	$	115,953
Current portion of long-term debt	$	5,876	$	1,260
Long-term debt - net of unamortized discount and deferred financing costs of $3,258 and $3,443 as of March 31, 2025, and December 31, 2024, respectively	109,968		114,693
Total debt	$	115,844	$	115,953

Term Loan

On October 25, 2021, the Company and certain of its direct and indirect subsidiaries (the "Obligors") entered into a Credit and Guaranty Agreement with JPMorgan Chase Bank, N.A., as administrative agent for the lenders, pursuant to which the Company borrowed a $125,000 senior secured term loan (“Term Loan”). The Term Loan was amended by Amendment No. 1 to the Credit and Guaranty Agreement (“Amendment No. 1”) effective on June 27, 2023, to replace the London Interbank Offered Rate ("LIBOR") referenced rates with Secured Overnight Financing Rate ("SOFR") referenced rates. Pursuant to Amendment No. 1, any Term Loan that constitutes a Eurodollar Rate Loan that is outstanding as of the Amendment No. 1 closing date shall continue until the end of the applicable interest period for such Eurodollar Rate Loan and the provisions of the Term Loan applicable thereto shall continue and remain in effect (notwithstanding the occurrence of the Amendment No. 1 closing date) until the end of the applicable interest period for such Eurodollar Rate Loan, after which such provisions shall have no further force or effect. Such Eurodollar Rate Loan shall subsequently either be an ABR Loan or a Term Benchmark Loan. The ABR Loans shall bear interest at the Alternate Base Rate (with a 2.0% floor) plus 4.50%, and Term Benchmark Loans shall bear interest at the Adjusted Term SOFR Rate (with a 1.0% floor), plus 5.50%. The ABR Loan and Term Benchmark Loan credit spreads of 4.50% and 5.50%, respectively, within the Amendment No. 1 have not changed from the credit spreads in the original Term Loan. The foregoing description of Amendment No. 1 does not purport to be complete and is qualified in its entirety by reference to the provisions of Amendment No. 1, included as Exhibit 10.9 to the 2024 Annual Report. Capitalized terms referenced above are defined in the Term Loan.

The Term Loan was subject to a call premium of 1% if called prior to October 25, 2023, and 0% thereafter, and matures on October 25, 2028 ("Maturity Date"). Deferred financing costs are being amortized to interest expense over the term of the loan. For the three months ended March 31, 2025, the effective interest rate was 10.93% and interest expense was $3,214, which includes amortization of deferred financing costs and discount of $185.

The principal amounts of the Term Loan are required to be repaid in consecutive quarterly installments in amounts equal to 0.25% of the original principal amount of the Term Loan, reduced pro-rata by any additional payments made, on the last day of each fiscal quarter commencing March 31, 2022, with the balance of the Term Loan payable on the Maturity Date. The Company is also required to make mandatory prepayments in the event of (i) achieving certain excess cash flow criteria, including the achievement and maintenance of a specific leverage ratio, (ii) certain asset sales that are collateral, or (iii) upon the issuance, offering, or placement of new debt obligations.

As described in Note 3 – Restructuring and Asset Sales, the Company completed the Asset Sale for gross proceeds of $8,660 in May 2024. The net cash proceeds of approximately $6,300 from this transaction are subject to a provision whereby such net cash proceeds can be reinvested into certain investments, such as capital expenditures. This provision of the Term Loan includes (i) cash investments made within a one-year period from the Asset Sale, and (ii) investments which are contractually committed within one-year of the Asset Sale and paid within 180 days after entering into such contractual commitment. The amount of any net cash proceeds which are not reinvested would require the Company to make an offer to prepay the corresponding amount on the Term Loan in 2025. As of March 31, 2025, in accordance with this provision, the Company has estimated the total reinvestments and believe it is probable that an offer to prepay may be made in an estimated amount of $4,600. The amount the Company may offer to prepay is uncertain and based on future activity. The estimated amount has been classified as current debt on the condensed consolidated balance sheet. The foregoing description of the reinvestment provision does not purport to be complete and is qualified in its entirety by reference to the provisions of the Term Loan.

The Term Loan requires the Company to maintain certain reporting requirements, affirmative covenants, and negative covenants, and the Company was in compliance with all requirements as of March 31, 2025. The Term Loan is secured by a first lien on the non-working capital assets of the Company and a second lien on the working capital assets of the Company.

Revolving Credit Facility

On March 29, 2021, the Obligors entered into a Senior Secured Revolving Credit Facility (the "Revolving Credit Facility") with JPMorgan Chase Bank, N.A., as administrative agent, issuing bank and swingline lender, and the lenders from time to time party thereto. The Revolving Credit Facility is due on June 30, 2026, or any earlier date on which the revolving commitments are reduced to zero.

The Revolving Credit Facility originally had a borrowing limit of $50,000. On August 31, 2021, the Obligors entered into an amendment to the Revolving Credit Facility (the "First Amendment") to increase their original borrowing limit to $100,000. In connection with the First Amendment, the Company's previously acquired subsidiaries became party to the Revolving Credit Facility as either borrowers or as guarantors. On October 25, 2021, the Company and its subsidiaries entered into a second amendment to the Revolving Credit Facility (the “Second Amendment”), pursuant to which the parties consented to the Term Loan described above, and made certain conforming changes to comport with the Term Loan provisions. The Revolving Credit Facility was further amended by a third amendment and joinder to the Revolving Credit Facility dated August 23, 2022 (the “Third Amendment”), pursuant to which several previously acquired subsidiaries became parties to the Revolving Credit Facility and granted liens on their assets. On December 22, 2022, the Company entered into a fourth amendment to the Revolving Credit Facility (the “Fourth Amendment”), pursuant to which a sale-leaseback transaction was permitted, and certain other changes were made, including a reduction of the maximum commitment amount under the Revolving Credit Facility from $100,000 to $75,000 and transitioning the LIBOR based rates to SOFR based rates. On March 31, 2023, the Company and certain of its subsidiaries entered into a fifth amendment to the Revolving Credit Facility (the “Fifth Amendment”), pursuant to which the maturity date was extended to June 30, 2026, the maximum commitment amount under the Revolving Credit Facility was reduced to $55,000, and the interest rate on borrowings was revised to various spreads, based on the Company's fixed charge coverage ratio. On November 1, 2024, the Company and certain of its subsidiaries entered into a sixth amendment to the Revolving Credit Facility (the “Sixth Amendment”) which reduced the maximum commitment amount under the Revolving Credit Facility to $35,000.

The unamortized debt discount and deferred financing costs were $203 and $237 as of March 31, 2025, and December 31, 2024, respectively, and are included in other assets in the condensed consolidated balance sheets. Debt discount and deferred financing costs are being amortized to interest expense over the term of the Revolving Credit Facility.

The Revolving Credit Facility is an asset-based facility that is secured by a first priority lien on the working capital assets of the Company and a second priority lien on the non-working capital assets of the Company (including most of the Company’s subsidiaries). The borrowing base is based on a detailed monthly calculation of the sum of (a) a percentage of the Eligible Accounts at such time, plus (b) the lesser of (i) a percentage of the Eligible Inventory, at such time, valued at the lower of cost or market value, determined on a first-in-first-out basis, and (ii) the product of a percentage multiplied by the Net Orderly Liquidation Value percentage identified in the most recent inventory appraisal ordered by the Administrative Agent multiplied by the Eligible Inventory, valued at the lower of cost or market value, determined on a first-in-first-out basis, minus (c) Reserves (each of the defined terms above, as defined in the Revolving Credit Facility documents).

The Company is required to maintain certain reporting requirements, affirmative covenants and negative covenants, pursuant to terms outlined in the agreement. Additionally, if the Company’s Excess Availability is less than an amount equal to 10% of the Aggregate Revolving Commitment ($35,000 as of March 31, 2025), the Company will be required to maintain a minimum fixed charge coverage ratio of 1.1x on a rolling twelve-month basis until the Excess Availability is more than 10% of the Aggregate Revolving Commitment for thirty consecutive days (each of the defined terms above, as defined in the Revolving Credit Facility documents). In order to consummate permitted acquisitions or to make restricted payments, the Company would be required to comply with a higher fixed charge coverage ratio of 1.15x, but no such acquisitions or payments are currently contemplated. The Company received a consent from JPMorgan Chase Bank, N.A., as administrative agent, to permit the cash settlement of fractional shares in connection with the Reverse Stock Split, which is described further in Note 2 – Basis of Presentation and Significant Accounting Policies. As of March 31, 2025, the Company is in compliance with the covenants contained in the Revolving Credit Facility.

The Revolving Credit Facility provides for various interest rate options including the Adjusted Term SOFR Rate, the Adjusted REVSOFR30 Rate, the CB Floating Rate, the Adjusted Daily Simple SOFR, or the CBFR. The rates that use SOFR as the reference rate (Adjusted Term SOFR Rate, the Adjusted REVSOFR30 Rate, the Adjusted Daily Simple SOFR and the CBFR rate) use the Term SOFR Rate plus 1.95%. Each rate has a 0.0% floor. A fee of 0.40% per annum is charged for available but unused borrowings.

As of March 31, 2025, and December 31, 2024, the Company had zero borrowed under the facility. As of March 31, 2025, the Company would be able to borrow approximately $17 million under the Revolving Credit Facility, before the Company would be required to comply with the minimum fixed charge coverage ratio of 1.1x.

Other Debt

Other debt of $107 and $93 as of March 31, 2025, and December 31, 2024, respectively, was primarily comprised of a foreign subsidiary's other debt which constitutes an immaterial revolving line of credit and mortgage.

Aggregate future principal payments

As of March 31, 2025, the aggregate future principal payments under long-term debt are as follows:

	Debt
For the period of April 1, 2025 to December 31, 2025	$	5,563
Year ending December 31,
2026	1,249
2027	1,250
2028 and thereafter	111,040
Total	$	119,102

Subsequent event - Revolving Credit Facility 7th Amendment

On May 9, 2025, the Company and certain of its subsidiaries entered into a seventh amendment to the Revolving Credit Facility (the “Seventh Amendment”), pursuant to which the maturity date of the Revolving Credit Facility was extended from June 30, 2026 to June 30, 2027, the maximum commitment amount under the Revolving Credit Facility was reduced from $35,000 to $22,000, and certain other changes were made, including the addition of a $2,000 availability block, an increase of the cash dominion trigger from less than 10% of availability to less than 50% of availability and an increase of the fixed charge ratio trigger from less than 10% excess availability to less than 20% of excess availability. The foregoing description of the Seventh Amendment does not purport to be complete and is qualified in its entirety by reference to the Seventh Amendment, filed as Exhibit 10.3 to this Quarterly Report on Form 10-Q.

XML

STOCKHOLDERS’ EQUITY

3 Months Ended

Mar. 31, 2025

Equity [Abstract]

STOCKHOLDERS’ EQUITY

STOCKHOLDERS’ EQUITY

Common stock

Each holder of common stock is entitled to one vote for each share of common stock. Common stockholders have no pre-emptive rights to acquire additional shares of common stock or other securities. The common stock is not subject to redemption rights and carries no subscription or conversion rights. In the event of liquidation, the stockholders are entitled to share in corporate assets on a pro rata basis after the Company satisfies all liabilities and after provision is made for any class of capital stock having preference over the common stock. Subject to corporate regulations and preferences to preferred stock, if any, dividends are at the discretion of the board of directors. As of March 31, 2025, there were 4,615,725 shares outstanding and 300,000,000 shares authorized.

XML

STOCK-BASED COMPENSATION

3 Months Ended

Mar. 31, 2025

Share-Based Payment Arrangement [Abstract]

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION

Stock-based compensation plan overview

The Company maintains three equity incentive plans: the 2018 Equity Incentive Plan (“2018 Plan”), the 2019 Employee, Director and Consultant Equity Incentive Plan (“2019 Plan”) and the 2020 Employee, Director, and Consultant Equity Incentive Plan (“2020 Plan” and collectively, “Incentive Plans”). The 2020 Plan serves as the successor to the 2019 Plan and 2018 Plan and provides for the issuance of incentive stock options ("ISOs"), nonqualified stock options, stock grants and stock-based awards to employees, directors, and consultants of the Company. No further awards will be issued under the 2018 Plan and 2019 Plan. As of March 31, 2025, a total of 309,377 shares were available for grant under the 2020 Plan.

The Incentive Plans are administered by the Company's board of directors. Notwithstanding the foregoing, the board of directors may delegate concurrent responsibility for administering each plan, including with respect to designated classes of persons eligible to receive an award under each plan, to a committee or committees (which term shall include subcommittees) consisting of one or more members of the board of directors (collectively, the “Plan Administrator”), subject to such limitations as the board of directors deem appropriate.

In November 2020, the board of directors and stockholders approved the 2020 Plan and reserved an aggregate of 2,284,053 shares of common stock for issuance under the 2020 Plan. Pursuant to the 2020 Plan, the number of shares available for issuance under the 2020 Plan may be increased on January 1 of each year, beginning on January 1, 2021, and ending on January 2, 2030, in an amount equal to the lesser of (i) 4% of the outstanding shares of the Company’s common stock on such date or (ii) such number of shares determined by the Plan Administrator.

The 2020 Plan provides for the grant of ISOs, nonqualified stock options, stock grants, and stock-based awards that are based in whole or in part by reference to the Company’s common stock.

•The Plan Administrator may grant options designated as ISOs or nonqualified stock options. Options shall be granted with an exercise price per share not less than 100% of the fair market value of the common stock on the grant date, subject to certain limitations and exceptions as described in the plan agreements. Generally, the maximum term of an

option shall be 10 years from the grant date. The Plan Administrator shall establish and set forth in each instrument that evidences an option the time at which, or the installments in which, the option shall vest and become exercisable.

•The Plan Administrator may grant stock grants and stock-based awards, including securities convertible into shares, stock appreciation rights, phantom stock awards or stock units on such terms and conditions which may be based on continuous service with the Company or a related company or the achievement of any performance goals, as the Plan Administrator shall determine in its sole discretion, which terms, conditions and restrictions shall be set forth in the instrument evidencing the award.

The tax benefits recognized in the condensed consolidated statements of operations for stock-based compensation arrangements for the three months ended March 31, 2025, and 2024, were not material to the financial statements.

Restricted Stock Unit Activity

RSUs granted to certain executives, employees and members of the board of directors expire 10 years after the grant date. The awards generally have a time-based vesting requirement (based on continuous employment). Upon vesting, the RSUs convert into shares of the Company's common stock. The stock-based compensation expense related to service-based awards is recorded over the requisite service period. During the three months ended March 31, 2025, the Company granted 91,618 RSU awards to certain executives and employees that are expected to vest with either one, two or three equal vesting tranches, annually on the anniversary of the grant date.

The following table summarizes the activity related to the Company's RSUs for the three months ended March 31, 2025. For purposes of this table, vested RSUs represent the shares for which the service condition had been fulfilled during the three months ended March 31, 2025:

	Number of RSUs	Weighted average grant date fair value
Balance, December 31, 2024	102,030	$	13.82
Granted	91,618	$	5.84
Vested	(2,267)	$	167.01
Forfeited	(34)	$	157.40
Balance, March 31, 2025	191,347	$	8.16

As of March 31, 2025, total unamortized stock-based compensation cost related to unvested RSUs was $800 and the weighted-average period over which the compensation is expected to be recognized is approximately one-year. For the three months ended March 31, 2025, the Company recognized $358 of total stock-based compensation expense for RSUs. As of March 31, 2025, there were 62,521 RSUs which had vested, but were not yet issued due to the recipients' elections.

Performance Stock Unit Activity

The Company granted 137,254 PSUs during the second quarter of 2024 that are subject to a one-year vesting requirement (based on continuous employment) and contain performance conditions based on certain performance metrics. The following table summarizes the activity related to the Company's PSUs for the three months ended March 31, 2025:

	Number of PSUs	Weighted average grant date fair value
Balance, December 31, 2024	125,783	$	9.89
Forfeited	(1,839)	$	9.89
Balance, March 31, 2025	123,944	$	9.89

During the three months ended March 31, 2025, the PSU forfeitures were due to employee terminations. The majority of the PSUs outstanding as of March 31, 2025, will be forfeited during the second quarter of 2025, as a result of not meeting

certain performance conditions. As of March 31, 2025, total unamortized stock-based compensation cost related to unvested PSUs was $6 and the weighted-average period over which the compensation is expected to be recognized is less than one-year. For the three months ended March 31, 2025, the Company recognized $116 of total stock-based compensation expense for PSUs.

Stock Options

The vesting of stock options is subject to certain change in control provisions as provided in the incentive plan agreements and stock options may be exercised up to 10 years from the date of issuance.

There were no stock options granted or exercised during the three months ended March 31, 2025. The following table summarizes the stock option activity for the three months ended March 31, 2025:

	Number	Weighted average exercise price		Weighted average grant date fair value		Weighted average remaining contractual term (years)
Outstanding and exercisable as of December 31, 2024	40,654	$	96.36	$	22.76	3.67
Cancelled	(4,679)	$	100.56	$	16.30
Outstanding and exercisable as of March 31, 2025	35,975	$	95.81	$	23.60	3.89

As of March 31, 2025, and December 31, 2024, there were no unvested stock awards, and no compensation cost related to options not yet recognized.

XML

INCOME TAXES

3 Months Ended

Mar. 31, 2025

Income Tax Disclosure [Abstract]

INCOME TAXES

INCOME TAXES

The Company recorded income tax expense of $82 for the three months ended March 31, 2025, representing an effective tax rate of (0.6)%. The Company’s effective tax rate for the three months ended March 31, 2025, differs from the federal statutory rate of 21% primarily due to U.S. and foreign jurisdictions in full valuation allowance. The income tax expense for the three months ended March 31, 2025, was primarily due to foreign taxes in certain jurisdictions and U.S. state taxes.

The Company recorded income tax expense of $196 for the three months ended March 31, 2024, representing an effective tax rate of (1.6)%. The Company’s effective tax rate for the three months ended March 31, 2024, differs from the federal statutory rate of 21% primarily due to the Company maintaining a full valuation allowance against its net deferred tax assets in the U.S. and most foreign jurisdictions. The income tax expense for the three months ended March 31, 2024, was primarily due to U.S. state taxes and foreign taxes in certain jurisdictions

XML

COMMITMENTS AND CONTINGENCIES

3 Months Ended

Mar. 31, 2025

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES

Purchase commitments

From time to time in the normal course of business, the Company will enter into agreements with suppliers which provide favorable pricing in return for a commitment to purchase minimum amounts of inventory over a defined time period.

Contingencies

In the normal course of business, certain claims have been brought against the Company and, where applicable, its suppliers. While there is inherent difficulty in predicting the outcome of such matters, management has vigorously contested the validity of these claims. Based on available information, management does not expect that the outcome of any matters, individually or in the aggregate, would have a material adverse effect on the condensed consolidated financial position, results of operations, cash flows or future earnings of the Company.

XML

FAIR VALUE MEASUREMENTS

3 Months Ended

Mar. 31, 2025

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS

Recurring and Nonrecurring

As described in Note 3 – Restructuring and Asset Sales, during 2024, the Company sold approximately 20 acres of the 140 acres of excess owned land at its Goshen, New York location. The Company measured the held-for-sale land asset at estimated fair value based on the agreement, which was considered a Level 2 fair value measurement. The land had a carrying value of $470, which was consistent with the estimated sale price less costs to sell, and therefore no estimated gain or loss was recorded during 2024. The transaction closed in the fourth quarter of 2024.

The Company did not have any other assets or liabilities that were remeasured to fair value on a recurring or nonrecurring basis during the periods presented.

Other Fair Value Measurements

The following table summarizes the fair value of the Company’s assets and liabilities which are provided for disclosure purposes:

		March 31, 2025		December 31, 2024
	Fair Value Hierarchy Level	Carrying Amount	Estimated Fair Value	Carrying Amount	Estimated Fair Value
Assets
Cash and cash equivalents	Level 1	13,728	13,728	26,111	26,111
Liabilities
Finance leases	Level 3	8,178	8,418	8,289	8,437
Term Loan	Level 2	118,995	95,196	119,303	95,442

Cash and cash equivalents included funds deposited in banks, and the fair values approximated carrying values due to their short-term maturities. The fair values of other current assets and liabilities including accounts receivable, accounts payable, accrued expenses and other current liabilities approximated their carrying value due to their short-term maturities.

The estimated fair value of finance leases, which were considered Level 3 fair value measurements, were calculated as the present value of the required future cash outflows discounted at an estimated borrowing rate. The fair value of the Term Loan was estimated based on Level 2 fair value measurements and was based on bank quotes. The carrying amount of the Term Loan reported above excludes unamortized debt discount and deferred financing costs. Refer to Note 7 – Leases and Note 10 – Debt, for further details of the Company's finance leases and Term Loan, respectively.

The Company did not have any transfers between Levels within the fair value hierarchy during the periods presented.

XML

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Pay vs Performance Disclosure
Net loss	$ (14,385)	$ (12,608)

XML

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2025
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

XML

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)

3 Months Ended

Mar. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of presentation

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the requirements of the SEC for interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP can be condensed or omitted. These condensed consolidated financial statements have been prepared on the same basis as the Company's annual consolidated financial statements and, in the opinion of management, reflect all normal and recurring adjustments which are necessary for the fair statement of the Company’s financial information. These interim results are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2025, or for any other interim period or for any other future year. All intercompany balances and transactions have been eliminated in consolidation.

The condensed consolidated balance sheet as of December 31, 2024, has been derived from the audited consolidated financial statements of the Company, which is included in the 2024 Annual Report. These condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto included in the 2024 Annual Report.

On February 12, 2025, the Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware to effect a 1-for-10 reverse stock split of the Company's common stock, effective February 12, 2025 at 5:00 p.m., Eastern Time and the Company's shares of common stock began trading on a split-adjusted basis on The Nasdaq Capital Market at the commencement of trading on February 13, 2025, under the Company's existing trading symbol “HYFM”. There was no adjustment to the number of authorized shares or the par value. The Company has adjusted the presentation of all periods covered by the condensed consolidated financial statements contained herein to give retroactive effect to the Reverse Stock Split, including adjustments to net loss per share and other per share of Common Stock amounts.

Use of estimates

The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Significant estimates include provisions for sales returns, rebates and claims from customers, realization of accounts receivable and inventories, fair value of assets acquired and liabilities assumed for business combinations, valuation of intangible assets, estimated useful lives of long-lived assets, incremental borrowing rate applied in lease accounting, valuation of stock-based compensation, recognition of deferred income taxes, classification of debt pursuant to certain terms in the Company's credit agreements, recognition of liabilities related to commitments and contingencies, asset retirement obligations ("AROs"), and valuation allowances. Actual results may differ from these estimates.

On an ongoing basis, the Company reviews its estimates to ensure that these estimates appropriately reflect changes in its business or new information available.

Fair value measurements

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company has applied the framework for measuring fair value which requires a fair value hierarchy to be applied to all fair value measurements. All financial instruments recognized at fair value are classified into one of three levels in the fair value hierarchy as follows:

Level 1 — Valuation based on quoted prices (unadjusted) observed in active markets for identical assets or liabilities.

Level 2 — Valuation techniques based on inputs that are quoted prices of similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not in active markets; inputs other than quoted prices used in a valuation model that are observable for that instrument; and inputs that are derived from or, corroborated by, observable market data by correlation or other means.

Level 3 — Valuation techniques with significant unobservable market inputs.

The Company measures certain non-financial assets and liabilities, including long-lived assets and intangible assets at fair value on a nonrecurring basis.

Inventories

Inventories consist of finished goods, work-in-process, and raw materials used in manufacturing products. Inventories are stated at the lower of cost or net realizable value, principally determined by the first in, first out method of accounting. The Company maintains an allowance for excess and obsolete inventory. The estimate for excess and obsolete inventory is based upon assumptions about current and anticipated demand, customer preferences, business strategies, and market conditions. Management reviews these assumptions periodically to determine if any adjustments are needed to the allowance for excess and obsolete inventory. The establishment of an allowance for excess and obsolete inventory establishes a new cost basis in the inventory. Such allowance is not reduced until the product is sold or otherwise disposed. If inventory is sold, any related reserves would be reversed in the period of sale. During the year ended December 31, 2024, the Company estimated inventory markdowns relating to restructuring charges based upon current and anticipated demand, customer preferences, business strategies, and market conditions including management's actions with respect to inventory raw materials and products and brands being removed from the Company's portfolio.

Revenue recognition

The Company follows ASC 606 - Revenue from Contracts with Customers which requires that revenue recognized from contracts with customers be disaggregated into categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. The Company has determined that revenue is generated from one category, which is the distribution and manufacture of CEA equipment and supplies.

Revenue is recognized as control of promised goods is transferred to customers, which generally occurs upon receipt at customers’ locations determined by the specific terms of the contract. Arrangements generally have a single performance obligation and revenue is reported net of variable consideration which includes applicable volume rebates, cash discounts and sales returns and allowances. Variable consideration is estimated and recorded at the time of sale.

The amount billed to customers for shipping and handling costs included in net sales was $1,403 and $2,939 during the three months ended March 31, 2025 and 2024, respectively. Shipping and handling costs that occur before the customer obtains control of the goods are deemed to be fulfillment activities and are accounted for as fulfillment costs included in cost of goods sold. The Company does not receive noncash consideration for the sale of goods. Contract consideration received from a customer prior to revenue recognition is recorded as a contract liability and is recognized as revenue when the Company satisfies the related performance obligation under the terms of the contract. The Company's contract liabilities, which consist primarily of customer deposits reported within deferred revenue in the condensed consolidated balance sheets, totaled $2,307 and $2,611 as of March 31, 2025, and December 31, 2024, respectively. During the three months ended March 31, 2025, the Company recognized $657 of previously deferred revenue, recorded customer deposits of $589 and noted $236 of additional decreases primarily due to customer refunds. There are no significant financing components and the majority of revenue is recognized within one year. Excluded from revenue are any taxes assessed by governmental authorities, including value-added and other sales-related taxes that are imposed on and concurrent with revenue-generating activities.

Income taxes

The income tax provision is calculated for an interim period by distinguishing between elements recognized in the income tax provision through applying an estimated annual effective tax rate to a measure of year-to-date operating results referred to as “ordinary income (or loss),” and discretely recognizing specific events referred to as “discrete items” as they occur. The income tax provision or benefit for each interim period is the difference between the year-to-date amount for the current period and the year-to-date amount for the prior period.

Recent accounting pronouncements

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires greater disaggregation of information in the effective tax rate reconciliation, income taxes paid disaggregated by jurisdiction, and certain other amendments related to income tax disclosures. This guidance will be effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of this ASU on its consolidated financial statements.

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires a public entity to disclose additional information about specific expense categories in the notes to financial statements on an annual and interim basis. The amendments are effective for annual periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with early adoption permitted. A public entity should apply the amendments either prospectively to financial statements issued for reporting periods after the effective date of this ASU or retrospectively to any or all prior periods presented in the financial statements. The Company is currently evaluating the impact that adoption of this accounting standard will have on its financial disclosures.

Restructuring

The Company began a restructuring plan (the "Restructuring Plan") in 2022, and undertook significant actions to streamline operations, reduce costs and improve efficiencies. The major initiatives of the first phase of the Restructuring Plan included (i) narrowing the Company's product and brand portfolio and (ii) the relocation and consolidation of certain manufacturing and distribution centers, including headcount reductions and reorganization to drive a solution based approach. The Company completed the first phase of the Restructuring Plan during the year ended December 31, 2023.

As a result of the continued adverse market conditions, the Company implemented a second phase of the Restructuring Plan beginning in the third quarter of 2023, including U.S. manufacturing facility consolidations, in particular with respect to production of certain durable equipment products. Restructuring activities included termination and disposal costs associated with inventory, facilities, and headcount reductions, and non-cash charges consisting of fixed asset and inventory write-downs.

Purchase commitments

From time to time in the normal course of business, the Company will enter into agreements with suppliers which provide favorable pricing in return for a commitment to purchase minimum amounts of inventory over a defined time period.

Contingencies

In the normal course of business, certain claims have been brought against the Company and, where applicable, its suppliers. While there is inherent difficulty in predicting the outcome of such matters, management has vigorously contested the validity of these claims. Based on available information, management does not expect that the outcome of any matters, individually or in the aggregate, would have a material adverse effect on the condensed consolidated financial position, results of operations, cash flows or future earnings of the Company.

XML

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Mar. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Revenue from External Customers by Geographic Areas

Net sales and property, plant and equipment, net and operating lease right-of-use assets in the United States and Canada, as determined by the location of the subsidiaries, are shown below. Other foreign locations, which are immaterial, individually and in the aggregate, are included in the United States below.

	Three months ended March 31,
	2025		2024
United States	$	32,277	$	40,455
Canada	9,022		14,425
Eliminations	(765)		(708)
Total consolidated net sales	$	40,534	$	54,172

	March 31, 2025		December 31, 2024
United States	$	48,558	$	50,928
Canada	28,761		29,513
Total property, plant and equipment, net and operating lease right-of-use assets	$	77,319	$	80,441

Long-lived Assets by Geographic Areas

Net sales and property, plant and equipment, net and operating lease right-of-use assets in the United States and Canada, as determined by the location of the subsidiaries, are shown below. Other foreign locations, which are immaterial, individually and in the aggregate, are included in the United States below.

	Three months ended March 31,
	2025		2024
United States	$	32,277	$	40,455
Canada	9,022		14,425
Eliminations	(765)		(708)
Total consolidated net sales	$	40,534	$	54,172

	March 31, 2025		December 31, 2024
United States	$	48,558	$	50,928
Canada	28,761		29,513
Total property, plant and equipment, net and operating lease right-of-use assets	$	77,319	$	80,441

XML

RESTRUCTURING AND ASSET SALES (Tables)

3 Months Ended

Mar. 31, 2025

Restructuring and Related Activities [Abstract]

Restructuring Costs

The following tables present the activity in accrued expenses and other current liabilities for restructuring costs related to the second phase of the Restructuring Plan for the three months ended March 31, 2024:

	Three Months Ended March 31, 2024
Restructuring Accruals as of December 31, 2023	$	187
Expense	130
Cash Payments	(180)
Restructuring Accruals as of March 31, 2024	$	137

XML

INTANGIBLE ASSETS, NET (Tables)

3 Months Ended

Mar. 31, 2025

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Indefinite-Lived Intangible Assets

Intangible assets, net comprised the following:

	March 31, 2025						December 31, 2024
	Gross Carrying Amount		Accumulated Amortization		Net Book Value		Gross Carrying Amount		Accumulated Amortization		Net Book Value
Finite-lived intangible assets:
Computer software	$	8,995	$	(8,688)	$	307	$	8,982	$	(8,625)	$	357
Customer relationships	99,806		(41,066)		58,740		99,806		(39,230)		60,576
Technology, formulations and recipes	110,381		(35,727)		74,654		110,381		(33,401)		76,980
Trade names and trademarks	131,492		(25,106)		106,386		131,492		(23,432)		108,060
Other	4,717		(4,526)		191		4,716		(4,488)		228
Total finite-lived intangible assets, net	355,391		(115,113)		240,278		355,377		(109,176)		246,201
Indefinite-lived intangible asset:
Trade name	2,801		—		2,801		2,801		—		2,801
Total Intangible assets, net	$	358,192	$	(115,113)	$	243,079	$	358,178	$	(109,176)	$	249,002

Schedule of Finite-Lived Intangible Assets

Intangible assets, net comprised the following:

	March 31, 2025						December 31, 2024
	Gross Carrying Amount		Accumulated Amortization		Net Book Value		Gross Carrying Amount		Accumulated Amortization		Net Book Value
Finite-lived intangible assets:
Computer software	$	8,995	$	(8,688)	$	307	$	8,982	$	(8,625)	$	357
Customer relationships	99,806		(41,066)		58,740		99,806		(39,230)		60,576
Technology, formulations and recipes	110,381		(35,727)		74,654		110,381		(33,401)		76,980
Trade names and trademarks	131,492		(25,106)		106,386		131,492		(23,432)		108,060
Other	4,717		(4,526)		191		4,716		(4,488)		228
Total finite-lived intangible assets, net	355,391		(115,113)		240,278		355,377		(109,176)		246,201
Indefinite-lived intangible asset:
Trade name	2,801		—		2,801		2,801		—		2,801
Total Intangible assets, net	$	358,192	$	(115,113)	$	243,079	$	358,178	$	(109,176)	$	249,002

The following are the estimated useful lives and the weighted-average amortization period remaining as of March 31, 2025, for the major classes of finite-lived intangible assets:

	Useful lives	Weighted-average amortization period remaining
Computer software	3 to 5 years	1 year
Customer relationships	7 to 18 years	9 years
Technology, formulations and recipes	8 to 12 years	8 years
Trade names and trademarks	15 to 20 years	16 years

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense

The estimated aggregate future amortization expense for intangible assets subject to amortization as of March 31, 2025, is summarized below:

	Estimated Future Amortization Expense
For the period of April 1, 2025 to December 31, 2025	$	17,801
Year ending December 31,
2026	23,532
2027	23,359
2028	22,713
2029	21,582
2030	21,394
Thereafter	109,897
Total	$	240,278

XML

LOSS PER COMMON SHARE (Tables)

3 Months Ended

Mar. 31, 2025

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following table presents basic and diluted loss per common share for the three months ended March 31, 2025 and 2024:

	Three months ended March 31,
	2025		2024
Net loss	$	(14,385)	$	(12,608)
Weighted-average shares of common stock outstanding	4,614,510		4,581,221
Dilutive effect of share based compensation awards using the treasury stock method	—		—
Diluted weighted-average shares of common stock outstanding	4,614,510		4,581,221
Basic loss per common share	$	(3.12)	$	(2.75)
Diluted loss per common share	$	(3.12)	$	(2.75)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The computation of the weighted-average shares of common stock outstanding for diluted loss per common share excludes the following potential shares of common stock as their inclusion would have an anti-dilutive effect on diluted loss per common share:

	Three months ended March 31,
	2025	2024
Shares subject to unvested or deferred performance and restricted stock units	377,812	112,949
Shares subject to stock options outstanding	35,975	44,374

XML

ACCOUNTS RECEIVABLE, NET, AND INVENTORIES (Tables)

3 Months Ended

Mar. 31, 2025

Receivables [Abstract]

Schedule of Accounts Receivable, Net

Accounts receivable, net comprised the following:

	March 31, 2025		December 31, 2024
Trade accounts receivable	$	20,309	$	14,112
Allowance for doubtful accounts	(621)		(706)
Other receivables	1,231		1,350
Total accounts receivable, net	$	20,919	$	14,756

Schedule of Change in the Allowance for Doubtful Accounts

The change in the allowance for doubtful accounts consisted of the following:

	Three months ended March 31,
	2025		2024
Beginning balance	$	(706)	$	(920)
Changes in estimates	(585)		(124)
Write-offs	712		229
Collections/Other	(42)		31
Ending balance	$	(621)	$	(784)

Schedule of Inventories

Inventories comprised the following:

	March 31, 2025		December 31, 2024
Finished goods	$	43,745	$	44,372
Work-in-process	962		1,137
Raw materials	11,863		12,398
Allowance for inventory obsolescence	(6,668)		(7,274)
Total inventories	$	49,902	$	50,633

XML

LEASES (Tables)

3 Months Ended

Mar. 31, 2025

Leases [Abstract]

Schedule of Assets And Liabilities, Lessee

Total right-of-use ("ROU") assets, finance lease assets, and lease liabilities were as follows:

	Balance Sheet Classification	March 31, 2025		December 31, 2024
Lease assets
Operating lease assets	Operating lease right-of-use assets	$	40,863	$	42,869
Finance lease assets	Property, plant and equipment, net	7,091		7,279
Total lease assets		$	47,954	$	50,148
Lease liabilities
Current:
Operating leases	Current portion of operating lease liabilities	$	7,785	$	7,731
Finance leases	Current portion of finance lease liabilities	467		459
Noncurrent:
Operating leases	Long-term operating lease liabilities	35,629		37,553
Finance leases	Long-term finance lease liabilities	7,711		7,830
Total lease liabilities		$	51,592	$	53,573

Schedule of Lessee, Operating Lease, Liability, Maturity

The aggregate future minimum lease payments under long-term non-cancelable operating and finance leases with remaining terms greater than one year as of March 31, 2025 are as follows:

	Operating		Finance
For the period of April 1, 2025 to December 31, 2025	$	7,137	$	661
Year ending December 31,
2026	8,693		847
2027	8,781		850
2028	8,243		805
2029	5,374		822
2030	4,240		838
Thereafter	6,643		6,379
Total lease payments	49,111		11,202
Less portion representing interest	(5,697)		(3,024)
Total principal	43,414		8,178
Less current portion	(7,785)		(467)
Long-term portion	$	35,629	$	7,711

Schedule of Finance Lease, Liability, Fiscal Year Maturity

The aggregate future minimum lease payments under long-term non-cancelable operating and finance leases with remaining terms greater than one year as of March 31, 2025 are as follows:

	Operating		Finance
For the period of April 1, 2025 to December 31, 2025	$	7,137	$	661
Year ending December 31,
2026	8,693		847
2027	8,781		850
2028	8,243		805
2029	5,374		822
2030	4,240		838
Thereafter	6,643		6,379
Total lease payments	49,111		11,202
Less portion representing interest	(5,697)		(3,024)
Total principal	43,414		8,178
Less current portion	(7,785)		(467)
Long-term portion	$	35,629	$	7,711

XML

PROPERTY, PLANT AND EQUIPMENT, NET (Tables)

3 Months Ended

Mar. 31, 2025

Property, Plant and Equipment [Abstract]

Schedule of Property, Plant and Equipment

Property, plant and equipment, net comprised the following:

	March 31, 2025		December 31, 2024
Machinery and equipment	$	23,606	$	23,531
Peat bogs and related development	11,936		11,895
Building and improvements	10,327		10,313
Land	5,640		5,630
Furniture and fixtures	4,267		4,239
Computer equipment	3,160		3,152
Leasehold improvements	3,247		3,185
Gross property, plant and equipment	62,183		61,945
Less: accumulated depreciation	(25,727)		(24,400)
Total property, plant and equipment, net	$	36,456	$	37,545

Schedule of Asset Retirement Obligations

The following table presents changes in asset retirement obligations for the following periods:

	Three months ended March 31,
	2025		2024
Balance, beginning of the period	$	4,516	$	5,216
Liabilities incurred in the period	—		—
Liabilities settled in the period	(10)		(224)
Accretion expense	37		46
Other	6		(110)
Balance, end of the period	$	4,549	$	4,928

XML

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)

3 Months Ended

Mar. 31, 2025

Payables and Accruals [Abstract]

Schedule of Accrued Liabilities and Other Current Liabilities

Accrued expenses and other current liabilities comprised the following:

	March 31, 2025		December 31, 2024
Accrued compensation and benefits	$	2,448	$	1,987
Interest accrual	73		2,141
Freight, custom and duty accrual	1,007		1,130
Goods in transit accrual	711		574
Income tax accrual	229		127
Asset retirement obligations	274		284
Other accrued liabilities	2,672		4,404
Total accrued expenses and other current liabilities	$	7,414	$	10,647

XML

DEBT (Tables)

3 Months Ended

Mar. 31, 2025

Debt Disclosure [Abstract]

Schedule of Debt

Debt is comprised of the following:

	March 31, 2025		December 31, 2024
Term Loan - Principal	$	118,995	$	119,303
Term Loan - unamortized discount and deferred financing costs	(3,258)		(3,443)
Term Loan - net of unamortized discount and deferred financing costs	115,737		115,860
Other	107		93
Total debt	$	115,844	$	115,953
Current portion of long-term debt	$	5,876	$	1,260
Long-term debt - net of unamortized discount and deferred financing costs of $3,258 and $3,443 as of March 31, 2025, and December 31, 2024, respectively	109,968		114,693
Total debt	$	115,844	$	115,953

Schedule of Maturities of Long-term Debt

As of March 31, 2025, the aggregate future principal payments under long-term debt are as follows:

	Debt
For the period of April 1, 2025 to December 31, 2025	$	5,563
Year ending December 31,
2026	1,249
2027	1,250
2028 and thereafter	111,040
Total	$	119,102

XML

STOCK-BASED COMPENSATION (Tables)

3 Months Ended

Mar. 31, 2025

Share-Based Payment Arrangement [Abstract]

Share-based Payment Arrangement, Outstanding Award, Activity, Excluding Option

The following table summarizes the activity related to the Company's RSUs for the three months ended March 31, 2025. For purposes of this table, vested RSUs represent the shares for which the service condition had been fulfilled during the three months ended March 31, 2025:

	Number of RSUs	Weighted average grant date fair value
Balance, December 31, 2024	102,030	$	13.82
Granted	91,618	$	5.84
Vested	(2,267)	$	167.01
Forfeited	(34)	$	157.40
Balance, March 31, 2025	191,347	$	8.16

The following table summarizes the activity related to the Company's PSUs for the three months ended March 31, 2025:

	Number of PSUs	Weighted average grant date fair value
Balance, December 31, 2024	125,783	$	9.89
Forfeited	(1,839)	$	9.89
Balance, March 31, 2025	123,944	$	9.89

Share-based Payment Arrangement, Option, Activity

The following table summarizes the stock option activity for the three months ended March 31, 2025:

	Number	Weighted average exercise price		Weighted average grant date fair value		Weighted average remaining contractual term (years)
Outstanding and exercisable as of December 31, 2024	40,654	$	96.36	$	22.76	3.67
Cancelled	(4,679)	$	100.56	$	16.30
Outstanding and exercisable as of March 31, 2025	35,975	$	95.81	$	23.60	3.89

XML

FAIR VALUE MEASUREMENTS (Tables)

3 Months Ended

Mar. 31, 2025

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

The following table summarizes the fair value of the Company’s assets and liabilities which are provided for disclosure purposes:

		March 31, 2025		December 31, 2024
	Fair Value Hierarchy Level	Carrying Amount	Estimated Fair Value	Carrying Amount	Estimated Fair Value
Assets
Cash and cash equivalents	Level 1	13,728	13,728	26,111	26,111
Liabilities
Finance leases	Level 3	8,178	8,418	8,289	8,437
Term Loan	Level 2	118,995	95,196	119,303	95,442

XML

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) $ in Thousands		3 Months Ended
	Feb. 12, 2025	Mar. 31, 2025 USD ($) segment	Mar. 31, 2024 USD ($)	Dec. 31, 2024 USD ($)
Restructuring Cost and Reserve [Line Items]
Reverse stock split	0.1
Number of operating segments | segment		1
Number of reportable segments | segment		1
Net sales		$ 40,534	$ 54,172
Deferred revenue		2,307		$ 2,611
Revenue recognized		657
Increase (decrease) in customer deposits		589
Customer refunds		236
Shipping and Handling
Restructuring Cost and Reserve [Line Items]
Net sales		$ 1,403	$ 2,939

XML

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES - Entity-wide Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024	Dec. 31, 2024
Segment Reporting Information [Line Items]
Net sales	$ 40,534	$ 54,172
Property, plant and equipment, and operating lease right-of-use assets, net	77,319		$ 80,441
United States
Segment Reporting Information [Line Items]
Property, plant and equipment, and operating lease right-of-use assets, net	48,558		50,928
Canada
Segment Reporting Information [Line Items]
Property, plant and equipment, and operating lease right-of-use assets, net	28,761		$ 29,513
Operating segments | United States
Segment Reporting Information [Line Items]
Net sales	32,277	40,455
Operating segments | Canada
Segment Reporting Information [Line Items]
Net sales	9,022	14,425
Eliminations
Segment Reporting Information [Line Items]
Net sales	$ (765)	$ (708)

XML

RESTRUCTURING AND ASSET SALES - Narrative (Details) $ in Thousands		3 Months Ended		12 Months Ended	18 Months Ended
	May 31, 2024 USD ($)	Mar. 31, 2025 USD ($)	Mar. 31, 2024 USD ($)	Dec. 31, 2024 USD ($) a	Mar. 31, 2025 USD ($)	May 10, 2024 USD ($)	Dec. 31, 2023 USD ($)
Restructuring Cost and Reserve [Line Items]
Accrued liability for restructuring costs			$ 137				$ 187
Expense			130
Provision for inventory obsolescence		$ 312	568
Net cash proceeds		6,300
Number of acres to be sold | a				20
Number of acres owned | a				140
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Durable Manufacturing Facility
Restructuring Cost and Reserve [Line Items]
Proceeds from sale of assets						$ 8,660
Inventories sold or disposed of	$ 11,616
Property, plant and equipment sold or disposed	3,721
Intangible assets sold or disposed of	2,573
Other liabilities sold or disposed of	90
Proceeds from operating lease termination	1,275
Proceeds from equipment finance lease termination	668
Costs to sell	$ 417
Loss on asset disposition				$ 11,520
Provision for inventory obsolescence				4,960
Sale of property, plant and equipment				3,700
Restructuring Plan, Phase Two
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 362
Accrued liability for restructuring costs				$ 103
Restructuring Plan, Phase Two | Cost of Sales
Restructuring Cost and Reserve [Line Items]
Restructuring charges			91
Restructuring Plan, Phase Two | Selling, General and Administrative Expenses
Restructuring Cost and Reserve [Line Items]
Restructuring charges			47
Facility Closing | Restructuring Plan, Phase Two
Restructuring Cost and Reserve [Line Items]
Restructuring charges			$ 138		$ 2,034
Inventory Writedown | Restructuring Plan, Phase Two
Restructuring Cost and Reserve [Line Items]
Restructuring charges					$ 9,737

XML

RESTRUCTURING AND ASSET SALES - Restructuring Costs (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($)
Restructuring Reserve [Roll Forward]
Restructuring accruals, beginning balance	$ 187
Expense	130
Cash Payments	(180)
Restructuring accruals, ending balance	$ 137

XML

INTANGIBLE ASSETS, NET - Intangible Assets, net (Details) - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 355,391	$ 355,377
Accumulated Amortization	(115,113)	(109,176)
Total	240,278	246,201
Indefinite-lived Intangible Assets [Line Items]
Gross Carrying Amount	358,192	358,178
Total	243,079	249,002
Trade name
Indefinite-lived Intangible Assets [Line Items]
Gross Carrying Amount	2,801	2,801
Computer software
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	8,995	8,982
Accumulated Amortization	(8,688)	(8,625)
Total	307	357
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	99,806	99,806
Accumulated Amortization	(41,066)	(39,230)
Total	58,740	60,576
Technology, formulations and recipes
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	110,381	110,381
Accumulated Amortization	(35,727)	(33,401)
Total	74,654	76,980
Trade names and trademarks
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	131,492	131,492
Accumulated Amortization	(25,106)	(23,432)
Total	106,386	108,060
Other
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	4,717	4,716
Accumulated Amortization	(4,526)	(4,488)
Total	$ 191	$ 228

XML

INTANGIBLE ASSETS, NET - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 5,933	$ 6,084

XML

INTANGIBLE ASSETS, NET - Useful Life Finite-lived Intangible Assets (Details)	Mar. 31, 2025
Minimum | Computer software
Finite-Lived Intangible Assets [Line Items]
Useful lives	3 years
Minimum | Customer relationships
Finite-Lived Intangible Assets [Line Items]
Useful lives	7 years
Minimum | Technology, formulations and recipes
Finite-Lived Intangible Assets [Line Items]
Useful lives	8 years
Minimum | Trade names and trademarks
Finite-Lived Intangible Assets [Line Items]
Useful lives	15 years
Maximum | Computer software
Finite-Lived Intangible Assets [Line Items]
Useful lives	5 years
Maximum | Customer relationships
Finite-Lived Intangible Assets [Line Items]
Useful lives	18 years
Maximum | Technology, formulations and recipes
Finite-Lived Intangible Assets [Line Items]
Useful lives	12 years
Maximum | Trade names and trademarks
Finite-Lived Intangible Assets [Line Items]
Useful lives	20 years
Weighted Average | Computer software
Finite-Lived Intangible Assets [Line Items]
Weighted-average amortization period remaining	1 year
Weighted Average | Customer relationships
Finite-Lived Intangible Assets [Line Items]
Weighted-average amortization period remaining	9 years
Weighted Average | Technology, formulations and recipes
Finite-Lived Intangible Assets [Line Items]
Weighted-average amortization period remaining	8 years
Weighted Average | Trade names and trademarks
Finite-Lived Intangible Assets [Line Items]
Weighted-average amortization period remaining	16 years

XML

INTANGIBLE ASSETS, NET - Future Amortization Expense (Details) - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
For the period of April 1, 2025 to December 31, 2025	$ 17,801
2026	23,532
2027	23,359
2028	22,713
2029	21,582
2030	21,394
Thereafter	109,897
Total	$ 240,278	$ 246,201

XML

LOSS PER COMMON SHARE - Calculation for Basic and Diluted EPS (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (14,385)	$ (12,608)
Weighted-average shares of common stock outstanding (in shares)	4,614,510	4,581,221
Diluted weighted-average shares of common stock outstanding (in shares)	4,614,510	4,581,221
Basic loss per common share (in dollars per share)	$ (3.12)	$ (2.75)
Diluted loss per common share (in dollars per share)	$ (3.12)	$ (2.75)
Share Based Compensation Awards and Warrants
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Dilutive effect of warrants and share based compensation awards using the treasury stock method (in shares)	0	0

XML

LOSS PER COMMON SHARE - Antidilutive (Details) - shares	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Shares subject to unvested or deferred performance and restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares subject to (in shares)	377,812	112,949
Shares subject to stock options outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares subject to (in shares)	35,975	44,374

XML

ACCOUNTS RECEIVABLE, NET, AND INVENTORIES - Accounts Receivable, Net (Details) - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Receivables [Abstract]
Trade accounts receivable	$ 20,309	$ 14,112
Allowance for doubtful accounts	(621)	(706)
Other receivables	1,231	1,350
Total accounts receivable, net	$ 20,919	$ 14,756

XML

ACCOUNTS RECEIVABLE, NET, AND INVENTORIES - Change in Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	$ (706)	$ (920)
Changes in estimates	(585)	(124)
Write-offs	712	229
Collections/Other	(42)	31
Ending balance	$ (621)	$ (784)

XML

ACCOUNTS RECEIVABLE, NET, AND INVENTORIES - Inventories (Details) - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Inventory [Line Items]
Finished goods	$ 43,745	$ 44,372
Work-in-process	962	1,137
Raw materials	11,863	12,398
Allowance for inventory obsolescence	(6,668)	(7,274)
Total inventories	$ 49,902	$ 50,633

XML

LEASES - Narrative (Details) - USD ($) $ in Thousands	1 Months Ended		3 Months Ended
	Apr. 30, 2032	Apr. 30, 2025	Mar. 31, 2025	Mar. 31, 2024
Lessee, Lease, Description [Line Items]
Lease term			20 years
Operating lease, cost			$ 2,384	$ 2,750
Sublease income			1,188	738
Non-cash operating lease expense			$ 1,941	$ 2,244
Forecast | Edmonton, Canada
Lessee, Lease, Description [Line Items]
Non-cash operating lease expense	$ 419
Subsequent Event | Edmonton, Canada
Lessee, Lease, Description [Line Items]
Extended term		7 years
Non-cash operating lease expense		$ 347

XML

LEASES - Balance Sheet (Details) - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Lease assets
Operating lease right-of-use assets	$ 40,863	$ 42,869
Property, plant and equipment, net	7,091	7,279
Total lease assets	47,954	50,148
Lease liabilities
Current portion of operating lease liabilities	7,785	7,731
Current portion of finance lease liabilities	467	459
Long-term operating lease liabilities	35,629	37,553
Long-term finance lease liabilities	7,711	7,830
Total lease liabilities	$ 51,592	$ 53,573

XML

LEASES - Future Minimum Lease Payment (Details) - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Operating
For the period of April 1, 2025 to December 31, 2025	$ 7,137
2026	8,693
2027	8,781
2028	8,243
2029	5,374
2030	4,240
Thereafter	6,643
Total lease payments	49,111
Less portion representing interest	(5,697)
Total lease liabilities	43,414
Less current portion	(7,785)	$ (7,731)
Long-term portion	35,629	37,553
Finance
For the period of April 1, 2025 to December 31, 2025	661
2026	847
2027	850
2028	805
2029	822
2030	838
Thereafter	6,379
Total lease payments	11,202
Less portion representing interest	(3,024)
Total principal	8,178
Less current portion	(467)	(459)
Long-term finance lease liabilities	$ 7,711	$ 7,830

XML

PROPERTY, PLANT AND EQUIPMENT, NET - Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	$ 62,183	$ 61,945
Less: accumulated depreciation	(25,727)	(24,400)
Total property, plant and equipment, net	36,456	37,545
Machinery and equipment
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	23,606	23,531
Peat bogs and related development
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	11,936	11,895
Building and improvements
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	10,327	10,313
Land
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	5,640	5,630
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	4,267	4,239
Computer equipment
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	3,160	3,152
Leasehold improvements
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	$ 3,247	$ 3,185

XML

PROPERTY, PLANT AND EQUIPMENT, NET - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024	Dec. 31, 2024
Property, Plant and Equipment [Abstract]
Depreciation and amortization expense	$ 1,376	$ 1,801
Finance lease assets cost	9,801		$ 9,823
Finance lease assets, accumulated depreciation	2,710		2,544
Asset retirement obligations	274		284
Asset retirement obligations, noncurrent	$ 4,275		$ 4,232

XML

PROPERTY, PLANT AND EQUIPMENT, NET - Asset Retirement Obligations (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Asset Retirement Obligation, Roll Forward Analysis [Roll Forward]
Balance, beginning of the period	$ 4,516	$ 5,216
Liabilities incurred in the period	0	0
Liabilities settled in the period	(10)	(224)
Accretion expense	37	46
Other	6	(110)
Balance, end of the period	$ 4,549	$ 4,928

XML

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Payables and Accruals [Abstract]
Accrued compensation and benefits	$ 2,448	$ 1,987
Interest accrual	73	2,141
Freight, custom and duty accrual	1,007	1,130
Goods in transit accrual	711	574
Income tax accrual	229	127
Asset retirement obligations	274	284
Other accrued liabilities	2,672	4,404
Total accrued expenses and other current liabilities	$ 7,414	$ 10,647

XML

DEBT - Components (Details) - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024	Oct. 25, 2021
Debt Instrument [Line Items]
Long-term debt, gross	$ 119,102
Total debt	115,844	$ 115,953
Current portion of long-term debt	5,876	1,260
Long-term debt - net of unamortized discount and deferred financing costs of $3,258 and $3,443 as of March 31, 2025, and December 31, 2024, respectively	109,968	114,693
Total debt	115,844	115,953
Term loan
Debt Instrument [Line Items]
Long-term debt, gross	118,995	119,303	$ 125,000
Term Loan - unamortized discount and deferred financing costs	(3,258)	(3,443)
Total debt	115,737	115,860
Other
Debt Instrument [Line Items]
Total debt	$ 107	$ 93

XML

DEBT - Term Loans (Details) - USD ($) $ in Thousands		3 Months Ended
	Jun. 27, 2023	Mar. 31, 2025	Dec. 31, 2024	May 10, 2024	Oct. 25, 2021
Debt Instrument [Line Items]
Long-term debt, gross		$ 119,102
Net cash proceeds		6,300
Current portion of long-term debt		5,876	$ 1,260
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Durable Manufacturing Facility
Debt Instrument [Line Items]
Proceeds from sale of assets				$ 8,660
Senior Secured Term Loan
Debt Instrument [Line Items]
Long-term debt, gross		$ 118,995	$ 119,303		$ 125,000
Debt instrument, call premium rate, year one					1.00%
Debt instrument, call premium rate, thereafter					0.00%
Debt instrument, interest rate during period		10.93%
Interest expense, debt		$ 3,214
Amortization of deferred financing costs		185
Debt instrument, quarterly payment, principal outstanding, percentage					0.25%
Term Loan, Amendment No. 1 | Alternative Base Rate
Debt Instrument [Line Items]
Debt instrument, floor on variable rate	2.00%
Debt instrument, basis spread on variable rate	4.50%
Term Loan, Amendment No. 1 | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Debt instrument, floor on variable rate	1.00%
Debt instrument, basis spread on variable rate	5.50%
Secured debt | Senior Term Loan
Debt Instrument [Line Items]
Current portion of long-term debt		$ 4,600

XML

DEBT - Revolving Asset-backed Credit Facilities (Details)	3 Months Ended
	Mar. 31, 2025 USD ($)	May 09, 2025 USD ($)	Dec. 31, 2024 USD ($)	Nov. 01, 2024 USD ($)	Mar. 31, 2023 USD ($)	Dec. 22, 2022 USD ($)	Aug. 31, 2021 USD ($)	Mar. 29, 2021 USD ($)
Debt Instrument [Line Items]
Other debt	$ 107,000		$ 93,000
JPMorgan Credit Facility
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	$ 35,000,000
Excess availability threshold	10.00%
Covenant , minimum fixed charge coverage ratio, term	12 months
Covenant, excess availability term	30 days
Fixed charge coverage ratio	1.15
Borrowings outstanding	$ 0		0
Line of credit facility, remaining borrowing capacity	$ 17,000,000
Revolving Asset-baked Credit Facility | Revolving Credit Facility
Debt Instrument [Line Items]
Fixed charge ratio, cash dominion	0.10
Fixed charge ratio, excess availability	0.10
Revolving Asset-baked Credit Facility | Revolving Credit Facility | Subsequent Event
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity		$ 22,000,000
Availability block		$ 2,000,000
Fixed charge ratio, cash dominion		0.50
Fixed charge ratio, excess availability		0.20
Revolving Asset-baked Credit Facility | JPMorgan Credit Facility | Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity				$ 35,000,000	$ 55,000,000	$ 75,000,000	$ 100,000,000	$ 50,000,000
Deferred financing costs and discount	$ 203,000		$ 237,000
Covenant , minimum fixed charge coverage ratio multiplier	1.1
Debt instrument, basis spread on variable rate	1.95%
Debt instrument, floor on variable rate	0.00%
Line of credit facility, unused capacity, commitment fee percentage	0.40%

XML

DEBT - Future Principal Payments (Details) $ in Thousands	Mar. 31, 2025 USD ($)
Debt Disclosure [Abstract]
For the period of April 1, 2025 to December 31, 2025	$ 5,563
2026	1,249
2027	1,250
2028 and thereafter	111,040
Total	$ 119,102

XML

STOCKHOLDERS’ EQUITY (Details)	Mar. 31, 2025 vote shares	Dec. 31, 2024 shares
Class of Warrant or Right [Line Items]
Common stock, shares outstanding (in shares)	4,615,725	4,614,279
Common stock, shares authorized (in shares)	300,000,000	300,000,000
Common Stock
Class of Warrant or Right [Line Items]
Votes per share of stock | vote	1

XML

STOCK-BASED COMPENSATION - Narrative (Details)	1 Months Ended	3 Months Ended
	Nov. 30, 2020 shares	Mar. 31, 2025 USD ($) plan tranche shares	Jun. 30, 2024 shares	Dec. 31, 2024 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of equity plans maintained | plan		3
Expiration period	10 years
Granted (in shares)		0
Exercised (in shares)		0
RSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)		91,618
Cost not yet recognized, amount | $		$ 800,000
Cost not yet recognized, period for recognition (less than)		1 year
Stock-based compensation expense | $		$ 358,000
Awards vested but not yet issued (in shares)		62,521
RSU | Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting tranches | tranche		1
RSU | Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting tranches | tranche		2
RSU | Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting tranches | tranche		3
PSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)			137,254
Vesting period			1 year
Cost not yet recognized, amount | $		$ 6,000
Cost not yet recognized, period for recognition (less than)		1 year
Stock-based compensation expense | $		$ 116,000
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cost not yet recognized, amount | $		$ 0		$ 0
2020 Employee, Director, and Consultant Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)		309,377
Capital shares reserved for future issuance (in shares)	2,284,053
Percentage of outstanding stock maximum	4.00%
Purchase price of common stock, percent	100.00%
Expiration period	10 years

XML

STOCK-BASED COMPENSATION - RSU Activity (Details) - RSU	3 Months Ended
	Mar. 31, 2025 $ / shares shares
Number of RSUs
Beginning (in shares) | shares	102,030
Granted (in shares) | shares	91,618
Vested (in shares) | shares	(2,267)
Forfeited (in shares) | shares	(34)
Ending (in shares) | shares	191,347
Weighted average grant date fair value
Beginning (in dollars per shares) | $ / shares	$ 13.82
Granted (in dollars per share) | $ / shares	5.84
Vested (in dollars per share) | $ / shares	167.01
Forfeited (in dollars per share) | $ / shares	157.40
Ending (in dollars shares) | $ / shares	$ 8.16

XML

STOCK-BASED COMPENSATION - PSU Activity (Details) - PSU - $ / shares	3 Months Ended
	Mar. 31, 2025	Jun. 30, 2024
Number of PSUs
Beginning (in shares)	125,783
Granted (in shares)		137,254
Forfeited (in shares)	(1,839)
Ending (in shares)	123,944
Weighted average grant date fair value
Beginning (in dollars per shares)	$ 9.89
Forfeited (in dollars per share)	9.89
Ending (in dollars shares)	$ 9.89

XML

STOCK-BASED COMPENSATION - Stock Option Activity (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2025	Dec. 31, 2024
Number
Outstanding, beginning (in shares)	40,654
Cancelled (in shares)	(4,679)
Outstanding, ending (in shares)	35,975	40,654
Weighted average exercise price
Outstanding, beginning (in dollars per share)	$ 96.36
Cancelled (in dollars per share)	100.56
Outstanding, ending (in dollars per share)	95.81	$ 96.36
Weighted average grant date fair value
Outstanding, beginning (in dollars per share)	22.76
Cancelled (in dollars per share)	16.30
Outstanding, ending (in dollars per share)	$ 23.60	$ 22.76
Weighted average remaining contractual term (years)
Outstanding, term	3 years 10 months 20 days	3 years 8 months 1 day

XML

INCOME TAXES (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Income Tax Disclosure [Abstract]
Income tax expense	$ 82	$ 196
Effective income tax rate	(0.60%)	(1.60%)

XML

FAIR VALUE MEASUREMENTS (Details) $ in Thousands	Dec. 31, 2024 USD ($) a
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Number of acres to be sold	20
Number of acres owned	140
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Durable Manufacturing Facility
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets held for sale | $	$ 470

XML

FAIR VALUE MEASUREMENTS - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Assets
Cash and cash equivalents	$ 13,728	$ 26,111
Level 1 | Estimated Fair Value
Assets
Cash and cash equivalents	13,728	26,111
Level 3 | Carrying Amount | Finance leases
Liabilities
Debt	8,178	8,289
Level 3 | Estimated Fair Value | Finance leases
Liabilities
Debt	8,418	8,437
Level 2 | Carrying Amount | Term Loan
Liabilities
Debt	118,995	119,303
Level 2 | Estimated Fair Value | Term Loan
Liabilities
Debt	$ 95,196	$ 95,442